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Abstract 
Development of Novel Energy-based Musculoskeletal Therapies 
by 
Devante Aaron Horne 
 
Back pain is the most common musculoskeletal condition, affecting 80% of Americans at 
some point in their lifetimes. Intervertebral disc (IVD) pathologies, such as annular tears and 
herniated discs, are the most common source of low back pain and account for more than 40% of 
cases. Current treatment options, including discectomy and intradiscal injections, involve invasive 
procedures and are limited to short-term symptom relief without repairing damaged IVDs. This 
dissertation explores the stimulatory effects and dose-response relationships of low-intensity 
pulsed ultrasound (LIPUS) and pulsed electromagnetic fields (PEMF), with the goal of advancing 
the development of these energy-based therapies for the noninvasive treatment of low back pain. 
Towards this goal, this dissertation is broken into 4 studies. In the first study, we demonstrate the 
technical feasibility of targeted, noninvasive delivery of acoustic energy to rat-tail IVDs and 
evaluate gene expression changes in injured IVDs in response to LIPUS exposure. We found that 
LIPUS exposure regulates extracellular matrix and inflammatory gene expression in rats with 
increased pro-inflammatory gene expression. In the second study, we design, fabricate, 
characterize, and validate an in-vitro LIPUS exposimetry system for delivering uniform acoustic 
energy to cells while removing potentially confounding factors including beam reflections and 
sample heating. We demonstrate that far-field LIPUS exposure upregulates collagen synthesis in 
annulus fibrosus cells and is equivalent to growth factor treatment. In the third study, we present 
the use and validation of design of experiments (DOE) for LIPUS parameter exploration, response 
 viii 
prediction, and optimization. We discovered that pulse repetition frequency is the most significant 
factor for modulating catabolic and pro-inflammatory gene expression while peak intensity is most 
significant for modulating anabolic gene expression, and that both factors interact with treatment 
duration to influence extracellular matrix gene expression in inflammatory annulus fibrosus cells. 
In the last study, we show that magnetic nano-bone substitutes (MNBS) synergize with PEMF to 
stimulate in-vitro osteogenesis. We found that the combination of PEMF and MNBS accelerates 
osteogenesis by stimulating early alkaline phosphatase activity and increasing mineralization over 
time in mesenchymal stem cells. Collectively, the work presented in this dissertation represents 
significant contributions to the development of two novel energy-based therapies for painful spine 
conditions. These findings will motivate the use of noninvasive, biologically active treatments for 
repairing damaged IVDs and alleviating low back pain. 
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1 Introduction 
1.1 Clinical Motivations 
Low back pain (LBP) is one of the most significant non-lethal medical ailments in society, 
affecting 80% of the population at some point in their lifetime [1]. Intervertebral disc (IVD) 
pathologies, including tears in the annulus fibrosus and disc herniation, are the most common 
source of LBP, accounting for more than 40% of cases [2]. Current LBP treatments begin 
conservatively with pain management through physical therapy and medication and may advance 
to invasive interventions including surgical removal of the disc and segmental fusion [3]. For less 
severe herniation cases, the standard treatment is discectomy, or surgical removal of the protruding 
herniation tissue.  Discectomy is an effective therapy for pain relief in patients suffering from 
sciatica due nerve impingement. However, removing a portion of the protruding nucleus pulposus 
leaves behind a hole in the annulus which likely contributes to the high re-herniation rates (up to 
21%) and persisting post-operative LBP [4, 5]. Oftentimes, surgeons opt to leave the annular defect 
to heal on its own; however, the IVD has limited healing capacity related to it being sparsely 
cellularized and having a poor blood supply. Restoration of the damaged annulus fibrosus tissue 
may prevent further progression of disc herniation; however, there is no effective treatment to 
repair annulus fibrosus damage that effectively promotes tissue regeneration and restores IVD 
biomechanics [6]. There is a clinical need for a more effective and noninvasive treatment for 
annulus fibrosus repair. In particular, mechanical stimulation of IVD cells is a potential therapeutic 
modality that could be used to stimulate local extracellular matrix synthesis at the injury site. It is 
well known that IVD cells and tissue respond to mechanical stimulation by increasing 
proteoglycan and collagen synthesis [7-9]. However, a restorative disc therapy would rely on some 
remaining viable disc tissue, and therefore may not be effective in cases of severe IVD 
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degeneration which may ultimately require spinal fusion. The goal of spinal fusion is to stimulate 
the vertebrae to fuse into a rigid, immovable column of bone; however, in some cases the bones 
do not properly fuse, allowing for continued joint motion and causing pain, and require a second 
surgery. Due to high pseudarthrosis rates, there is an increased interest in the development of 
adjuvant therapies to improve the successful fusion rates. Various techniques, including bone 
grafts loaded with osteoinductive proteins or stem cells, have shown some success in increasing 
fusion rates, but with limited efficacy and low efficiency. 
The primary focus of this research is the investigation of the targeting ability and dose-
response metrics for low-intensity pulsed ultrasound for stimulating annulus fibrosus repair.  In 
addition, we evaluate the synergistic effects of pulsed electromagnetic fields and magnetic 
nanoparticles for stimulating spinal fusion. 
1.2 Intervertebral Disc Structure and Function Overview 
The IVD is an articulating, load-bearing structure between the vertebral bodies of the spine. 
In the center of the disc is the nucleus pulposus (NP); this soft, proteoglycan rich tissue imbibes 
water and provides compressive resistance. The NP is surrounded the stiffer annulus fibrosus (AF), 
composed of lamellae of collagen fibers which accounts for its tensile strength. Between the IVD 
and each vertebral body are the cartilage endplates which serve as barriers for nutrient and waste 
exchange between the IVD and vertebrae. While the etiology of LBP is not fully understood, IVD-
related pathologies account for a significant portion of LBP cases [2, 3, 5].  
1.2.1 Tissue Structure and Biomechanics 
The intervertebral disc is a ligamentous tissue, connecting adjacent vertebral bodies, and 
serves to support and dissipate both tensile and compressive loads while concurrently providing 
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flexibility by allowing multiaxial spinal motion. The structure of the three primary regions of the 
IVD are closely related to their biomechanical function.  
In the center of the IVD is the NP, a gel-like structure with an extracellular matrix similar 
to cartilage, containing mostly proteoglycans in addition to randomly organized collagens, and 
radially oriented elastin fibers [10]. The extracellular matrix (ECM) of the NP is rich in 
proteoglycans containing many sulfated glycosaminoglycan chains that are negatively charged, 
causing the NP to imbibe water and create a swelling pressure in the disc and allowing the disc to 
maintain its height and resist compressive loads. The water content of healthy discs is high 
(80 – 88%), helping to resist compression during physiological loading which ranges from 
0.4 – 2.3 MPa [11, 12]. 
Surrounding the NP is the AF, a lamellar structure comprised of layers of collagen fibers 
acting as a vessel wall supporting the radial swelling pressure of the NP. The AF consists of 15 - 25 
concentric lamellae in which collagen fibers are arranged at alternating angles of ± 35° from the 
end plate [13], allowing the disc to withstand tensile loads during bending and twisting of the 
spine. In addition, the inter-lamellae space consists of water-binding proteoglycan aggregates that 
interact with the collagen fibers and aid the AF in resisting circumferential tension when the NP 
expands under axial compressive loading [14]. Regions of the AF differ based on structural and 
cellular variation. The outer layers are composed mostly of highly organized type I collagen fibers, 
making it more fibrous and resistant to tensile loads. In contrast, the inner AF (or transition zone) 
is composed mostly of type II collagen and proteoglycans, making it more fibrocartilaginous and 
resistant to high hydrostatic pressure from the NP. 
Between the IVD and each vertebral body is a thin cartilage end plate (CEP) which serve 
as a barrier through which nutrients and waste are diffused between the vertebral body and the 
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disc. In addition, the CEP, which boarders the NP and the inner AF, serves to constrain the 
pressurized NP superiorly and inferiorly as well as to distribute the hydrostatic pressure from the 
NP into the vertebrae. While the CEP is avascular, its permeability is thought to impact disc cell 
health as diminished permeability can decrease transport between the NP and vertebral capillaries 
[15, 16]. 
1.2.2 Cellular Structure and Function 
The ECM network of the IVD, which provides its mechanical characteristics, is synthesized 
and maintained by a sparse population of cells. The specialized cell types within the disc contribute 
to the structure and function of the tissue. This dissertation primarily focuses on AF cells. 
The AF cell phenotype is fibroblast-like, highlighting the morphology and propensity to 
synthesize type I collagen. AF cells assume a flattened, spindle-shaped (elongated) morphology, 
aligning with collagen fibers [17] forming the AF lamellar structure. The AF-cell morphology and 
phenotype correlates with the structural gradient present in the AF tissue from outer AF to inner 
AF. The average AF-cell density in human discs is 9 x 106 cells/cm3, with lowest density near the 
NP and increasing density towards the outer annulus [18, 19]. Compared to cells of the inner AF, 
outer-AF cells are more elongated with interconnected processes [20], tend to align more with the 
lamellae [19], and are more fibroblastic while inner AF cells are more chondrocyte-like [20]. AF 
cells can be distinguished from NP cells by their higher collagen I: collagen II ratio, higher 
collagen I: proteoglycan ratio, and expression of collagen V [18]. 
The NP cell phenotype is chondrocyte-like, assuming a more spherical shape and greater 
expression of aggrecan than type II collagen. The average NP-cell density in humans is less than 
half that of the AF at 4 x 106 cells/cm3 [21]. 
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CEP cells are similar to articular chondrocytes both in their rounded morphologically as well 
in expression profile for proteoglycans, type II collagen, and type I collagen. The CEP is also 
sparsely cellular, with an average density of 15 x 103 cells/cm3 [22]. 
1.2.3 Molecular Structure and Function 
The IVD extracellular matrix is a highly specialized framework of macromolecules that 
attract and contain water. The major macromolecules of the IVD are type I collagen, type II 
collagen, and proteoglycan [23], and the ratios of their expression vary among the NP, AF, and 
CEP tissues [24]. The fibular collagens align to form the lamellae in the AF and provide tensile 
strength while the proteoglycans accumulate primarily in the NP creating a net negative charge 
that attracts water and provides resistance to compressive loads [25].   
Regulation of the healthy IVD involves a balance of the synthesis and degradation of these 
matrix molecules is vital for the integrity of the IVD [23]. Moreover, repair of damaged IVD is a 
highly regulated process controlled by a variety of molecules including growth factors, cytokines, 
and matrix metalloproteinases (MMPs).  Among various metabolic enzymes present in the IVD, 
matrix metalloproteinase -1 (MMP1) and matrix metalloproteinase -13 (MMP13) are the primary 
enzymes that are capable of cleaving interstitial collagen molecules. Insufficient regulation of 
these enzymes may lead to excess matrix degradation, offsetting the normal balance and leading 
to pathological conditions including the initiation and progression of IVD degeneration. 
1.3 Intervertebral Disc Damage and Degeneration 
Degeneration of the IVD is a cascade of events related to changes in disc cells, the ECM 
regulation, and the biomechanics of the disc. Each of these degenerative changes are related, 
creating a degenerative cycle [26]. Disc degeneration begins in early adulthood and has been 
observed as early as the second decade of life [27]. As degeneration progresses with age, metabolic 
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balance is disrupted, proteoglycan concentration decreases, and with that, disc height is reduced 
due to dehydration. Loss in disc height further exacerbates biomechanical changes related to the 
abnormal loading and depressurization of the NP and increased strain on collagen fibers of the AF, 
leading to AF tears and fissures and ultimately protrusion (i.e. herniation) of the NP [28]. Age-
related degeneration may be accelerated by traumatic failure of the AF due to acute injury caused 
by overloading, provoking herniation. Additionally, damage and over-mineralization of the CEP 
is thought to reduce permeability and disrupt nutrient exchange leading to cell death [15]. 
Moreover, disruptions to the CEP affect loading distributions, further amplifying the magnitude of 
stress concentrations and local instability [29].  Age-related changes within the disc structure 
including decreased availability of nutrients, cell senescence, matrix disorganization, 
accumulation of pro-inflammatory cytokines, and increased catabolism are thought to contribute 
to complex etiology of pathologic degeneration. 
Disc degeneration can be diagnosed via noninvasive imaging methods, with magnetic 
resonance (MR) imaging being the current gold standard diagnostic method. T1 and T2 weighted 
MR imaging can clearly show pathological features including disc bulges, herniation, and nerve 
impingement [30]. In addition, sequences such as T1-𝝆 [31] have been used to detect advanced 
degeneration properties including dehydration, decreased disc height, altered fat content, annular 
defects, Modic changes, and changes in the CEP [32]. Discography is standard diagnostic method 
for identifying discogenic pain and involves injecting contrast agent into the disc during 
radiographic imaging. Discography is a controversial technique due to concerns about the 
sensitivity and subjectivity of the test as well as the possibility of increased degeneration risk due 
to mechanical disruption of the AF with needle puncture [33].  
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1.3.1 Structural and Biomechanical Changes 
Disc related low back pain may be associated with herniation of the NP due to mechanical 
failure of the AF [34, 35], typically occurring due to progressive degeneration or acute injury. In 
the degenerated IVD, mechanical integrity is compromised as proteoglycan content decreases 
while collagen denaturation increases. These degenerative changes lead to abnormal loading and 
eventual tearing of the AF, opening the door for mechanical failure of the IVD. 
Tissue-level changes during disc degeneration include loss of disc height due to desiccation 
of the NP, loss of AF layers, tearing and delamination of the AF, and protrusion and herniation of 
the NP. Loss of disc height is thought to be related to CEP damage and loss of porosity, reducing 
the exchange of nutrients and leading to cell death or senescence [15] and eventually a reduction 
in the production of proteoglycan molecules responsible for attracting water into the disc and 
creating the swelling pressure giving the disc its height [36, 37]. Decreased swelling pressure 
decreases the weight-bearing capacity of the disc and reduces the disc height, forcing the AF to 
bear an abnormal load [38]. 
Along with increased biomechanical stress, changes in ECM metabolism contribute to the 
loss in the number of distinct AF layers as the distribution of collagen fiber bundles become 
irregular, with buckling of fibers [39, 40]. With a dehydrated NP and diminished AF lamellar 
structure, the normal anisotropic characteristics of a healthy disc are reduced, resulting in 
insufficient load-bearing capacity in response to increased axial compression caused by 
depressurization of the NP [41], and leading to abnormal deformation and fiber breaks in the AF. 
The lamellar structure in the healthy AF is an efficient mechanism for arresting crack propagation. 
However, with depressurization of the NP and increased AF shearing, delamination may occur, 
resulting in mechanical failure of the AF. The greatest stresses during loading are observed in the 
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posterolateral region of the disc, and consequently, this is the most common location for the 
development of annular tears, fissures, protrusions, and herniations [20]. 
1.3.2 Cellular and Molecular Changes 
Structural and biomechanical changes in the degenerative disc are likely the result of and 
may also contribute to cellular and molecular changes in the disc. In addition to the gradual loss 
of proteoglycans and water content in the ECM of the NP, there are also significant changes in the 
phenotype of NP cells from a chondrogenic to a more fibrotic phenotype [39]. Degenerated NP 
cells synthesize less proteoglycans and instead synthesize collagens. Moreover, it is type I collagen 
that is upregulated in lieu of type II collagen [39]. The degenerative microenvironment including 
abnormal loading resulting from a CEP damage, depressurization of the NP, and disorganization 
of the collagen network also affects AF cell phenotype and expression profile. 
Changes in cell phenotype in degenerative discs are associated with changes in the disc 
microenvironment including decreased diffusion of nutrient and waste products, reduced cell 
viability, accumulation of apoptosis debris, upregulated catabolic enzyme activity, accumulation 
of degraded matrix macromolecules, mechanical fatigue failure of matrix components, and an 
imbalance of macromolecule ratios and distribution [42].  
The degenerative disc microenvironment is acidic due to lactic acid accumulation. 
Decreased permeability associated with damage to the CEP and other disc tissues may increase 
hypoxia and reduce glucose availability in the disc to 0.5 – 5.0% oxygen and < 5 mmol/L glucose, 
respectively [43]. This subsequently leads to the production of lactic acid due to an increase in 
anaerobic glycolysis in this hypoxic environment [44]. The lactic acid accumulates due to limited 
transport, lowering disc pH to < 6.8 or as low as 5.7 in severe cases [45]. This cyclic response 
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gradually worsens and leads to reduced cell viability, increased matrix degradation, and 
contributes to the development of a pro-inflammatory environment.  
While a comprehensive understanding of the mechanisms underlying chronic low back pain 
remain unclear, many symptoms are attributed to chronic inflammation, supported by several 
inflammatory mediators [46, 47]. Cells from painful and degenerated discs have been shown to 
produce pro-inflammatory cytokines including tumor necrosis factor α (TNFα), Interleukin-1 
(IL1), and Interleukin-6 (IL6), stimulating disc cells to release additional inflammatory and 
catabolic molecules [48]. The accumulation of inflammatory cytokines can increase pain and 
downregulate ECM synthesis slowing, or even inhibiting, regeneration in the disc [23]. In 
particular, IL-1α and IL-1β are thought to play a major role in the recruitment of other 
inflammatory mediators like TNFα and IL6 [49]. These cytokines activate NF-κβ signaling, which 
further promotes IL6 and IL17 expression within the disc [48]. Moreover, this pro-inflammatory 
feedback loop stimulates the catabolic degradation of the collagen matrix via the upregulation of 
proteases including MMP2, MMP13, and A Disintegrin And Metalloproteinase with 
Thrombospondin Motifs (ADAMTs), leading to an imbalance in matrix metabolism towards a 
degenerative phenotype [23, 48]. 
This imbalance in matrix metabolism is a key hallmark of disc degeneration, where 
overexpression of these proteases leads to degradation of the ECM, compromising the mechanical 
integrity of the disc and exacerbating the degeneration cycle. Therefore, it is imperative that matrix 
metabolic balance is restored to stop or slow progressive disc degermation and subsequent 
mechanical failure of the AF which may lead to herniation, or displacement of disc material beyond 
the normal perimeter of the IVD [50]. 
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1.4 Treatment of Damaged Intervertebral Discs 
1.4.1 Surgical Intervention 
The standard treatment for IVD herniation is discectomy, or surgical removal of the 
protruding herniation tissue. Discectomy is an effective therapy for pain relief in patients suffering 
from sciatica due to nerve impingement. However, removing portion of the protruding NP leaves 
behind a hole that is classified as an annular defect, which likely contributes to the high re-
herniation rates (up to 21%) and persisting postoperative LBP [4, 5]. Options for closing AF 
defects include suturing and insertion of tissue engineered scaffolds or an annular prosthesis. These 
therapies are limited in clinical evidence of long-term safety and efficacy [4] and have been 
suggested to further aggravate existing AF damage due to their invasive nature [40].  
Oftentimes, surgeons opt to leave the annular defect to heal on its own; however, the AF 
has limited healing capacity related to it being sparsely cellularized and having a poor blood supply 
[44, 51]. Due to characteristically low cell density and limited exchange, it is difficult for even 
healthy discs to repair damage without intervention. Several animal studies have demonstrated that 
this results in partial healing of annular defects occurring only in the outer annulus, forming a 
granulation tissue plug and promoting neovascularization and nerve ingrowth [4, 34, 52-54]. AF 
healing structure varied dramatically depending on the technique used to induce injury, oftentimes 
resulting in a thin layer of tissue with significantly reduced strength [55].  
Lumbar fusion is indicated in severe cases of degenerative instability where there is no 
pain relief with aggressive conservative treatment [56]. Fusion is usually achieved by the removal 
of disc tissue and the insertion of an autogenous bone graft or other osteoinductive material over 
the decorticated vertebral surfaces [57]. However, fusion procedures are not always effective, with 
pseudarthrosis rates increasing over time (41 - 81%), likely due to poor patient selection [58-62]. 
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Moreover, there are many risks associated with spinal fusion, including the high likelihood of 
upper level degeneration and postoperative instability due to increases in stress on adjacent intact 
segments [63]. 
Many surgical interventions, including discectomy and spinal fusion, address immediate 
symptoms but fall short of solving fundamental causes of degeneration and pain. Currently, there 
is no effective treatment to repair AF damage that effectively promotes tissue regeneration and 
restores IVD biomechanics to provide a clinically significant therapeutic benefit [6]. 
1.4.2 Tissue Engineering 
The primary aim of IVD tissue engineering is to restore the structure and function of the 
disc. Emerging biologic therapies include the delivery of some combination of biomaterials [6, 
64], cells [65], growth factors [66], or other stimuli - including the delivery high frequency 
mechanical stimulus - to replace or regenerate the ECM [67]. Therapies that are condition- and 
patient-specific may produce more favorable outcomes. Discs with mild-to-moderate degeneration 
with a sufficient viable cell density and nutrient flux may be candidates for treatment with 
molecular therapies such as growth factor injections, gene therapy, or stem cell injections [65, 68]. 
On the other hand, more severely degenerated discs may be too damaged to respond to biological 
therapies and may require complete removal and replacement of the disc or fusion of the segment. 
While there have been many recent advances made in biomaterials, growth factors, and gene 
therapy [69], the primary limitation of these therapies are sustainability and biological safety 
concerns associated with ischemic and pro-inflammatory conditions in the IVD [23, 68]. Many of 
these therapeutic mechanisms are based on increasing the metabolic demand of the resident cells, 
which may be insurmountable in a damaged disc with diminished nutrient supply [68]. 
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Specifically, while growth factors have been shown in several studies to upregulate matrix 
synthesis [70-72], nutrient demand is also increased at a rate that cannot be sustained.  
1.4.3 Therapeutic Ultrasound for Stimulating Intervertebral Disc Repair 
Discogenic back pain presents a major public health issue, with current therapeutic 
interventions limited to short term symptom relief without providing regenerative remedies for 
diseased IVDs. Further, many of these interventions, including discectomy and intradiscal 
injections, are invasive and can diminish the biomechanical integrity of the IVD [5, 73]. This has 
created a significant unmet clinical need for a noninvasive and biologically active treatment for 
IVD damage and back pain.  
Recently, the potential of therapeutic ultrasound (US) for stimulating tissue regeneration 
has been evaluated. It is possible to deliver focused ultrasound energy to deep tissues, such as the 
IVD, while sparing skin, fat, and muscle tissues along the way [74]. In particular, low-intensity 
pulsed ultrasound (LIPUS), offers a potential treatment option, where ultrasound mechanical 
energy targeted to a damaged IVD may produce favorable biological response to enhance IVD 
repair and stall or even reverse IVD degeneration in a completely noninvasive manner.  
LIPUS is a low energy, pulsed pressure waveform that primarily delivers mechanical 
energy, rather than thermal energy, to target tissues. LIPUS systems remove the thermal 
component, which is the primary mechanism of high intensity, continuous wave systems 
commonly used in tissue ablation and hyperthermia applications [75]. LIPUS mechanical energy 
in the kilopascal (kPa) range [76, 77] is transmitted into tissues as acoustic pressure waves. The 
mechanical signal is detected by integrin mechanoreceptors on the surface of the resident cells and 
is transduced into a biochemical response, ultimately triggering downstream effects, such as 
alterations in gene and protein expression [121]. Mechanical stimulation of the IVD cells may be 
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a nontoxic alternative that could be used alone or in conjunction with other forms of biochemical 
treatment. It is well known that IVD cells respond to mechanical stimulation by increasing 
proteoglycan and collagen synthesis [7-9]. 
There are five primary parameters commonly defined in LIPUS systems: transducer 
operating frequency (MHz), average acoustic intensity (mW/cm2), duty (%), pulse repetition 
frequency (kHz), and treatment duration (min). LIPUS technology typically operates at low 
acoustic intensity values (≤ 100 mW/cm2) and transmits from low-frequency acoustic sources 
(≤ 1.5 MHz) using short duty cycles (≤ 20 %) and a pulse repetition rate around 1 kHz. These 
sonication parameters are significantly different from those applied in thermal therapy 
applications, which rely on acoustic intensities that are 1 - 4 orders of magnitude greater than 
LIPUS. 
The majority of LIPUS studies have focused on bone regeneration [78-81], and have shown 
accelerated healing of bone fractures, including non-union fractures, possibly due to stimulating 
neovascularization at the fracture site and promoting enhanced endochondral ossification [78, 82, 
83]. Interest in LIPUS has expanded in recent years with evidence that LIPUS may also stimulate 
repair of soft tissues.  
LIPUS is a widely used and accepted modality in physiotherapy for the treatment of soft 
tissue injuries, likely stimulating increased perfusion to the injury site [84]. In addition, it is a good 
candidate for IVD tissue repair as it is capable of selectively targeting the human IVD tissue while 
sparing superficial tissues. It has been established that LIPUS stimulates cell proliferation and 
matrix synthesis in various cell types inclusive of human IVD cells [40, 85]. LIPUS has been 
shown to enhance the mechanical properties of acutely injured collagenous tissues including 
tendon, ligament, and cartilage likely due to upregulation of collagen synthesis and enhanced 
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alignment of collagen fibers [86-90]. Several studies provide insight into signaling pathways that 
mediate LIPUS-induced effects in IVD cells. LIPUS mechanical stimulus is detected by integrins 
on the cell surface which cluster to form focal adhesions, and in NP cells, this activates the 
FAK/PI3K/Akt pathway and leads to downstream gene expression of important matrix proteins 
such as aggrecan, and type II collagen [121]. LIPUS exposure stimulates the matrix metabolism 
of AF cells through the upregulate of TGF-β1 and ERK pathways [40]. In addition to promoting 
anabolic expression, downregulation of TNFα and other pro-inflammatory factors demonstrates 
that LIPUS may affect inflammatory pathways as well [91, 92].  
Although LIPUS has been shown to have beneficial therapeutic effects in IVD cells, the 
are several limitations and challenges. Many experimental devices have been developed and used 
to for preclinical assessment of therapeutic US [93-97]. These typically include US transducers 
directed at cells cultured in a polystyrene cell culture plate in the acoustic near-field. This and 
similar configurations exhibit major limitations due to the presence of several acoustic phenomena 
related to the interaction between the acoustic wave and the plastic cell culture plate and lead to 
near field interference, standing wave formation, and uncontrolled temperature elevation [98]. An 
additional limitation is the lack of knowledge about dose-response relationships. Although 
researchers have demonstrated various LIPUS-induced effects, the efficacy of LIPUS is debated 
[99] and the mechanism of LIPUS modification of cell behavior is not well understood. While the 
majority of published work has focused on the established exposure settings for bone healing, there 
is currently no clear understanding of which LIPUS parameters cells are most sensitive to nor 
which parameter combination is most effective for maximizing desirable effects. However, there 
are limited parametric studies that have shown dose dependent LIPUS effects including increased 
proteoglycan synthesis in AF cells treated at higher intensities and for more days [67, 85, 100]. 
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The principal goal of LIPUS therapy is to modulate changes in IVD matrix metabolism 
that in a way that alters the degeneration-synthesis balance in favor of synthesis. Additional 
preclinical investigations are necessary for identifying an optimal dose for patient selection as 
researchers seek to advance this technology into the clinic. However, the advancement of LIPUS 
technology to the clinic has been limited thus far, likely due to the lack of reproducibility in in-
vitro studies, limiting the transferability into in-vivo models. To overcome this challenge, there is 
a need for a reliable in-vitro LIPUS exposimetry system that delivers uniform acoustic energy 
while eliminating standing wave formation and allowing accurate temperature control. In addition, 
a comprehensive exploration of LIPUS parameters is required to identify optimal dosing and 
therapeutic delivery protocols to generate favorable bioactivity within the IVD that can increase 
matrix production, stimulate remodeling, and ultimately stop or reverse the pain cascade.   
It can be expected that the success of a LIPUS therapeutic may depend on the extent of 
degeneration in a particular disc. While mildly degenerated discs that still contain viable cells may 
be salvageable, discs with severely damaged tissues or unhealthy cells may not respond to any 
therapeutic. Ultimately, the most severely degenerated and painful discs may have lost much of 
their basic structure and need to be surgically removed to make way for vertebral fusion.  
1.4.4 Pulsed Electromagnetic Fields for Stimulating Spinal Fusion 
Spinal fusion is recommended for the restoration of mechanical stability in the spine in 
cases of degenerative disease that are associated with severe pain by the removal of disc tissue and 
the formation of a bone bridge in the intervertebral space. The process of spinal fusion is 
mechanistically similar to bone fracture regeneration as it includes an inflammatory stage, callus 
formation stage, and a bone remodeling phase [101]. Bone grafts are widely used to promote 
vertebral fusion, and the gold standard procedure involves the placement of an autogenous bone 
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graft between the vertebrae. However, autogenous grafts are limited by increased surgical time, 
significant donor-site morbidity, and high rates of pseudarthrosis [60]. High rates of pseudarthrosis 
have be addressed by the use of bone graft substitutes including collagen, calcium phosphate, 
tricalcium phosphate, and demineralized bone that are engineered to be highly osteoinductive, 
osteoconductive, and osteogenetic [102, 103]. Other techniques that have shown some success in 
increasing fusion rates include the use of bone grafts loaded with osteoinductive proteins such as 
recombinant human bone morphogenetic protein-2, bone marrow aspirates, mesenchymal stem 
cells, or platelet-rich plasma [104, 105]. Recently, novel technologies such as gene therapy and 
tissue engineered biomaterials have shown promising results in animal studies [106]. While many 
of these methods have shown to accelerate fusion, many are plagued by lack of clinical outcomes 
data, high cost of procedure, and low efficiency [60, 107].  
Pulsed Electromagnetic Field (PEMF) stimulation therapies have shown success in the 
clinic as a noninvasive treatment modality for promoting bone healing [108, 109], including 
increased fusion rates for cervical and lumbar fusions in high-risk patients [110]. PEMF devices 
such as the SpinalSTEMTM device (Orthofix Medical Inc., Lewisville, TX, USA) have shown high 
clinical success rates and is FDA approved for cervical and lumbar spinal fusion.  
PEMF signals are commonly defined by four main parameters: waveform type, frequency, 
intensity, and pulsing scheme. Most PEMF systems produce low frequency a sine or square waves 
in the range of 1 Hz to 10 kHz and relatively low magnetic field intensities on the order of 0.2 – 
0.4 T. For example, the Physio-Stem waveform (Orthofix Medical Inc.) consists of a square wave 
with a 25% duty cycle, 3.85 kHz frequency, 15 Hz burst frequency, and slew rate of 10 T/s [111]. 
Clinical studies utilizing comparable PEMF signals have validated the effectiveness of PEMF 
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devices, showing these signals to be safe and effective in improving fusion rates as an adjective 
treatment [110] as well as promoting fusion in patients with established pseudarthrosis [112].  
Considering the strong evidence for the osteoinductive properties of bone graft substitutes 
such as tricalcium phosphate [113-115] as well as PEMF signals, there is increasing interest in the 
investigation of their potential to synergize to enhance bone healing. 
1.5 Overview of Chapters 
The central objective of this dissertation is to contribute to the development of two novel 
energy-based therapeutic modalities for treating IVD pathologies and alleviating low back pain. 
Towards this goal, the following chapters are broken down as follows:  
While there are promising in-vitro studies demonstrating the effects of LIPUS stimulation 
on cultured IVD cells, there is a lack of published work demonstrating the effects of LIPUS in an 
in-vivo model of IVD degeneration. Chapter 2 demonstrates the technical feasibility of delivering 
targeted LIPUS energy to a rat-tail IVD and evaluates LIPUS-induced effects on gene expression 
in rat-tail IVDs with acute injury. A LIPUS exposimetry system was fabricated and characterized 
to verify the delivery of acoustic energy to the center of the rat-tail IVD. Discs were injured using 
an established stab-incision model for disc degeneration then treated with LIPUS for 20 minutes 
daily for five days. IVDs treated with LIPUS demonstrated significant upregulation of type II 
collagen and downregulation of TNFα gene expression. The results of this study indicate technical 
feasibility of targeted delivery of ultrasound to a rat-tail IVD for studies of LIPUS biological 
effects and also suggest that LIPUS may modulate gene expression of cells in inflammatory 
conditions. 
The results of this in-vivo work lead to increased interest in understanding dose-response 
relationships between LIPUS and IVD cells. In preparation for a comprehensive parametric 
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analysis, we identified a need for a fully characterized and validated in-vitro LIPUS system that 
mitigates the confounding factors often observed in conventional in-vitro LIPUS configurations. 
This need inspired the work presented in Chapter 3, which describes the development and 
validation of a far-field LIPUS exposimetry system for stimulating matrix synthesis in bovine AF 
cells. We designed and fabricated a LIPUS exposimetry system that mitigated previously found 
problems with nonuniform near-field exposure, beam reflections, and temperature elevation within 
target samples. When bovine AF cells were exposed to far-field LIPUS, sample heating was 
minimal and collagen content was increased by 2.6-fold compared to the control and was 
equivalent to BMP-7 growth factor treatment. The results of this study support the gene expression 
results in Chapter 2 and suggest that LIPUS is a potential noninvasive therapeutic for stimulating 
IVD repair. 
Motivated by the LIPUS-induced effects observed in Chapter 2 and following the successful 
development and validation of a relevant preclinical LIPUS system as described in Chapter 3, 
Chapter 4 explores the dose-response relationships between LIPUS and ECM gene expression in 
inflammatory AF cells. In this chapter, we present the use and validation of Design of Experiments 
(DOE) for LIPUS parameter exploration, response prediction, and dose optimization. We modeled 
the effects of LIPUS peak intensity, pulse repetition frequency (PRF), and treatment duration, 
simultaneously, on ECM gene expression in inflammatory AF cells using a screening DOE. We 
found that LIPUS exposure significantly downregulated MMP1, MMP13, and IL6 gene expression 
but did not significantly affect COL1 gene expression, and that PRF was the most significant factor 
for modulating MMP1, MMP13, and IL6 expression, while peak intensity was most significant for 
modulating COL1 expression. Validation experiments demonstrated that DOE-predicted 
responses were 12 - 86% different from actual responses. The results of this study demonstrate 
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LIPUS-induced anti-catabolic and anti-inflammatory activity in AF cells and illustrate the 
capability and benefits of implementing DOE in the context of therapeutic ultrasound optimization. 
Chapters 2 – 4 explore the use of LIPUS for stimulating IVD repair; however, in severe cases 
where IVD degeneration has progressed beyond repair, spinal fusion may be necessary. Due to 
high pseudarthrosis rates, there is increased interest in the development of adjuvant therapies for 
improve the rate of successful bone fusion. Chapter 5 describes a study exploring how magnetic 
nanoparticles synergize with pulsed magnetic fields to stimulate osteogenesis in-vitro. Intrinsically 
magnetic nano-bone substitutes (MNBS) were added to human mesenchymal stem cell culture and 
cell viability, alkaline phosphatase activity, mineralization, and osteogenic gene expression in the 
presence and absence of PEMF were quantified for up to 10 days. MNBS attached to the surface 
of and were internalized by human mesenchymal stem cells without impacting cell viability. 
PEMF combined with MNBS accelerated the induction of osteogenesis demonstrated by an early 
peak in ALP activity compared to all other treatment groups. Moreover, PEMF combined with 
MNBS demonstrated continuously increasing mineralization over time. The results of this study 
demonstrate the synergistic effects of PEMF and MNBS on osteogenesis and highlight a potential 
combination therapy for improving spinal fusion success rates. 
Chapter 6 summarizes the conclusions of this dissertation and suggests areas for future 
work. In particular, this chapter discusses the use of response surface methodology to expand upon 
the DOE models generated in Chapter 4, and also discusses the development of an animal model 
to further explore whether the findings in Chapter 5 translate to an in-vivo model of spinal fusion. 
Chapter 2 is a published conference proceedings article in the Proceedings of SPIE, and 
Chapter 3 is a published research article in Biomedical Physics and Engineering Express. 
Chapter 4 represents a body of work that is currently being expanded upon and will be submitted 
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as a manuscript to Ultrasound in Medicine and Biology in June 2020. Chapter 5 is a manuscript 
that was recently submitted and is currently in review for publication in Tissue Engineering, 
Part A. 
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2 LIPUS Regulates Type II Collagen and TNFα Expression in Injured Rat-tail Discs 
The content of this chapter is published as a conference proceedings article in the Proceedings of 
SPIE with the following citation: Horne D, Jones P, Salgaonkar V, et al (2017) Low Intensity 
Pulsed Ultrasound (LIPUS) for the treatment of intervertebral disc degeneration. SPIE BiOS. 
SPIE, pp 1006609–7. doi: 10.1117/12.2255761 
2.1 Introduction 
Discogenic back pain (DBP) is one of the most significant non-lethal medical ailments in 
society. The American Academy of Orthopaedic Surgeons estimates that more than 6 million 
people are diagnosed with DBP annually, with 80% of the US population experiencing DBP 
sometime in their lives. The treatment costs of lower back pain exceed $27 billion annually, but 
the societal cost of the disease exceeds $86 billion [3, 116-118]. The intervertebral disc (IVD) is 
an articulating, load-bearing structure between the vertebral bodies of the spine. In the center of 
the disc is the nucleus pulposus (NP); this proteoglycan-rich structure imbibes water and provides 
compressive resistance. Surrounding the NP are lamellae of collagen fibers called the annulus 
fibrosis (AF) which accounts for tensile strength. Between the IVD and each vertebral body is the 
cartilage end-plate which serves as a barrier for nutrient and waste exchange between the IVD and 
vertebra. Intervertebral disc degeneration is associated with the loss of extracellular matrix (ECM) 
molecules, resulting in modification in biochemical and biomechanical tissue properties. While 
the etiology of IVD degeneration is unclear, it is suspected that it is the result of metabolic 
imbalance within the tissue [119]. This imbalance may cause a gradual loss of important matrix 
proteins such as aggrecan and type II collagen, which may lead to depressurization of NP and 
breakdown of the AF. Another factor likely related to disc degeneration is cartilage end-plate 
damage which may impair proper nutrient and waste exchange, leading to a loss of cells due to 
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apoptosis. Current therapeutic options for treating discogenic back pain include procedures such 
as discectomy (removing part of most of the disc nucleus) and laminectomy (removing part of the 
bone anatomy), which are largely focused on addressing manifested symptoms (i.e. pain) rather 
than functional causes. The major limitations of these procedures are that they are invasive and 
may actually lead to biomechanical failure and further degeneration. Incidence rates and costs 
associated with biomechanical damage from these interventions are significant, creating a 
significant need for noninvasive alternatives. Recently emerging alternative strategies for treating 
IVD degeneration including cell transplantation, gene therapy, and growth factor injection are 
under investigation. While these options have advantages over invasive surgeries, their primary 
limitations include concerns about sustainability and biological safety. Mechanical stimulation of 
the IVD cells may be a nontoxic alternative that could be used alone or in conjunction with other 
forms of biochemical treatment. 
Low intensity pulsed ultrasound (LIPUS) is a mechanical treatment option that is potentially 
both noninvasive and regenerative. LIPUS is a low energy, pulsed waveform, removing the 
thermal component found at higher intensity, continuous wave systems. LIPUS technology 
typically operates at low acoustic intensity values (30 mW/cm2) and transmits from low-frequency 
acoustic sources (1.5 MHz) using short duty cycles (20%) and a pulse repetition rate around 1 kHz. 
These sonication parameters are significantly different from those applied for heat-induced 
interventions, which rely on acoustic intensities that are 1 – 4 orders of magnitude larger than 
LIPUS. LIPUS has been shown to accelerate healing of cortical and cancellous bone fractures 
[120], including non-union fractures, possibly due to enhanced callus formation and angiogenesis 
near the fracture site [81]. LIPUS is widely used in physiotherapy for the treatment of soft tissue 
injuries, likely stimulating increased perfusion to the injury site [84]. 
 23 
IVD degeneration is known to result from alteration in biosynthesis of proteoglycan (PG) 
and pro-inflammatory cytokines in the disc [119]. It has been established that LIPUS stimulates 
PG and collagen synthesis, and induces an anti-inflammatory and anti-catabolic responses in 
human IVD cells [121]. These LIPUS effects have been shown to be mechanically regulated 
through the FAK/PI3K/Akt pathway [121]. Promoting the synthesis of major ECM proteins and 
reducing inflammatory factors may stall or even reverse the degenerative cascade. While findings 
support the application of LIPUS for repair of IVD damage and degeneration, it is unclear whether 
these LIPUS effects are translatable to an in vivo IVD degeneration model. We hypothesize that 
LIPUS can be applied noninvasively to stimulate favorable biological activity within the acutely 
damaged rat tail IVD. The objective of this research project was to demonstrate the technical 
feasibility of building a LIPUS system that can target the rat tail IVD and apply this setup to a 
model for acute IVD degeneration. 
2.2 Methodology 
2.2.1 Ultrasound exposimetry system 
Ultrasound exposimetry systems were devised and fabricated, following our generalized 
schema (Figure 2.1 a), specific to delivering calibrated and characterized LIPUS to rat tail 
intervertebral discs. Three configurations considered consisted of 2.5 cm diameter PZT4 
transducers (1.0 MHz, f=1; 1.6 MHz, f=3.8; 1.0 MHz planar), mounted water-tight with air-
backing on a 3D-printed assembly, and integrated within a degassed water-filled plastic housing 
with a thin Mylar window marked with central cross-hairs (Figure 2.1 b). The housing is designed 
as an acoustic standoff to place the distal focus, or uniform far-field zone, within the targeted rat 
tail disc and to prevent the influence of transducer heating. The acoustic energy is isolated to a 
single targeted disc and portions of the adjacent vertebral body by selection of a standoff distance 
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which gives an appropriate beam cross-section. Additional isolation was achieved by use of 
peripheral brass reflectors and a custom acoustic absorber placed beyond the target (Figure 2.1 a).   
 
Figure 2.1 Generalized schematic representing the in-vivo LIPUS exposimetry system 
The system was designed for LIPUS delivery with calibrated intensity to rat-tail IVDs (a). LIPUS 
applicators were constructed with various frequencies and focusing (b). 
2.2.2 Acoustic characterizations 
LIPUS applicators were evaluated with comparative beam plot measurements to assess 
whether the systems can deliver LIPUS to the narrow (~1.5 mm x 5 mm) rat tail disc. The planar 
device with a 5 cm standoff provided a more uniform beam of appropriate width (~8 mm) for 
easier alignment and full exposure of the disc (Figure 2.2 a). Partial disc exposure may be 
achievable with focused devices (< 3 mm) (Figure 2.2 b, c). Radiation force observations and 
intensity measurements, with and without insertion of sectioned rat tails ex vivo, were made to 
evaluate whether sufficient intensity could reach the center of the rat tail disc (Figure 2.3). It was 
confirmed that approximately 45% incident energy was delivered to central disc while reducing 
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exposure to significant portions of the adjacent bone and with negligible (< 1°C) temperature 
elevation measured.  
Figure 2.2 Axial beam plots with selected standoff distance marked by vertical line 
Plots are representative of a planar transducer (a) and transducers of different focusing (b and c). 
2.2.3 Rat tail stab model 
A well-characterized and established protocol demonstrates that a single stab incision 
through the rat tail intervertebral disc induces inflammation that mirrors the early stages of IVD 
degeneration [122]. Five three-month-old female Sprague-Dawley rats were used in this study. All 
procedures were approved by the Institutional Animal Care and Use Committee of the University 
of California, San Francisco. Rats were anesthetized and an analgesic (Buprenorphine, 
1.0 MHz, f=1
1.0 MHz planar
1.6 MHz, f=3.8
a
b c
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0.01 mg/kg) was delivered before stab-incisions were administered. Rat tails were sanitized with 
alcohol wipes and betadine topical antiseptic solution. The 3 most proximal discs were selected; 
two to be stabbed and the remaining disc as a control. Under fluoroscopic guidance, a 20-guage, 
short-bevel needle (Fisher Scientific, Cat. No. 305179) was laterally inserted through the disc and 
stopped just before penetrating the outer annulus on the opposite side. The needle was turned 180° 
before fully retracting the needle. Injury to multiple discs does not result in systemic inflammation 
in rats nor does it affect healthy adjacent discs. Female rats were chosen over male rats since 
previous studies have suggested that male rats are more aggressive and may bite the injury site of 
other rats in the cage, potentially affecting results. Relative disc location was marked with a tissue 
pen and verified daily with fluoroscopy prior to LIPUS treatment. 
  
Figure 2.3 Transverse beam plots of acoustic energy passing through rat-tail disc tissue 
Intensity distributions of a 1.6 MHz, focused transducer; without sectioned tail (a) and with 
sectioned tail in beam path (b). 
2.2.4 LIPUS delivery 
LIPUS was delivered shortly following the completion of stab incisions. Five daily LIPUS 
exposures (ISPTA 60 mW/cm2, 200 µs burst, 1 kHz repetition frequency, 20 min duration) were 
a b
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applied to one disc and compared to stab only and normal controls. Acoustic coupling gel was 
applied between the applicator and tail, and a silicone absorber coupled with gel was mounted on 
tail (Figure 2.4) to best reduce standing waves and reflections off of the dorsal surface. Day 1 
exposure was 30 min after injury, and Day 5 sacrifice was 2-3 hours post-LIPUS. 
 
Figure 2.4 Rodent positioning and LIPUS delivery system during treatment 
Caudal vertebral segment of anesthetized rat positioned over center of aperture (a). Ultrasound gel 
and apical absorber secured prior to treatment (b). Assembly uses a 1.0 MHz planar transducer 
with a 5-cm standoff, delivering an 8-mm diameter beam (i.e. FWHM = 8 mm) to the surface of 
the tail (c).  
2.2.5 Histology 
After day 5 treatment, a cohort of rats was euthanized, and motion segments were 
harvested. Discs and adjacent vertebrae were harvested, fixed in formalin, decalcified in formic 
acid, dehydrated, and embedded in paraffin. Sagittal sections were cut through the motion 
segments, perpendicular to the direction of the stab. Sections were stained with Heidenhain’s stain. 
Disc and vertebral morphology were examined at 2X magnification.  
a
b
c
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2.2.6 Measurement of gene expression 
The remaining cohorts of rats were euthanized following day 5 treatment and complete 
discs were harvested and snap frozen in liquid nitrogen. Disc tissue was homogenized, and total 
RNA was extracted using the using Trizol reagent (Life Technologies, Cat. No. 15596026) and 
the RNeasy mini kit (Qiagen, Cat. No. 74104); cDNA was synthesized using iScript reverse 
transcriptase (BioRad, Cat. No. 1708840). The mRNA expression of matrix related (ACAN, 
Col2a1, Sox9) and pro-inflammatory cytokines (TNFα, IL-1β, IL6) were measured by RT-qPCR 
with TaqMan Fast Advance Master Mix (Life Technologies, Cat. No. 4444557) using the BioRad 
CFX96 RealTime Thermal Cycler. Relative gene expression was calculated using the ∆∆Ct 
method and normalized to B2M and the control group. Results were compared using t-tests. P 
values < 0.05 were considered significant. 
2.3 Results 
2.3.1 Stab-induced Morphological Changes 
All control discs appeared to have a rounded nucleus and well-organized collagen lamellae 
in the annulus (Figure 2.5). Stab incisions resulted in depressurization of the disc and reduced disc 
height (Figure 2.5). Stabbed discs displayed an irregularly shaped nucleus and denatured collagen 
fibers that appear lax in the inner annulus. These are all positive signs of acute disc injury and 
precursors to further degeneration.  
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Figure 2.5 Mid-sagittal histology sections of rat-tail motion segments 
Control discs (a) display a rounded nucleus and lamellae of collagen in the annulus, while stabbed 
discs (b) are depressurized and have lax collagen fibers in the annulus. Note that stab orientation 
was into the page. 
2.3.2 LIPUS Effect on Gene Expression 
Real-time quantitative PCR analysis was performed at 5 days after injury to assess the impact 
of LIPUS stimulation on extracellular matrix and inflammatory gene expression. Previous in vitro 
studies suggest that LIPUS treatment stimulates proteoglycan and collagen synthesis in IVD cells 
while inhibiting pro-inflammatory cytokine expression [67, 85, 121, 123]. Results indicated 
favorable trends but exhibited large variation when gene expression was averaged over all animals 
(n = 5), showing no statistical significance between stab only and stab plus LIPUS groups. 
However, as typically applied with the stab-injury model, when selecting the subset (n = 2) of 
animals that had successful stabs which produced a significant injury response, LIPUS treatment 
had an anti-inflammatory effect and anabolic response (Table 2.1): Col2a1 expression was 
significantly upregulated (p = 0.03) and TNFα expression was significantly downregulated 
a b
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(p = 0.05). Expression of pro-inflammatory cytokines IL–1β and IL6 was not significant affected, 
but results suggest a trend towards downregulation. Unexpectedly, LIPUS appears to downregulate 
Aggrecan and Sox9 gene expression.  
Table 2.1 Gene expression after 5 days of LIPUS treatment 
Data have been normalized by their respective control group. Fold change is reported as an average 
among animals with an injury response (n = 2). 
 
   Fold Change   
Gene Gene Name Description Stab Only 
Stab + 
LIPUS 
p - 
value 
IL-1b Interleukin – 1b Pro-inflammatory Cytokine 5.54 1.00 0.25 
IL6 Interleukin – 6 Pro-inflammatory Cytokine 3.57 0.20 0.42 
TNFα  Tumor Necrosis Factor – a Pro-inflammatory Cytokine 1.29 0.02 0.05* 
ACAN Aggrecan ECM Protein 2.48 1.61 0.74 
Col2a1 Collagen type 2a1 ECM Protein 1.56 16.31 0.03* 
Sox9 Sox9 Transcription factor for Collagen II synthesis 2.61 1.65 0.62 
 
2.4 Conclusions 
This preliminary study demonstrates technical feasibility of delivering LIPUS isolated to a 
targeted rat tail IVD for the study of LIPUS exposure and biological effects. Our analyses indicate 
that previously observed in vitro effects seem to carry over to our in vivo model. While several 
favorable trends were observed, statistical significance was only achieved in two genes of interest, 
likely due to large animal to animal variation. One of the major limitations of the rat tail stab model 
is that minute variations between individual’s stabbing technique may significantly affect the 
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animal’s injury response. Future studies will include additional animals to improve statistical 
power as well as implementation of a refined stab technique to ensure more a consistent injury 
response. Subsequent studies will evaluate a wider variety of genes to determine the healing 
mechanism by which LIPUS most significantly acts (e.g. anti-inflammatory, anti-catabolic, 
anabolic). Additional end points (14 and 28 days) will be included to assess the healing response 
over time. Successful completion of these studies can lead to similar evaluations in larger IVD 
degeneration models (e.g. ovine, bovine), to more closely replicate the dimensions of the human 
IVD and lead to development of delivery strategies for treating discogenic back pain in humans. 
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3 LIPUS Far-field Exposimetry System for Uniform Stimulation of Tissues in-vitro: 
Development and Validation with Bovine Intervertebral Disc Cells 
The content of this chapter is published as a research article in Biomedical Physics and 
Engineering Express with the following citation: Horne DA, Jones PD, Adams MS, et al (2020) 
LIPUS far-field exposimetry system for uniform stimulation of tissues in-vitro: development and 
validation with bovine intervertebral disc cells. Biomed Phys Eng Express 6:035033–13. doi: 
10.1088/2057-1976/ab8b26 
3.1 Introduction 
Ultrasound (US) can deliver mechanical or thermal energy to induce therapeutic effects 
including hyperthermia, ablation, regeneration or remodeling, enhanced local drug delivery, and 
immunotherapy [77, 124-127]. Devices for these purposes can be distinguished by their 
dimensions and position relative to the body, driving frequency and acoustic waveforms, as well 
as spatial-temporal intensity and pressure profiles, all of which largely dictate the distribution of 
the acoustic energy delivered and the effects on tissue. Low-intensity pulsed ultrasound (LIPUS) 
is one therapeutic US approach that is applied in pulsed wave modes with relatively low average 
intensities, thereby generating little to negligible heating and primarily delivering mechanical 
energy [125]. Therapeutic LIPUS has been shown to have significant regenerative capabilities in 
numerous tissue types through stimulation of cellular proliferation and matrix metabolism [78, 82, 
88, 128-135]. Recently, with U.S. Food and Drug Administration approval for bone fracture 
healing, LIPUS has advanced into the clinic as a noninvasive and regenerative therapy.   
Interest in therapeutic LIPUS has expanded in recent years with evidence that LIPUS may 
also stimulate repair of injuries in soft tissues including cartilage, ligament, tendon, and 
intervertebral disc (IVD). Several in-vivo studies have demonstrated LIPUS-induced enhancement 
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of wound healing by stimulating increased collagen synthesis and alignment, tissue integration, 
and improved biomechanical function including enhanced stiffness and failure strength [87, 89, 
136-138]. Additionally, LIPUS has been shown to promote matrix anabolism in IVD cells by 
increasing collagen and glycosaminoglycan synthesis while simultaneously decreasing matrix 
metalloproteinase expression [40]. Yet, there is little known about the mechanism of its effects at 
the cellular level, nor which other cell or tissue types may respond to LIPUS exposure. The 
Exogen® clinical system, and other experimental devices, have been used to evaluate LIPUS 
bioeffects [67, 139-144], with the majority of published work focused on the established exposure 
settings for bone healing (1.5 MHz; 200µs pulse; delivered at 20% duty cycle (1kHz); ISATA 
30 mW/cm2; 20 minutes daily). Investigations of LIPUS bioeffects at other exposure settings, such 
as at frequencies below 1.0 MHz and acoustic intensity profiles representative of far-field (FF) 
delivery, are limited and may be required for acoustic energy to penetrate to deep tissues such as 
the human IVD.  
In-vitro testing systems have been developed for preclinical assessment of therapeutic US 
under controlled experimental conditions. In the most common LIPUS configuration, cells are 
exposed by placing a commercial polystyrene cell culture plate (CCP) containing cellular material 
in the acoustic near-field (NF), directly on top of the US transducer with acoustic coupling gel. 
While a simple and straightforward approach, this configuration is vulnerable to several 
undesirable acoustic artifacts including NF interference, standing wave formation, and 
uncontrolled temperature elevation [98]. These phenomena represent significant confounding 
factors when attempting to establish dose-response relationships [145]. Many groups have studied 
US fields in CCPs [93, 94, 96, 98, 145, 146]. Hensel et al. (2011) investigated the wave propagation 
characteristics of several typical in-vitro configurations. They reported that reproducibility was 
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negatively affected by reflecting surfaces (i.e. allowing standing wave formation), and that small 
differences in system configuration, such as well size, media volume, and alignment with beam 
axis can significantly affect the acoustic field distribution and ultimately the biological response. 
Further, the effect of uncontrolled temperature fluctuations due to direct heating from contact with 
the US transducer as well as absorption of US-energy and heating within the plastic well-bottom 
and sidewalls can be particularly problematic. LIPUS systems have previously been developed to 
address these confounding factors. Fung et al. (2014) varied the acoustic standoff distance of their 
in-vitro LIPUS system and found that osteocytes were sensitive to the axial distance of LIPUS, 
suggesting that FF US exposure could enhance osteogenic activities. In the system developed by 
Marvel et al. (2010), BioFlex CCPs with flexible well-bottoms were used and found to be more 
acoustically transparent than typical polystyrene CCPs. In the 2014 study by Leskinen et al., the 
authors found that there was substantial temperature variation among different wells within a CCP, 
and that this variation correlated with variations in cell behavior. They found that temperature 
elevations were minimal when using a CCP well area larger than the width of the US beam [147]. 
Additionally, several LIPUS studies have implemented the use of an acoustic absorber placed 
above the CCP well to attenuate standing wave formation [94, 96, 98, 148]. These results highlight 
the importance of characterizing parameter- and configuration-specific acoustic field distributions 
and temperature fluctuations during in-vitro LIPUS exposure. 
In consideration of investigating extracorporeal delivery of LIPUS to deep tissue targets such 
as IVDs, lower than typical transducer operating frequencies and focused or uniform FF exposure 
are assumed technical requirements. The objective of this study was to design and characterize an 
in-vitro LIPUS system that mimics attributes of a deep delivery system, and as such delivers 
uniform, FF acoustic energy profiles while minimizing reflections and standing waves within 
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target wells and unwanted temperature elevation within target samples. Further, the system was 
validated by exposing IVD cells and assessing LIPUS-induced biological effects. 
3.2 Methods 
3.2.1 System Design and Characterization 
To meet the primary objective of maximizing FF acoustic dose uniformity at the location 
of the target sample in the in-vitro setup, CCP dimensions, transducer dimensions, and offset 
distance between the transducer surface and the CCP-well were determined. Two CCP setups were 
evaluated, each with an effective cell culture area of 1.91 cm2. One setup included a narrow 24-
well plate (15.6 mm diameter), and the other a wider 6-well plate (34.8 mm diameter) with a 
custom toroidal spacer (15.6 mm inner diameter). This spacer serves to constrain the cells within 
the CCP-well center while limiting exposure to sidewall acoustic reflections and maintaining a 
small volume similar to the 24-well plate. To identify the ideal separation distance from the 
transducer to the CCP-well (acoustic standoff) for specific CCP well coverage, several constraints 
were imposed: (i) the acoustic standoff must place the target sample beyond the heterogeneous 
NF; (ii) the full width at half maximum (FWHM), or 50% contour of beam maximum, must cover 
at least 80% of the effective cell culture area (1.91 cm2); and (iii) the acoustic standoff distance 
and minimum transducer size must be constrained to avoid an excessively divergent field and 
potential well-wall absorption and reflections. 
3.2.1.1 Specification and Characterization of Transducers 
Transducer specifications were identified by investigating a range of transducer diameter 
(20 – 35 mm), frequency (0.5, 1.0, and 1.5 MHz), and acoustic standoff distance within the FF 
(120 – 400 mm) on corresponding US intensity distributions, uniformity, and coverage area based 
upon acoustic field simulations. Full-field acoustic intensity distributions were calculated using 
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the rectangular radiator method [149] for numerical approximation to the Raleigh-Sommerfield 
diffraction integral, applying methods previously described by our group [150], and assuming 
uniform velocity across the transducer surface.  
 Planar disc PZT US transducers of 25 mm diameter (EBL #1, EBL Products, Inc., East 
Hartford, CT, USA), with a resonant frequency of approximately 0.5, 1.0, or 1.5 MHz, were 
selected. Transducer assemblies were fabricated separately with water-tight air-backing on custom 
3D-printed housing fixtures, as designed in Solidworks (Dassault Systemes, Waltham, 
Massachusetts, USA) and printed using the Clear resin material with a Form 2 3D-printer 
(Formlabs Inc., Somerville, MA, USA). Black silicone adhesive sealant (Permatex 81158, Solon, 
OH, USA) was applied along the edge of the transducer to secure it to the fixture and ensure air-
backing. Peak electrical impedance, zero phase cross-over, and resonance frequency for each 
transducer were measured using a Network Analyzer (E5070B ENA RF, Agilent). Acoustic beam 
plots of the intensity patterns for each transducer were acquired in the transverse plane using a 
custom 3D computer-controlled scanning system (Velmex, Bloomfield, NY, USA) with a 
calibrated hydrophone (HNP-0400, Onda Corp, Sunnyvale, CA, USA). Transducers were placed 
in a tank lined with an acoustic absorber to reduce reflections and filled with deionized, degassed 
water. A function generator (HP 33120A, Agilent, Santa Clara, CA, USA) and RF amplifier (ENI 
240L) were used to drive transducers with a power meter (N1914A EPM, Keysight Technologies, 
Inc., Santa Rosa, CA, USA) and power sensor modules (N8482A, Keysight Technologies, Inc., 
Santa Rosa, CA, USA) in-line for monitoring forward and reflected power.  For hydrophone 
measurements, a standard burst mode signal at the primary resonant frequency was used (1kHz 
pulse repetition, 100-200 cycle burst). Hydrophone scanning step sizes were 0.2 mm x 0.5 mm 
across transverse and axial axes, respectively. The peak-to-peak voltage (Vpp) signal from the 
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hydrophone was measured using a digital oscilloscope (DSOX2024A 200 MHz, Keysight 
Technologies, Santa Rosa, CA, USA) and converted to absolute intensity maps.  Beam intensity 
distributions were calculated, normalizing the maximum intensity value to one in each case to 
provide a simplified comparison of distributions.  
3.2.1.2 Assembly of LIPUS in-vitro System 
Informed by the simulations and measurements described above, exposimetry systems 
were devised and fabricated in-house following the schema (Figure 3.1). The LIPUS system 
consists of two independently driven, planar transducers mounted separately and affixed to an 
acrylic base. In order to operate with a single amplifier and function generator, paired transducers 
for each test system were individually impedance matched to a 100Ω load using an LC matching 
network and connected in parallel to achieve 50 Ω resultant impedance. The matching network 
capacitance was adjusted slightly for final matching to equalize peak output intensities as measured 
by needle hydrophone. The CCP-platform was fixed at the identified acoustic standoff for each 
frequency, as described above, and the transducer position was adjusted to direct acoustic energy 
towards the center of two opposing corner wells of the CCP. In order to further reduce well-wall 
reflections and US beam refocusing as observed when using narrow-diameter 24-well plates, a 
wide-diameter 6-well CCP (Costar 3471, Corning Incorporated, NY, USA) was used. An alginate 
disk (34.8 mm diameter; 10 mm height) was formed by mixing equal volumes of 1.2wt% sodium 
alginate (FMC BioPolymer, San Jose, CA) and 102 mM CaCl2 crosslinking solution inside each 
test well. Following 10 min incubation and removal of the crosslinking solution, a 3D-printed 
boring tool (15.6 mm outer diameter) was used to remove the center portion of the disk, creating 
an alginate ring.  The acoustically transparent alginate rings (measured attenuation coefficient = 
0 dB/cm) were used to constrain target samples within the FWHM of the diverging US beam and 
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maintain a sample volume comparable to the 24-well plates without introducing reflective 
surfaces. Two custom silicone absorbers (described in detail below) were positioned apically and 
coupled on the distal surface of the media-filled target wells. During exposures, the entire setup 
was placed in a deionized, degassed, and temperature-controlled water bath, with the water level 
reaching one-half the height of the CCP. 
 
Figure 3.1 Generalized schematic representing the in-vitro LIPUS exposimetry system 
The system was designed to deliver uniform acoustic energy to cells cultured in monolayer or 3D 
scaffolds and to adapt to a frequency range from 0.5 to 1.5 MHz. Two planar, PZT transducers 
were directed toward the center of two opposing corner wells of a standard cell culture plate. Cell 
culture targets were placed at a defined acoustic standoff distance and within an acoustically 
transparent alginate ring spacer to center the cells and reduce exposure to sidewall acoustic 
reflections. Wells were sealed distally with an acoustic absorber coupled to the media. The system 
was placed in a degassed, temperature-controlled water bath during exposures.  
3.2.1.3 Design of Acoustic Absorber 
Acoustic absorbers were designed to be in direct contact with the top surface of the media 
as a means to absorb acoustic energy transmitted through the target and eliminate reflections and 
standing wave formation within the well. Six biocompatible silicone materials were evaluated 
based on measurements of acoustic attenuation and reflection due to acoustic impedance mismatch 
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from water (Table 3.1). Each material was prepared according to manufacturer’s instructions, 
degassed, poured into cylindrical molds (4.2 cm diameter) to create two samples of different 
thicknesses (1.32 ± 0.10 cm and 2.55 ± 0.07 cm), and allowed to cure at room temperature 
overnight. Density was determined by using mass measurements and volume calculations. A 
pulse-echo transmit and receive US transmission system was used to determine the attenuation 
coefficient, reflection amplitude, and speed of sound through each material [151]. The test system 
consisted of an ultrasonic pulser-receiver (500PR, Panametrics, Inc., Waltham, MA, USA), two 
opposed 5 MHz immersion transducers (U8517054, Olympus NDT Instruments, Milwaukie, OR, 
USA) for transmit and receive, respectively, separated by 10 cm. The received amplitude 
waveform was measured using an oscilloscope (AFG3022C, Tektronix, Inc., Beaverton, OR, 
USA). Samples of various thickness were placed on a thin mylar stage between the two transducers 
and positioned perpendicularly to the US beam.  The speed of sound through each sample 𝐶! [m/s] 
was calculated as:  𝐶" = #!	%#"('#,!%'#,"	%	$"	&$!'( )            
where Z1 and Z2 are the respective sample thicknesses [m] of sample 1 and sample 2, ts,1 and ts,2   
are the respective times [s] for the US signal to travel from the emitting transducer to receiving 
transducer, and 𝐶* is the speed of sound [m/s] through water (1484 m/s at 22°C). The attenuation 
coefficient of each sample µ [dB/m] was calculated as:  
µ = +,-)*,!)*,".#"	%#! 	             
where Ao,1 and Ao,2, are the respective peak-to-peak voltage amplitudes [V] measured from the 
pulse waveform, and Z1 and Z2 are the respective sample thicknesses [m].  Reflection amplitude 
was assessed by measuring the amplitude of the signal reflected back toward the emitting 
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transducer. For each parameter assessed, measurements were taken four times in various positions 
throughout the sample and are reported as average values (Table 3.1).  
A custom mold was designed to create an absorber with the following characteristics: (i) a 
truncated-cone geometry (35.5 mm diameter x 8 mm depth; 25.4 mm total thickness) to allow 
direct coupling with media as well as air flow and media escape when placed in a media-filled 
well; and (ii) a ridged distal surface to baffle reflected waves, further increase absorption, and 
reduce re-transmission into the media. Mixed and degassed Sylgard 170 silicone (1696157, Dow 
Corning, Midland, MI, USA) was poured into a 3D-printed mold and cured by manufacturer’s 
instruction. Pulse-echo measurements, similar to above, were performed to characterize the 
reflection amplitude of the final absorber design. 
Table 3.1 Candidate absorber materials and associated acoustical properties.  
 
Product Name 
Density  
(g/cm3) 
Speed of 
Sound  
(m/s) 
Attenuation 
Coefficient  
(dB/cm) 
Reflection 
Amplitude  
(mVpp) 
Smooth-On Mold StarTM 15 SLOW 12.36 1425.30 7.50 789.05 
Smooth-On Mold StarTM 30 13.00 1428.60 6.70 859.40 
Smooth-On Dragon SkinTM 6.71  1436.55 7.50 892.60 
Smooth-On EcoflexTM 10.78 1444.38 1.77 1038.95 
Dow Sylgard® 170 8.27 1433.70 18.44 253.90 
MomentiveTM RTV60 8.47 1439.94 16.39 324.23 
 
3.2.1.4 Characterization of US Beam Uniformity at Cell Culture Position 
 US intensity distributions directly inside CCP-wells was characterized for various 
configurations. The full LIPUS assembly was placed in a scan tank and hydrophone measurements 
were performed inside the well at 2 mm above the bottom of the CCP, representing the location of 
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the center of a 3D cell culture material. Six configurations were assessed, representing those 
commonly used for in-vitro LIPUS exposures [67, 85, 93, 96, 98, 100, 146, 152]: in the NF (no 
plate, 24-well CCP, and 6-well CCP) and in the FF (no plate, 24-well CCP, and 6-well CCP + 
alginate ring insert). Scan dimensions in the x-y plane were limited for some configurations due 
to narrow well diameter. As a quantitative measure of acoustic uniformity across the well area, the 
mean gradient magnitude was calculated using the numerical gradient function in the MATLAB 
Image Processing Toolbox (MATLAB Release 2016b, The MathWorks, Inc., Natick, 
Massachusetts, USA). The gradient vector magnitude was computed by the summation of the 
absolute value of the gradient vectors in the x and y dimensions. 
3.2.1.5 Measurement of Temperature Elevation 
Temperature elevation within the well and absorber was evaluated during LIPUS exposure. 
Copper-constantan thermocouples (Size 0.002in, California Fine Wire Company, Grover Beach, 
CA, USA) were fabricated and calibrated in-house and connected to a Data Acquisition/Switch 
Unit and Thermometry Modules (Model HP34970A, Keysight Technologies, Santa Rosa, CA, 
USA) set to one reading per second. Target wells contained a custom alginate ring and 10 alginate 
beads (3D cell culture scaffold material), all submerged in cell culture media (Dulbecco’s modified 
Eagle’s medium, Gibco; Invitrogen Inc., Carlsbad, CA, USA) which formed a liquid column inside 
the well. The acoustic absorber was partially submerged in the well as designed, coupling directly 
with the media while avoiding bubble formation. Multiple thermocouple probes were passed 
through the absorber and positioned parallel to the direction of US propagation in three different 
locations: centered and in contact with the well bottom, inside an alginate bead, and inside (2 mm 
from the bottom surface) the acoustic absorber. The full LIPUS assembly was submerged in a tank 
with water conditioned as described above and maintained at 37°C. The top of the exposure system 
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was covered with plastic sheeting to minimize heat and water vapor escape and to maintain 
temperature uniformity throughout the apparatus. LIPUS sonication was performed using the 
following parameters: 1.5 MHz operating frequency, 200 µs pulse, 1 kHz pulse repetition 
frequency, and ISPTA=120 mW/cm2. After a short baseline measurement, the LIPUS was switched 
on for 20-minute sonication followed by a cooldown back to steady-state. Measurements of 
temperature rise were repeated three times for each setup. 
3.2.2 Biological Validation of LIPUS System 
The FF LIPUS system described above, operating at 1.5 MHz, was used to apply pulsed 
US in-vitro to IVD cells which were then assessed for induced biological response. Bovine IVD 
cells were encapsulated in 3D alginate scaffolds and cultured in 6-well CCPs. Samples were 
randomly assigned to the nontreated control, growth factor treatment (BMP-7) as a positive 
control, or LIPUS treatment group. After 14 days in culture, extracellular matrix accumulation 
within the alginate scaffold was evaluated by hydroxyproline assay for total collagen content. 
3.2.2.1 Cell Culture 
 IVDs were harvested from 18 to 24-month old bovine tails (Marin Sun Farms Inc., 
Petaluma, CA, USA) and annulus fibrosus (AF) cells were extracted and expanded as previously 
described [153], then encapsulated in alginate beads. Alginate hydrogels are widely used as an 
encapsulation method in a variety of in-vitro applications, including chondrocyte [154, 155], 
fibroblast [156], and IVD [85, 111, 157-159] cell culture, and have been used in several LIPUS 
studies involving IVD cells [67, 85, 121, 123]. The alginate bead culture system has many 
advantages over other hydrogel systems for IVD cell culture. AF cells cultured in alginate have 
been shown to maintain phenotypic stability [20, 160]. An additional advantage is that unlike many 
other hydrogels, alginate can be rapidly solubilized by calcium-chelating agents, allowing retrieval 
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of viable cells while removing trace elements of the hydrogel material [160, 161]. Further, 
culturing samples in several beads rather than a single disc is advantageous as it facilitates the 
randomization of samples for various outcome assays following treatment. Extracted AF cells were 
suspended in 1.2 wt% sodium alginate (FMC BioPolymer) in D-PBS at a density of 
4x106 cells/mL. Beads of approximately 25 µL in volume were formed by dispensing the solution 
dropwise through a 22-gauge needle into a reservoir of 102 mM CaCl2 crosslinking solution. The 
beads were allowed to crosslink at room temperature for 10 minutes before washing with PBS and 
cell culture media. Twelve alginate beads (one sample) were cultured in two opposing corner wells 
of a CCP with 3 mL of Standard Disc Media (low-glucose DMEM with 5% FBS, 1% 
antibiotic/antimycotic, 1% nonessential amino acids, and 1.5% osmolarity salt solution containing 
5 M NaCl and 0.4 M KCl). To avoid US exposure in neighboring, non-sonicated wells [98], each 
sample was cultured in opposing corner-wells, and control samples were not cultured in the same 
plate. Cells were kept in a 37°C, 5% CO2 incubator and allowed to acclimate for 24-hours before 
initial treatment. 
3.2.2.2 Evaluation of LIPUS Exposure 
Twelve samples were divided among three groups: (1) nontreated control, (2) BMP-7 
treatment, and (3) LIPUS treatment. The BMP-7 treatment group received Standard Disc Media 
supplemented with 200 ng/mL of Human Bone Morphogenetic Protein-7 (BMP-7) (Z02751, 
GenScript, Piscataway, NJ, USA). BMP-7 solution was exchanged on each treatment day. The 
LIPUS group was exposed to an US waveform (1.5 MHz operating frequency, 200 µs pulse, 1kHz 
pulse repetition frequency, ISPTA=120 mW/cm2) for 20 minutes each treatment day. When the CCP 
was placed on its platform, care was taken to remove air bubbles from and allow water to fill the 
crevices in the corners of the plate to allow proper coupling. To simulate environmental conditions 
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without LIPUS, control and BMP-7-treated samples were placed in the LIPUS exposimetry system 
for 20 minutes with the US turned off. All samples were cultured for 14 total days, with LIPUS 
exposure taking place on 8 of the 14 days. Media was changed on each day of treatment or every 
other day. 
3.2.2.3 Quantification of Collagen Concentration 
After 14 days of culture, the alginate beads were dissolved in 55 mM sodium citrate. 
Samples were concentrated by lyophilization for 2 total hours at a minimum of 75°C. Concentrated 
pellets were then dissolved in 40 µL of 6 N HCl for 16 hours at 110°C. The solution was 
centrifuged, and the supernatant was collected and neutralized. Total collagen content was 
quantified using acid hydrolysis followed by addition of p-dimethylaminobenzaldehyde and 
chloramine T (Sigma). DNA content was assayed with the Quant-iT PicoGreen dsDNA Assay Kit 
(P11496, Thermo Fisher, Waltham, MA, USA) and measured on a microplate reader (Spectramax 
M5, Molecular Devices, Sunnyvale, CA, USA) with 488 nm excitation and 525 nm absorption. 
Total collagen levels were normalized by the amount of total DNA to accommodate for differences 
in proliferation among treated and control samples.  
3.2.2.4 Quantification of Glycosaminoglycan Concentration 
After alginate beads were dissolved in 55 mM sodium citrate, the supernatant was digested 
in papain (P3125, Sigma-Aldrich, St. Louis, MO, USA) at 60°C overnight. Sulfated 
glycosaminoglycan (sGAG) content was quantified using the dimethylmethylene blue (DMMB) 
assay, with modifications for measuring alginate encapsulated samples [162], and normalized by 
DNA content as measured by PicoGreen assay. 
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3.2.2.5 Statistical Analysis 
Statistical significance of differences in intensity gradient was evaluated using a one-way 
analysis of variance (ANOVA) test, followed by multiple t-tests with a Tukey HSD correction. 
Statistical significance of differences in collagen concentration was evaluated using the Kruskal-
Wallis ANOVA test, followed by nonparametric comparisons for each pair using the Wilcoxon 
method. P-values < 0.05 were considered significant. 
3.3 Results 
3.3.1 Transducer and Acoustic Field Characterization 
Analysis of acoustic field simulations suggested that 25 mm-diameter transducers would 
provide a practical selection for 0.5, 1.0, and 1.5 MHz operating frequencies. Predicted acoustic 
standoff distances of 125, 250, and 350 mm would yield 107.3%, 97.5%, and 82.9% coverage of 
the effective cell culture area within the FWHM for 0.5, 1.0, and 1.5 MHz operating frequencies, 
respectively (Table 3.2 and Figure 3.2). Hydrophone measurements of the acoustic field 
distributions from fabricated transducers at these standoff distances (Figure 3.2 B, E, H) yielded 
133.23%, 104.7%, and 98.7% coverage, respectively over 1.91 cm2 area, demonstrating the 
feasibility of delivering broad, FF acoustic energy covering greater than 80% of the effective cell 
culture area. 
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Table 3.2 Summary of acoustic field metrics from simulations of various configurations 
FWHM and % Area Covered was calculated for each offset distance. Only configurations that 
covered greater than 80% of a 24-well plate well bottom were considered to meet the design 
criteria; therefore, 25 mm diameter transducers and offset distances of 350, 250, and 125 mm were 
chosen for 1.5, 1.0, and 0.5 MHz frequency configurations, respectively.  a Distance from the 
center of the transducer face to the center of the measurement plane. b Percentage of the surface 
area of a 24-well cell culture plate well bottom covered by the FWHM ultrasound beam (surface 
area of 24-well plate well bottom = 1.91 cm2). 
 
Operating 
Frequency (MHz) 
Transducer 
Diameter a (mm) 
Offset 
Distance (mm) 
FWHM at 
Offset (mm) 
%Area 
Covered b 
1.5 
20 225 14.0 80.5 
25 300 12.2 61.2 
25 350 14.2 82.9 
30 300 10.3 43.6 
35 300 9.3 35.5 
1.0 
20 175 14.0 80.5 
20 200 16.0 105.2 
25 225 14.0 80.5 
25 250 15.4 97.5 
20 300 19.2 75.5 
30 275 15.0 92.5 
30 400 20.0 81.9 
35 375 16.0 105.2 
0.5 
25 120 14.6 87.8 
25 125 16.2 107.3 
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Figure 3.2 Simulated and measured acoustic fields 
Axial simulations (A, D, G) demonstrated a heterogeneous near-field and a more uniform far-field 
region for each frequency as well as an expected reduction in focal depth with reduced frequency. 
Transverse line traces of these simulations (C, F, I) further highlighted differences in intensity 
distribution with depth in the acoustic field. Arrows indicate the location at which each line trace 
was taken within the simulated acoustic field. Multiple peaks were observed in the near-field, a 
uniform but narrow distribution at the focus, and a uniform and broad distribution past the focus. 
The latter was chosen for the LIPUS configuration and cross-sectional intensity measurements (B, 
E, H) were taken at the proposed depth via hydrophone scanning. The region within the dotted line 
is ≥ 50% of the maximum intensity and represents the location where the cellular target was placed. 
3.3.2 Evaluation of Acoustic Absorber  
Sylgard 170, a biocompatible silicone [163], demonstrated the greatest attenuation 
coefficient (18.4 dB/cm) with minimal reflection from the surface at less than 5% (Table 3.1). 
Absorber efficacy, as evaluated by pulse-echo measurements, demonstrated the elimination of 
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reflections back toward the well-bottom, thereby minimizing the generation of standing waves 
within CCP wells. The reflection amplitude was reduced by 99.1% with the absorber in position 
(3.375 Vpp vs 0.031 Vpp). 
3.3.3 US-beam Uniformity at Cell Culture Position 
Surface plots of normalized intensity (Figure 3.3) qualitatively demonstrate the 
heterogeneity of the beam profile in the NF compared to the more uniform profile in the FF. In 
addition, it is apparent that the introduction of a narrow-diameter 24-well CCP in the beam path 
increases the heterogeneity in both the NF and FF configurations. When replaced with a wide-
diameter 6-well CCP, the intensity distribution is less uniform than with no plate, but more uniform 
than with the narrow-diameter 24-well CCP. 
Quantitative measurements of uniformity for the FF configurations, as shown in 
Figure 3.4, demonstrated an 80.3 – 86.4% reduction in mean gradient magnitude and reduced 
standard deviation in gradient magnitude by 78.9 – 93.7% when compared to corresponding NF 
configurations. The FF configuration including an alginate ring placed within a 6-well CCP 
(Figure 3.3F) demonstrated a 60.1% reduction in mean gradient magnitude compared to the 
configuration with a 24-well CCP in at the same position (Figure 3.3E) (0.10 ± 0.06 W/cm2/mm 
vs 0.26 ± 0.16 W/cm2/mm) and is similar to the no-plate configuration (Figure 3.3D) 
(0.08 ± 0.02 W/cm2/mm vs 0.10 ± 0.06 W/cm2/mm). 
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Figure 3.3 Surface plots depicting normalized intensity distributions 
Intensity distributions were measured via hydrophone scanning at the sample location (2 mm 
above the well bottom) in various commonly used in-vitro LIPUS configurations (A-E) and the 
custom configuration (F). Overall, the intensity distribution within the near-field (5 mm offset) (A-
C) was extremely heterogeneous compared to the far-field (350 mm offset) (D-F). For both 
regions, there was more heterogeneity with a narrow-diameter 24-well plate compared to a wide-
diameter 6-well plate. The custom configuration (F), which included an alginate ring inserted in a 
6-well plate, had the most uniform intensity distribution compared to all other configurations that 
included a well-plate. Note that the plot for the far-field, 24-well plate setup has a single narrow 
peak in intensity gradient due to well-wall reflections, increasing the heterogeneity of its 
intensity field. 
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Figure 3.4 Quantification of acoustic field uniformity 
Acoustic field uniformity was quantified by measuring the intensity gradient and normalizing by 
the maximum value for each group. The intensity gradient of the custom in-vitro LIPUS 
configuration (F) was significantly less than all other configurations that included a well-plate (B, 
C, E). The normalized intensity gradient of each group was significantly different from all other 
groups (p < 0.05). Error bars represent standard deviation of the intensity gradient. 
3.3.4 Temperature Measurements 
Temperature elevation measured within the well and absorber material during sonication 
at 1.5 MHz, demonstrated low temperature elevations within alginate beads of 0.81 ± 0.15°C, and 
0.61 ± 0.31°C for the CCP-well bottom. Temperature rise was greatest within the acoustic 
absorber, with a temperature elevation of 2.32 ± 0.27°C. 
3.3.5 Extracellular Matrix Deposition 
LIPUS-induced bioactivity was evaluated and compared to BMP-7 exposure (as a positive 
control) by hydroxyproline assay for quantification of total collagen content and by DMMB assay 
for quantification of sGAG content. Exposure to both treatments had a profound effect on collagen 
concentration compared to nontreated controls (Figure 3.5A), with a 3.3-fold increase in the BMP-
7 group (1.12 ± 0.55 µg/µg DNA vs 0.34 ± 0.07 µg/µg DNA, p = 0.03), and a 2.6-fold increase in 
the LIPUS group (0.89 ± 0.42 µg/µg DNA vs 0.34 ± 0.07 µg/µg DNA, p = 0.03). There was no 
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significant difference in collagen concentration between the BMP-7 and LIPUS treatment groups, 
(p = 0.47). sGAG concentration was increased, but there was no significant difference between the 
BMP-7 and control groups (7.91 ± 4.23 µg/µg DNA vs 5.03 ± 1.26 µg/µg DNA, p = 0.77) nor the 
LIPUS and control groups (8.60 ± 9.41 µg/µg DNA vs 5.03 ± 1.26 µg/µg DNA, p = 0.68) 
(Figure 3.5B). 
 
Figure 3.5 Quantification of extracellular matrix deposition 
LIPUS and BMP-7 growth factor treatment upregulated collagen concentration by a similar 
magnitude and were both significantly greater than the nontreated control group (* p < 0.05) (A). 
sGAG concentration was increased, but not significantly upregulated by LIPUS nor BMP-7 
treatment (B). Both collagen and sGAG concentration were calculated as the sum of total collagen 
or sGAG content normalized by total DNA content in alginate beads. Error bars represent standard 
deviation of the collagen and sGAG concentration. 
3.4 Discussion 
In this study, we investigated design parameters for an in-vitro LIPUS exposimetry system 
to deliver uniform FF acoustic energy to a distal target while mitigating several common acoustic 
artifacts. We identified the proper combination of transducer dimensions, and acoustic standoff 
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distance for various low frequency (0.5 – 1.5 MHz) sources to deliver broad, uniform US energy 
to a target sample area within a CCP well. This configuration, combined with an optimized 
absorber and alginate ring design, enabled delivery of 50% prescribed ISATA across the target region 
within the CCP well. Using the final design, we treated bovine IVD cells over the course of several 
days then measured collagen content and found that FF LIPUS exposure upregulates collagen 
production in IVD cells comparable to BMP-7 growth factor treatment. 
Typically, in-vitro LIPUS systems include cells cultured in polystyrene CCPs placed 
directly above a planar transducer [67, 85]. When comparing intensity distributions at various axial 
distances, we observed extremely heterogeneous intensity fields directly above the transducer and 
a more uniform field at the transducer’s natural focus (i.e. FF transition). However, the intensity 
distribution at this location manifests as a narrow peak with a FWHM intensity of < 8.5 mm for 
each transducer frequency considered. At further distances within the FF, the intensity field 
demonstrated broader peaks, with a 2-fold increase in FWHM intensity. These data suggested that 
uniform, broad exposure can be achieved at positions past the focus, within the diverging FF. 
The presence of standing waves originating at the liquid-air interface of in-vitro US 
exposure systems can increase the pressure amplitude at the cell culture position by up to 2-fold, 
or decrease by up to 50%, which leads to uncertainty in the exposure conditions and could either 
significantly reduce cell viability or considerably reduce the expected therapeutic dose, resulting 
in a less predictable therapeutic effect [94, 164]. By addition of the custom absorber, the formation 
of standing waves within the CCP well would be negligible.  Since the total energy delivered to 
the target can vary widely due to standing waves, eliminating them is essential for the success of 
future parametric studies. 
 53 
Initial acoustic field simulations and hydrophone measurements gave insight into the 
acoustic intensity field devoid of obstruction; however, as previously mentioned, cells are typically 
cultured within the confinement of a CCP well. Therefore, a more relevant analysis requires 
assessing the intensity field just beyond CCP-well bottom where the cells are located. By 
calculating the intensity gradient within this region, we have quantified the uniformity of the 
acoustic intensity field at the cell culture position within various common in-vitro configurations 
and demonstrated that adaptations to these configurations can greatly reduce beam heterogeneity 
in terms of intensity gradient magnitude. We found that the configuration with a 24-well CCP 
placed in the NF had the greatest intensity gradient, suggesting that cells treated using this 
configuration are particularly susceptible to heterogeneous mechanical stimulation and heating 
throughout the sample. Previous studies have suggested that differences in bioeffects may be 
explained by the local heterogeneity in the intensity distribution when exposing cells within the 
transducer’s NF [146]. The FF configuration with an alginate ring inside a 6-well CCP had the 
lowest intensity gradient. This finding aligns with previous literature which hypothesized that the 
use of a well larger than the diameter of the transducer would reduce heterogeneity by minimizing 
reflections from well-walls [94]. The addition of an acoustically transparent alginate ring 
constrains the cells within a region outside the influence of the well-wall reflections believed to 
contribute the heterogeneity in narrow-welled configurations.  
It is well accepted that exposure to US-energy has a therapeutic effect on several 
musculoskeletal tissues; however, the common presence of uncontrolled, US-induced heating of 
the CCP-plastic (by attenuation as well as heat transfer through direct contact with the transducer), 
and subsequently the sample, suggests that the mechanism of these effects may not be exclusively 
due to mechanical effects. Previous studies have shown that temperature elevation greater than 
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3°C is enough to induce bioeffects on cell cultures and can be reached even when delivering low 
intensities (e.g. ISATA = 32 mW/cm2) [98, 145, 165]. US-induced temperature elevation within the 
cell culture media as well as the well-walls and bottom of a CCP has been investigated for 
monolayer cultures [98, 166]; however, those observations may not be relevant for understanding 
heating effects on cells encapsulated in 3D-constructs such as sodium alginate beads. In the LIPUS 
system developed herein, which included a circulating water bath and acoustic absorber, we 
observed negligible average temperature elevations of < 1.0 °C within the alginate beads and CCP-
well bottom, which is appreciably less than the temperature elevations previously reported in 
direct-contact systems [98] and demonstrates the ability to remove confounding temperature 
effects in LIPUS in-vitro studies.  
For validation, bovine AF cells were exposed to LIPUS using the FF exposimetry system. 
Results demonstrated that collagen production was significantly greater than the control group 
when treated with BMP-7 (3.3-fold) or LIPUS (2.6-fold); however, there was no significant 
difference between LIPUS treatment and BMP-7 treatment. The findings demonstrate that 
uniform, FF LIPUS exposure, while eliminating significant temperature elevation and standing 
waves, can promote increased extracellular matrix production in bovine IVD cells in-vitro at a 
magnitude similar to that of growth factor treatment. This increase in collagen content with LIPUS 
treatment aligns with previous studies which have demonstrated a 1.3-fold increase in total 
collagen in human annulus fibrosus cells [40] and fibroblast cells treated with LIPUS in the NF 
[156]. Our preliminary gene expression data suggest that both LIPUS and BMP-7 treatment 
regulate collagen I and II expression in AF cells at similar magnitudes. These results align with 
previous work [40, 167] and suggest that LIPUS may stimulate the production of major fibrillar 
collagens of the IVD, which are important for maintaining its structural integrity. Although this 
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study has not differentiated between ratios of collagen I and collagen II levels for LIPUS and BMP-
7, this could be further investigated in future studies to optimize LIPUS exposure levels by 
immunohistostaining or western blot analysis. 
Overall, the results indicate that uniform, FF acoustic energy fields can be delivered to 3D 
cellular constructs cultured in standard CCP-wells and enclosed by an alginate ring spacer at 
frequencies at and below 1.5 MHz with negligible heating. Additionally, we demonstrate that FF 
LIPUS exposure increases collagen content in IVD cells, suggesting that LIPUS may be a potential 
therapeutic for stimulating repair of tissues deep within the body such as the IVD. Further 
investigations are needed to elucidate the effect of varying LIPUS dose parameters on the cell 
response and to optimize the benefits of LIPUS treatment in an IVD-tissue repair context. 
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4 Design of Experiments Screening of Low-intensity Pulsed Ultrasound Parameters for 
Modulating Matrix Gene Expression in Annulus Fibrosus Cells 
The content of this chapter will be included as part of a research article that will be submitted to 
Ultrasound in Medicine and Biology in June 2020 by the following authors:  
Devante A. Horne, Chris J. Diederich, Jeffrey C. Lotz 
4.1 Introduction 
Damage and tears in the intervertebral disc (IVD) are associated with pain and disability and 
are related to risk of disc herniation and degeneration [168]. Current therapies for stimulating 
healing, such as intradiscal growth factor and stem cell injections are invasive, are invasive and 
have shown limited success rates [65]. New technologies for treating damaged discs are 
increasingly focused on the regeneration and repair of the annulus fibrosus (AF) [40].  
Among the various therapeutic modalities being explored, low-intensity pulsed ultrasound 
(LIPUS) has been shown to stimulate several musculoskeletal cell types to increase proliferation 
and extracellular matrix (ECM) synthesis [169]. LIPUS is well known for its use in stimulating 
bone healing and has shown bioeffects in soft tissues as well, including the nucleus pulposus [121, 
123] and AF [40, 170]. LIPUS has advantages over other potential therapies including the 
capability of delivering acoustic energy extracorporeally to target tissues of interest while sparing 
healthy tissues along the way. Our group has recently shown that LIPUS energy in the far-field 
can significantly upregulate collagen accumulation in AF cell cultures [170]. 
While LIPUS has been established as a promising therapeutic for bone repair, progress has 
been limited for other tissues such as the IVD, likely due to a lack of an established dose-response 
relationships. Many previous studies have focused on established LIPUS parameters: 1.5 MHz 
operating frequency, 1 kHz pulse repetition frequency (PRF), 30 mW/cm2 spatial and temporal 
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averaged intensity, and 20 min treatment duration. These settings have been proven effective for 
bone healing [78, 81, 171]; however, LIPUS parameters have not been fully optimized for soft 
tissues such as the IVD. Limited parametric studies have suggested significant dose-dependent 
LIPUS effects, including increased proteoglycan synthesis in AF cells treated with higher 
intensities and for more days [67, 85, 100, 123], increased calcium accretion in stem cells with 
increasing pulse repetition frequency [93], and increased proteoglycan and collagen synthesis in 
stem cells treated for longer durations [100]. Nonetheless, with the lack of a comprehensive 
evaluation of LIPUS parameters, there is no clear understanding of which parameters are most 
important for stimulating extracellular matrix (ECM) synthesis in AF cells, nor which parameter 
combination is most effective for stimulating a desired therapeutic effect. A better understanding 
of the effect of varying LIPUS parameters on cell phenotypes may allow patient and condition-
specific dosing. 
LIPUS parameter effects have generally been studied in-vitro by varying only one factor at 
a time (OFAT). The comprehensive application of this approach would require the evaluation of 
all possible combinations to achieve an optimal response. However, independent variables do not 
always act in isolation, and interaction effects can significantly influence the response; therefore, 
it can be difficult to make an informed decision on the best factor settings when evaluated OFAT 
as this method is incapable of identifying interactions between factors and moreover, it is very 
costly in terms of time and resources.  
Design of Experiments (DOE) is a statistical technique used to plan experiments and analyze 
data. The DOE method involves the design and use of a controlled set of tests to model and 
examine the relationships between factors and responses and is a tool for optimizing responses in 
a small number of experiments while also identifying any interactions among factors. DOE can 
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significantly improve the efficiency of factor screening and optimization and has been used 
successfully in various industries including biotherapeutics [172-175]. There are many advantages 
of the DOE method over the more traditional OFAT approach to factor exploration and 
optimization. With DOE, experimental factors are varied simultaneously, allowing the 
identification of factors affecting the response with the minimum number of experiments through 
nonlinear multivariate data analysis and prediction modeling. With a significantly reduced 
experimental matrix, factor optimization can be achieved while conserving time and cost.  
The DOE workflow is typically comprised of multiple phases including identification, 
screening, model validation, and optimization. The initial identification phase involves the 
collation of a list of factors expected to influence the response of interest. The screening phase 
involves experimentation to identify the main effect of the factors on the response as well as 
significant interaction effects of a factor on other factors, with the primary aim of reducing the 
number of factors to a smaller subset of those that have the most significantly impact on the 
response metric. In the screening phase, a DOE matrix is designed that ideally covers the entire 
experimental range by applying each factor at their maximum and minimum levels. DOE screening 
experiments typically use a Full-Factorial design, or Plackett-Burman design to build a first-order 
model of the response [174] and to generate a polynomial prediction formula. The accuracy of 
model predictions is evaluated by comparing model-predicted values to actual experimental 
responses.  Optimal conditions for individual responses are determined by the construction and 
numerical optimization of a desirability function to find a factor settings that maximize 
desirability. When multiple responses are to be optimized, all goals can be combined into an 
overall desirability function.  
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While LIPUS has been shown to stimulate ECM expression in AF cells, the relative 
significance and optimal combination of LIPUS factors on ECM gene expression in AF cells is 
largely unknown. Consequently, we sought to investigate the effects of LIPUS parameters on ECM 
gene expression in AF cells to improve our understanding of the underlying dose-response 
relationships. We hypothesized that the ECM gene expression in AF cells can be regulated by 
varying LIPUS parameter settings. 
4.2 Methods 
4.2.1 DOE Matrix 
An experimental matrix was generated using the DOE Screening Design platform of JMP 
(JMP® Pro 14.3.0). Three factors of interest were identified, including peak intensity (mW), PRF 
(kHz), and treatment duration (min), along with their corresponding value at each level 
(Table 4.1). Four responses were specified, including gene expression of Matrix 
Metalloproteinase-1 (MMP1), Matrix Metalloproteinase-13 (MMP13), Interleukin-6 (IL6), and 
Collagen Type I Alpha I (COL1), along with their corresponding goal (Table 4.2). A 2k full-
factorial experimental design was constructed where all factors were held at one of two discrete 
levels (high or low) during each run of the experiment. The experimental design included all 
possible combinations of factor settings and allowed for modeling all 2-factor interactions with 
only 8 runs for 3 factors identified (Table 4.3). 
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Table 4.1 LIPUS factors and levels for DOE 
The full-factorial design space was defined by 3 LIPUS parameters varied at 2 levels. Samples 
were treated once using a LIPUS system operating at 1.5 MHz. The waveform duty cycle was 
maintained at 20% during application of both low and high PRF levels by adjusting the burst count 
proportionally. 
 
Factors Low  High  
Peak Intensity (mW) 300 1200 
PRF (kHz) 0.1 1.0 
Treatment Duration (min) 5 20 
Operating Frequency (MHz) Fixed at 1.5 
Number of Treatments  Fixed at 1 
 
Table 4.2 Gene expression responses for DOE 
Relative expression levels of 4 ECM genes were assessed for each sample. The desired goal for 
each response was indicated for optimization. 
 
Response (FC Gene Expression) Goal 
MMP1 Minimize 
MMP13 Minimize 
IL6 Minimize 
COL1 Maximize 
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Table 4.3 Experimental matrix for screening design 
The 3-factor, full-factorial design consisted of 8 total experimental conditions with 3 replicates 
each. 
 
LIPUS ID Peak Intensity (mW) PRF (kHz) Duration (min) 
1 1200 1 20 
2 300 1 20 
3 1200 1 5 
4 300 1 5 
5 1200 0.1 20 
6 300 0.1 20 
7 1200 0.1 5 
8 300 0.1 5 
 
4.2.2 Cell Culture 
IVDs were harvested from 18 to 24-month old bovine tails (Marin Sun Farms Inc., 
Petaluma, CA, USA) and AF cells were extracted and expanded as previously described [153]. AF 
cells (passage 3) were seeded in two opposing corner wells of each tissue culture treated 6-well 
microplate (353046, Corning Incorporated, NY, USA) at a density of 0.5x106 cells/well. Cells 
were pre-cultured with 3 mL of standard disc media (low-glucose, phenol-free DMEM with 5% 
FBS, 1% antibiotic/antimycotic, 1% nonessential amino acids, and 1.5% osmolarity salt solution 
containing 5 M NaCl and 0.4 M KCl) in a 37°C, 5% CO2 incubator for 24 hours before treatment. 
4.2.3 LIPUS Exposure 
Samples were divided into 10 groups with 3 replicates each (n = 30): (1) nontreated control, 
(2) IL-1α treatment, and (3 - 10) IL-1α + LIPUS treatment at 8 different parameter settings 
(Table 4.3). At least two hours prior to LIPUS exposure, medium was exchanged for either fresh 
standard disc media or inflammatory media (standard disc media with 10ng/mL of IL-1α (12778, 
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Sigma-Aldrich, St. Louis, MO, USA)) to simulate normal and inflammatory disc environments. 
Samples were placed in a far-field LIPUS exposimetry system (Figure 4.1), as described 
previously [170], and exposed to LIPUS at settings defined by the DOE matrix (Table 4.3). To 
simulate environmental conditions without LIPUS, nontreated control and IL-1α-treated samples 
were placed in the LIPUS exposimetry system with the ultrasound turned off. 
 
 
Figure 4.1 Schematic representing the in-vitro LIPUS far-field exposimetry system 
Two planar transducers operating at 1.5 MHz delivered acoustic energy to cells cultured in 
monolayer at a 350 mm standoff placing samples in the uniform acoustic far-field. Target wells 
were sealed with an acoustic absorber coupled to the cell culture medium. The system was placed 
in a degassed, temperature-controlled water bath during exposure. A representative plot of the 
normalized acoustic intensity field at the cell location (inset) demonstrates uniform intensity 
distribution. 
4.2.4 Gene Expression Analysis 
ECM gene expression was assessed one day after LIPUS exposure. AF cells were lysed 
directly in the cell culture well using 150 µL of PicoPure RNA extraction buffer. Then, total RNA 
was isolated and purified using the PicoPure RNA Isolation Kit (Arcturus, Mountain View, CA, 
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USA) according to manufacturer’s instructions. cDNA was transcribed using the iScriptTM Reverse 
Transcription Supermix (1708841, Bio-Rad Laboratories, Hercules, CA, USA). RT-qPCR was 
performed using TaqMan Universal PCR Master Mix (4444557, Applied Biosystems, Foster City, 
CA, USA) and TaqMan primers and probe sets for MMP1, MMP13, IL6, and COL1. The B2M 
mRNA gene was co-amplified as an internal standard. Relative expression levels were calculated 
using the ∆∆Ct method [176], normalizing first to B2M then to the expression level measured in 
the IL-1α treatment group, and expressed as fold-change (FC) values. The FC data were then 
compiled and recorded in the respective response column of the DOE worksheet for analysis. 
Statistical differences in FC gene expression among the LIPUS conditions was evaluated using a 
one-way analysis of variance (ANOVA) test, followed by multiple t-tests with a Tukey HSD 
correction for differences between conditions. P-values < 0.05 were considered significant. 
4.2.5 DOE Analysis 
4.2.5.1 Two-level Screening and Model Reduction 
DOE screening analysis to investigate the main effects and interactions among LIPUS 
parameters (factors) and FC gene expression (responses) was performed in JMP. Two-level effect 
screening was performed for model reduction and to make inferences about factor effects by 
identifying factors which have the largest effect on each response. The Fit Two-level Screening 
platform in JMP takes the variation across the response values and evaluates the relationship with 
the effects in the factor space. The significance of factor effects, or the difference in the mean 
response between two levels of a factor, were evaluated by an F-test. Statistically significant 
(p < 0.10) factors and interactions were identified for each response, and a final model was 
generated with the exclusion of non-significant factors.  
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4.2.5.2 Fitting and Evaluating Linear Regression Models 
A standard least squares fit was used to construct the final model, with model effects 
designated as first- and second-degree (interaction) effects only. A model was generated for each 
of the 4 responses. Each model was evaluated for goodness-of-fit  by ANOVA, and a Whole Model 
Actual by Predicted Plot was generated.  
 Estimated coefficients of the regression equation were generated for each response, and the 
significance of each model term were evaluated by t-test; p-values < 0.05 were considered 
significant. To reduce collinearity in the model, interaction terms were centered by subtracting the 
mean of each value in the corresponding column of the DOE matrix. Matrices of interaction plots 
were created to visualize the interaction effects in the model of each response. 
4.2.5.3 Validation of DOE-predicted Responses 
Validation experiments were preformed using identical cell-culture and LIPUS-exposure 
methods as those described herein. Inflammatory AF-cell samples (n = 3) were treated once with 
LIPUS at parameter settings previously used by our group: 600 mW peak intensity, 1 kHz PRF, 
and 20 min duration [170]. Gene expression was analyzed by qPCR, and mean FC values were 
computed using the same methods described herein. DOE models were used to predict mean FC 
values and 95% confidence intervals for each response at these factor settings. To test the validity 
of model predictions, DOE-predicted FC values were compared against the actual FC values and 
the percentage difference was calculated. 
4.2.6 Response Optimization 
Optimization was performed in JMP using desirability functions, where desirability was 
defined according to the corresponding goal of each response (Table 4.2). The optimum factor 
settings within the design space and corresponding response value were predicted for each 
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individual response. The overall optimum factor settings (i.e. maximum desirability for all genes) 
were predicted using an overall desirability function, defined as the geometric mean of the 
desirability function of the individual responses [177]. 
4.3 Results 
4.3.1 Gene Expression Analysis 
The effect of LIPUS exposure on AF cells cultured in an inflammatory environment was 
evaluated by measuring the FC expression of catabolic genes (MMP1 and MMP13), a pro-
inflammatory gene (IL6), and an ECM synthesis gene (COL1). The addition of 10 ng/mL IL-1α  
to the cell culture media significantly upregulated MMP1 (p < 0.0001), MMP13 (p < 0.0001), and 
IL6 (p < 0.0001) expression compared to the control (Figure 4.2). However, IL-1α treatment did 
not significantly affect COL1 expression compared to the control (p = 0.9996).  
MMP1 expression was significantly downregulated compared to the IL-1α treatment group 
when exposed to LIPUS ID 1-5 (p < 0.05) but not 6-8 (p = 0.0509, 0.6970, and 0.0878, 
respectively). MMP13 expression was significantly downregulated when exposed to LIPUS ID 1-
6 (p < 0.05) but not 7 nor 8 (p = 0.6654 and 0.5480, respectively). IL6 gene expression was 
significantly downregulated when exposed to LIPUS ID 1-5 and 8 (p < 0.05), but not 6 nor 7 
(p = 0.1258 and 0.5855, respectively). For COL1 expression, there were no significant differences 
among groups (p = 0.9305). 
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Figure 4.2 Gene expression results demonstrate range of responses within design space 
IL-1α treatment upregulated catabolic and pro-inflammatory gene expression (# p < 0.0001). 
LIPUS exposure at several parameter settings downregulated catabolic and pro-inflammatory gene 
expression in cells cultured in inflammatory medium (* p < 0.05). Neither IL-1α nor LIPUS 
exposure significantly regulated COL1 expression. 
4.3.2 Effect Screening 
Two-level screening was used for model reduction by identifying about main effects and 
interaction effects for each response. The effect chart (Figure 4.3) shows the relative effect 
magnitude and direction for each response; effects extending beyond the reference line were 
considered significant (p < 0.10). Three factors significantly affected MMP1 expression: the main 
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effect of PRF (p = 0.0010), and the interaction effects of PRF*Duration (p = 0.0873) and Peak 
Intensity*Duration (p = 0.0917). A single factor significantly affected MMP13 expression: the 
main effect of PRF (p = 0.0020). Two factors significantly affected IL6 expression: the main effect 
of PRF (p = 0.0036), and the interaction effect of Duration*Peak Intensity (p = 0.0761). Peak 
intensity was the only factor that significantly affected COL1 expression (p = 0.0647). 
 
Figure 4.3 Two-level screening effect chart 
Main and interaction effects for each response were identified by two-level screening analysis for 
subsequent model reduction. Effect values were on the same scale as the corresponding response. 
Horizontal bars indicate relative effect, where effects extending beyond the red vertical lines 
indicate a significant effect (p < 0.10). Shaded rows indicate significant factors that were included 
in the final models. 
 68 
4.3.3 Evaluation of Prediction Models 
4.3.3.1 Goodness-of-fit 
Linear least squares regression models were generated for each response, excluding non-
significant factors identified by two-level effect screening (Figure 4.3). Goodness-of-fit  was 
evaluated by ANOVA and visualized by plotting actual experimental results against model 
predicted values for each response (Figure 4.4). The model-predicted values were significantly 
correlated with experimental values for MMP1 (R2 = 0.68, p < 0.0001), MMP13 
(R2 = 0.56, p < 0.0001), and IL6 (R2 = 0.58, p = 0.0001); however, COL1 model-predicted values 
were not significantly correlated with experimental values (R2 = 0.10, p = 0.1309). 
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Figure 4.4 Whole model actual by predicted leverage plots 
Goodness-of-fit for the final model of each response was evaluated to determine significance. 
Shaded region indicates 95% confidence interval. Confidence curves which cross the blue 
horizontal line (mean response) were considered significant. Models for MMP1, MMP13, and IL6 
were significant (p < 0.05). The model of COL1 was not significant. 
 
4.3.3.2 Regression Equations 
 The reduced models were used to generate a regression equation for each response. 
Estimates of term coefficients inform the relative magnitude and direction of term effects 
(Table 4.4). The main effect of PRF was significant, and negatively correlated with MMP1, 
MMP13, and IL6 expression (p < 0.0001), indicating that higher PRF is better for decreasing 
MMP1, MMP13, and IL6 expression compared to lower PRF. The main effect of Peak Intensity 
was positively correlated with COL1 expression but was not significant (p = 0.1309).  
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Table 4.4 Tabulated regression equations 
Significant effects and interactions were included as terms in the final model of each response. 
Estimated regression coefficients indicate the relative effect size and direction. Model terms with 
p-values < 0.05 were considered significant. 
 
Gene Term Coefficient t Ratio Prob>|t| 
MMP1 
Intercept 0.450 15.867   <0.0001* 
PRF -0.238  -5.966   <0.0001* 
(PRF-0.55)*(Duration-12.5) 0.010 1.950     0.0654 
(Peak Intensity-750)*(Duration-12.5) -0.001e-2  -1.911     0.0704 
MMP13 Intercept 0.550 18.20   <0.0001* PRF -0.223 -5.24   <0.0001* 
IL6 
Intercept 0.750 27.01   <0.0001* 
PRF -0.191  -4.89   <0.0001* 
(Duration-12.5)*(Peak Intensity-750) -1.13e-5  -2.17     0.0415* 
COL1 Intercept 0.838 3.92     0.0007* Peak Intensity 0.038e-2 1.57     0.1309 
 
4.3.3.3 Interactions Between Factors 
However, for MMP1 and IL6, main effects do not fully describe the relationship between 
factor and response due to the presence of factor interactions. Interaction plots (Figure 4.5) show 
the two-factor interaction profiles for MMP1 and IL6 expression, where parallel lines indicate no 
interaction and intersecting lines indicate factor interactions. Two interaction terms were identified 
in the model of MMP1 expression: PRF*Duration and Peak Intensity*Duration. Interaction plots 
indicate that the effect of PRF was sensitive to treatment duration: high PRF with low duration 
demonstrated reduced MMP1 expression compared to the same PRF with high duration. 
Moreover, the steeper slope of the line for low duration suggests that PRF had a greater effect on 
MMP1 expression when duration was low; however, this interaction was not statistically 
significant (p = 0.0654). The effect of peak intensity was also sensitive to treatment duration, 
where high peak intensity with high duration further reduced MMP1 expression compared to the 
same peak intensity with low duration. Additionally, the peak intensity was negatively correlated 
with MMP1 expression when duration was high but was positively correlated when duration was 
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low; however, this interaction was also not statistically significant (p = 0.0704). In the model of 
IL6 expression, duration significantly interacted with peak intensity (p = 0.0415). Low treatment 
duration with high peak intensity demonstrated reduced IL6 expression compared to the same 
duration with low peak intensity. Furthermore, treatment duration was negatively correlated with 
IL6 expression when peak intensity was high but was positively correlated when peak intensity 
was low. 
 
Figure 4.5 Factor interaction profiles 
Interaction plots show the interaction of the row effect with the column effect. Non-parallel lines 
suggest possible interactions, and the slope magnitude of the line segment indicates the effect size 
of the interaction. Interactions with p-values < 0.05 were considered significant in the final model. 
Dashed line segments are alias terms which were not included in the model. 
 
4.3.4 Validation of DOE-predicted Responses 
Validation experiments used LIPUS parameter settings that lay within the design space: 
600 mW peak intensity, 1 kHz PRF, and 20 min duration. Response values from these experiments 
were compared to DOE-predicted responses (Figure 4.6). The DOE-predicted mean and 95% 
confidence limits for MMP1 were 0.259 ± 0.066. The predicted mean was 86% different the actual 
mean FC of 0.647 ± 0.269. The DOE-predicted MMP13 expression was 0.327 ± 0.056, which was 
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66% different from the actual mean FC of 0.647 ± 0.308. The DOE-predicted IL6 expression was 
0.571 ± 0.053, which was 12% different from the actual mean FC of 0.647 ± 0.269. The DOE-
predicted COL1 expression was 1.068 ± 0.240, which was 17% different from the actual mean FC 
of 0. 894 ± 0.438. 
 
 
Figure 4.6 DOE-predicted and actual gene expression responses 
DOE models were used to predict changes in ECM gene expression in response to LIPUS exposure 
at 600 mW peak intensity, 1 kHz PRF, and 20 min duration. To test the validity of DOE 
predictions, they were compared to actual experimental data. Bars represent mean FC and error 
bars represent the 95% confidence interval. 
4.3.5 Response Optimization 
Optimum LIPUS parameters were identified for each response individually (Table 4.5) 
using desirability functions and overall (Table 4.6) by the geometric mean of the individual 
desirability functions. The predicted optimal LIPUS parameter settings for minimizing MMP1 and 
IL6 expression were identical: 300 mW peak intensity, 1 kHz PRF, and 5 min treatment duration. 
The estimated mean reduction in MMP1 and IL6 expression compared to the IL-1α treatment 
group was 86% and 48%, respectively. The optimal setting for minimizing MMP13 expression 
was predicted to include 1 kHz PRF and result in an estimated mean reduction in MMP13 
expression of 67% compared to the IL-1α treatment group. The optimal setting for maximizing 
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COL1 expression was predicted to include 1200 mW peak intensity and result in an estimated 
mean increase in COL1 expression of 30% compared to the IL-1α treatment group. The optimal 
settings for maximizing desirably for all gene expression responses was predicted to be 300 mW 
peak intensity, 1 kHz PRF, and 5 min treatment duration. 
Table 4.5 Predicted optimal factor settings for individual gene expression response 
Predicted optimal settings were determined individually for each response using desirability 
functions. Predicted mean fold-change values and 95% confidence intervals (CI) were determined 
for each response at the corresponding predicted optimal setting. 
 
Gene Peak Intensity 
(mW) 
PRF 
(kHz) 
Duration 
(min) 
Fold 
Change 
Lower 
CI 
Upper 
CI 
MMP1 300 1 5 0.143 0.068 0.218 
MMP13 - 1 - 0.327 0.271 0.383 
IL6 300 1 5 0.520 0.457 0.583 
COL1 1200 - - 1.298 0.975 1.620 
 
Table 4.6 Predicted optimal factor settings for overall gene expression responses 
Predicted overall optimal setting for maximizing desirability for all responses. Corresponding 
predicted mean fold-change values and 95% confidence intervals were determined for each 
response at the predicted optimal setting. 
 
Gene Peak Intensity 
(mW) 
PRF 
(kHz) 
Duration 
(min) 
Fold 
Change 
Lower 
CI 
Upper 
CI 
MMP1 
300 1 5 
0.117 0.035 0.199 
MMP13 0.238 0.159 0.316 
IL6 0.526 0.443 0.608 
COL1 0.850 0.300 1.400 
 
4.4 Discussion 
In this study, we investigated the effects of LIPUS peak intensity, PRF, and treatment 
duration, simultaneously, on ECM gene expression in AF cells using DOE. We exposed AF cells 
under inflammatory conditions to LIPUS at settings defined by a 2k full-factorial DOE matrix. FC 
gene expression responses were assessed by qPCR, significant factors and interactions for each 
gene expression response were identified by effect screening DOE, and significant factors and 
interactions were included in a least-squares regression model of each response. The resulting 
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models were used to further explore main effects and interactions, and to predict LIPUS settings 
for optimizing each response.  We found that LIPUS exposure significantly downregulated MMP1, 
MMP13, and IL6 gene expression in AF cells cultured in inflammatory media but did not 
significantly affect COL1 gene expression. The main effect of PRF was the most significant factor 
for modulating MMP1, MMP13, and IL6 expression, while peak intensity was most significant for 
modulating COL1 expression. Additionally, we found that treatment duration interacted with both 
peak intensity and PRF to regulate MMP1 and with peak intensity to regulate IL6 expression. 
Finally, validation experiments demonstrated that DOE-predicted responses were 12 - 86% 
different from actual responses. 
PRF was a significant factor for MMP1, MMP13, and IL6 expression and was the only 
significant main effect observed. When PRF level was adjusted from its high value to its low value, 
the burst count was increased proportionally such that the duty cycle remained at 20%. 
Nonetheless, applying LIPUS with a low PRF was less effective on average at reducing catabolic 
and pro-inflammatory gene expression compared to high PRF, across the levels of all other factors 
(Figure 4.2). These results suggest ECM gene expression may be sensitive to pulsed waveform 
characteristics. Similar effects have been shown in previous studies by Marvel et al. (2010), which 
demonstrated increased calcium accretion in stem cells with increasing PRF [93]. Miller et al. 
(2017) demonstrated that adherent chondrocytes exposed to an ultrasound field experienced strain 
at the adhesion points, with membrane displacements on the order of 10-100 nm [178]. This 
mechanical deformation is sensed by localized cellular mechanoreceptors such as integrins and 
mechanosensitive ion channels and are transduced into biochemical outputs including downstream 
changes in gene expression. Zhang et al. (2016) showed that in degenerative human IVD cells, 
mechanical stimulation from LIPUS was detected by integrins, leading to focal adhesion formation 
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and ultimately enhanced ECM synthesis [121]. Mechanosensitive ion channels such as Piezo1 and 
Piezo2 may also play a crucial role in the transduction of repetitive mechanical stimuli. Piezo 
channels are thought to function as bandpass filters, preferentially transmitting stimuli in only a 
narrow frequency range. Lewis et al. (2017) found that transduction efficiencies varied by stimulus 
frequency, waveform, and duration [179]. In this context, the long pulse intervals of the low PRF 
groups may be less efficiently transduced by AF-cell piezo channels, resulting in a damped 
response. 
LIPUS has been shown to modulate IVD-cell proteoglycan synthesis and collagen gene 
expression in an intensity-dependent manner [85, 123, 180]. Additionally, proteoglycan and 
collagen synthesis were increased in stem cells treated from longer durations [100]. This does not 
align with our finding that peak intensity and treatment duration were not significant factors for 
modulating ECM gene expression. However, by utilizing a DOE approach for effect screening, we 
found interactions between peak intensity and duration that influenced MMP1 and IL6 gene 
expression, as well as an interaction between PRF and duration that influenced MMP1 expression 
(Figure 4.5). These interactions represent important findings that were quickly established using 
DOE but would not have been observed by utilizing the traditional OFAT approach. 
Most of the previous literature investigating LIPUS bioeffects use waveform parameters 
originally established for bone fracture healing including 30 mW/cm2 spatial and temporal 
averaged intensity, 1 kHz PRF, and 20 min treatment durations. While LIPUS exposure at these 
settings has been shown to induce ECM synthesis and anti-catabolic activity in degenerative IVD 
cells, it is unclear whether these are the optimal parameter settings for stimulating this activity in 
AF cells. Here, we used a regression model and desirability functions for MMP1, MMP13, IL6, 
and COL1 gene expression to predict the optimal LIPUS settings for maximizing desirable 
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expression of each gene individually. We found 300 mW peak intensity, 1 kHz PRF, and 5 min 
duration to be the optimal settings for minimizing MMP1 and IL6 gene expression, and 1 kHz PRF 
to minimize MMP13 expression at any peak intensity or treatment duration. We also found 
1200 mW peak intensity to maximize COL1 gene expression at any PRF or treatment duration. 
We then sought to identify the overall optimal LIPUS parameter settings for maximizing desirable 
expression of all 4 genes. However, when optimizing for several responses together there were 
competing criteria. Since the importance, or weight, of each response was set to be equal, the 
overall optimal peak intensity favored the 3 genes which were minimized at 300 mW peak 
intensity, while resulting in a damped effect on COL1 expression (Table 4.6). These findings 
highlight the potential benefit of identifying a LIPUS dose for each desired disease-modifying 
activity as choosing a single dose may result in dampening of some responses. 
When constructing a DOE matrix, it is important to select a factor range that encompasses 
the entire applicable range for each factor, as this defines the design space for factor optimization. 
The factor ranges used in this study were selected based on previous literature and excluded higher 
intensities and treatment durations found to induce significant temperature elevations in our 
preliminary work. It is possible that the factor ranges chosen may not have included the actual 
optimum settings. However, results from this screening DOE inform the direction in which the 
current design space can be moved to approach the space where the optimal conditions can be 
found. We found that the model of COL1 expression was not significant, potentially due to a 
restricted design space. Future studies of COL1 modulation by LIPUS should include an expanded 
intensity range with consideration of potentially confounding thermal effects [145]. Expanding the 
peak intensity range may in turn broaden the effect range, improve the model fit, and ultimately 
increase the reliability of response predictions. 
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Validation experiments demonstrated variation in the accuracy of DOE predictions. While 
DOE predictions for IL6 and COL1 expression were within 17% of the actual values, predictions 
for MMP1 and MMP13 were 86% and 66% different, respectively, from actual values. This 
variation in accuracy suggests that our screening design may not have captured the complexity of 
the MMP1 and MMP13 gene expression response to LIPUS exposure. All 2k factorial DOEs, 
including the screening design utilized in this study, rely on the assumption that the effects of the 
factors on the response are linear within the design space. This assumes there is no curvature and 
may cause the model to miss the effect and incorrectly screen out a factor. It is possible that the 
effect of peak intensity, PRF, or duration reached a peak or plateau between the high and low 
levels. Therefore, in future studies, center points should be included in the factorial DOE to test 
the assumption of linearity and improve the accuracy of response predictions and factor 
optimization.  
While transducer operating frequency, number of treatments, and duty cycle were fixed in 
this study, their potential impact on AF-cell ECM gene expression warrant future study. Lower 
frequencies (0.5-1.0 MHz) are of interest as they are thought to be more relevant for penetrating 
to deep tissues such as the IVD. Moreover, cellular deformation and associated responses are 
thought to be frequency-dependent [178, 181]. Additionally, the number of LIPUS treatments has 
been consistently shown to influence ECM gene and protein expression in multiple cell types [85, 
156, 182, 183]. Finally, exploring the effect of duty cycle may allow the decoupling of pulse 
duration from PRF, which may have been a confounded variable in this study. 
We sought to investigate the effects of LIPUS parameters on ECM gene expression in 
inflammatory AF cells and hypothesized that ECM gene expression can be regulated by varying 
LIPUS exposure parameters. To test this hypothesis, a screening DOE was implemented. Overall, 
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the results suggest that the desired LIPUS modifying activity (i.e. anti-catabolism, anti-
inflammation, or ECM synthesis) can be specified by adjusting LIPUS parameter settings. 
Additionally, we identified PRF as the most influential main effect, and that duration interacted 
with PRF and peak intensity to influence MMP1 and IL6 gene expression, a finding which can be 
attributed to the use of DOE as an alternative to traditional OFAT methods. DOE is a powerful 
tool for factor exploration and optimization in the area of process development and manufacturing; 
however, to our knowledge, DOE has not previously been applied to study the effects of LIPUS 
parameters on IVD cells. This paper illustrates the capability and benefits of implementing DOE 
in the context of therapeutic ultrasound optimization. The results of this study may translate in the 
future to clinically relevant effects in human IVDs and could inform the application of patient- and 
condition-specific dosing to directly correct the metabolic imbalance that is often the driver of 
progressive IVD degeneration. 
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5 Magnetic nanoparticles synergize with pulsed magnetic fields to stimulate osteogenesis 
in-vitro 
The content of this chapter has been submitted as a research article to Tissue Engineering: Part A 
and is currently in review. The authors are as follows: Mohamed Habib*, Devante Horne*, Khalid 
Hussein, Dezba Coughlin,  Erik Waldorff, Nianli Zhang, James Ryaby, Jeffrey Lotz 
(*Equal Contribution) 
5.1 Impact Statement 
Novel approaches for stimulating new bone growth are necessary to overcome the challenge 
of delayed bone healing. In this study, we cultured mesenchymal stem cells with an iron-ion doped 
tri-calcium phosphate bone substitute (Fe-TCP) and exposed them to a pulsed electromagnetic 
field (PEMF) signal to investigate their effects on osteogenesis. We revealed the synergistic effects 
of Fe-TCP and PEMF and demonstrated that the combination of these technologies could provide 
a promising method for accelerating bone healing in a clinical setting. 
5.2 Introduction 
Delayed bone healing is a major challenge in orthopedic clinical practice, especially when 
treating patients with critical-size bone defects. For such indications, there is a need for 
technologies to overcome ineffective cell growth and osteogenic differentiation at the defect site 
[184, 185]. Recent strategies for enhanced bone healing include the development and application 
of new biomaterials [48, 153, 186, 187]. A novel aspect of new biomaterials is to utilize 
nanotechnology to incorporate trace elements within the construct [186]. Additionally, successful 
use of biomaterials for bone healing typically requires other technologies for construct stabilization 
and mechanical stimulation for optimal results [48, 153, 187, 188]. One such technical 
augmentation is the use of external magnetic fields [189, 190]. Beneficial synergism between 
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magnetic fields and biomaterials can occur by incorporating magnetic nanoparticles so as to 
modify the local stress environment, and thereby influence cellular activities, including 
proliferation and differentiation, by attaching to specific ion channels present on cellular 
membrane. Cells can thus be mechanically conditioned by remote magnetic actuation [190-192]. 
The most commonly used magnetic particles for biological applications are iron-ion based 
[193]. Iron oxide (Fe3O4) particles are known to be non-toxic and are eventually degraded in-vivo 
and incorporated into hemoglobin [194]. The mechanism of clinical effect is considered to be 
bone-cell adhesion, proliferation, and activation of mechano-transduction pathways [185, 190, 
191]. There have been several attempts to incorporate magnetic properties and evaluate their effect 
on bone regeneration under external static magnetic field stimulation (Table 5.1). In most of these 
studies, magnetite was used with hydroxyapatite (HA) [189, 190, 195, 196]. Alternative strategies 
include ion-doping of osteoconductive bioceramics [193, 197, 198], to develop magnetic nano-
bone substitutes (MNBS) that are intrinsically magnetic. Among different MNBS, hydroxyapatite 
(HA) is most frequently ion-doped with iron [193, 195], which has been shown to be non-toxic 
while enhancing cellular proliferation when combined with static external magnetic fields [199]. 
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Table 5.1 Summary of studies combining MNBS with external magnetic fields 
Ref. Composition Form Production Method Intrinsicality 
 Ms 
(emu/g) 
 External Mag. 
Field 
[195] Magnetite/HA Scaffold Infiltration No 0.94-0.24  Helmholtz coil 10 Oe / 50 Hz 
[199] Magnetite/HA Scaffold Ball mixing/Foaming No 34-53  MagnetoFACTOR-24 plate 320 mT  
[196] Fe-HA Powder Ion doped Yes 4.0-4.2  MagnetoFACTOR-24 plate 320 mT  
[190] Magnetite/Collagen/HA Scaffold Infiltration/Nucleation No 15-23 NdFeB magnet 1.2T 
[189] Magnetite/HA/PLA Scaffold Electrospinning No 0.049 NdFeB magnet 5-10T  
While this combination of MNBS with external magnetic fields may be useful for bone 
regeneration, there are challenges with the translation of this strategy into routine clinical practice. 
These include determining the optimal combination of a controllable external magnetic field with 
the properly designed MNBS. Most of the previous studies have used static magnetic fields in-
vitro [199, 200]. However, a dynamic, pulsed magnetic field has been shown to be superior for 
bone healing [187]. Consequently, we sought to  investigate the synergistic effects of an FDA-
approved Pulsed Electromagnetic Field (PEMF) signal with an Fe-ion doped tri-calcium phosphate 
bone substitute (Fe-TCP). We hypothesized that the osteogenic activity of standalone PEMF or 
MNBS will be significantly enhanced through their combined use.  
5.3 Methods 
5.3.1 Synthesis of Magnetic Nano Bone Substitute (MNBS) 
Intrinsically magnetic Fe-ion doped tri-calcium phosphate (MNBS) were obtained by 
substituting Ca2+ with Fe3+ cations, while maintaining the Ca + Fe / P molar ratio equal to 1.5 via 
the wet chemical process. Calcium nitrate tetrahydrate [Ca(NO3)2 • 4H2O] (Sigma Aldrich, 
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Germany), Di-ammonium hydrogen orthophosphate [(NH4)2HPO4] (Sigma Aldrich, India) and 
Iron (III)-chloride [FeCl3] (Sigma Aldrich, India) were used as a source of calcium, phosphorus, 
and iron ions, respectively. The pH of the solution was maintained at 9.5-10 by adding Ammonium 
hydroxide [NH4OH, ≤ 33% w/w] (EDWIC, Egypt) during the stirring of the reactant’s mixture. 
After the precipitation process, the solution was filtered, aged overnight, dried at 60°C for 24 
hours, and finally calcined at 800°C for 2 hours. The MNBS were sterilized with 25kGy gamma 
irradiation. 
5.3.2 Characterization of MNBS 
Phase composition of the MNBS were determined by X-ray diffraction (XRD) using AXS-
D8 Advance system (Bruker, Germany) equipped with a metal ceramic tube (Cu K-alpha 
wavelength = 1.5405981 Å at 1600 W, 40 kV, 40 mA). The samples were scanned at diffraction 
angles (2θ) between 20º and 60º with a step size of 0.02º 2θ per second.  
Functional groups of the MNBS were identified by Fourier transform infrared (FTIR) 
spectroscopy (FT-IR spectrometer 6100, JASCO, Japan), using KBr pellet technique in the range 
4000–400 cm−1, with a resolution of 8 cm−1). The powder sample was mixed with KBr salt at a 
concentration from 0.2% to 1%. The mixture was ground and then pressed into a small IR 
transparent pellet.  
The morphology of MNBS was studied by transmission electron microscopy (TEM) 
(JEOL 1010, Japan) operated at 80 kV accelerating voltage. Powder samples were suspended in 
ethanol at a concentration of 0.1 g/mL and ultrasonicated for 30 minutes to yield a homogeneous 
suspension. Carbon coated grids were dipped in the suspension and dried prior to their placement 
in a single tilt holder for TEM imaging. 
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Magnetic properties were evaluated using a vibrating sample magnetometer (VSM7410, 
Lakeshore, USA) with field from 0 to 25000 G (0 to 2.5 T) at room temperature to estimate the 
magnetic parameters of the material including remanent magnetization, coercitive force, and 
saturation magnetization. 
5.3.3 Cell Culture 
Human mesenchymal stem cells (hMSCs) (MSC-003, RoosterBio, Frederick, MD) were 
obtained from a single donor and expanded up to passage 2 using RoosterNourish™-MSC 
bioprocess media (KT-001, RoosterBio, Frederick, MD), which included RoosterBasal™-MSC 
media supplemented with 2% RoosterBooster™-MSC. Following expansion, hMSCs were 
cultured in MSC growth media (low-glucose, phenol-free DMEM with 10% FBS and 100U/mL 
Penicillin/Streptomycin). Medium was changed 3 times per week. Cells in all experimental groups 
were plated in monolayer at a seeding density of 2 x 104 cells/cm2 in standard 12-well cell culture 
plates and cultured in a cell culture incubator (37°C, 5% CO2). Cells were incubated for 24 hours 
to allow attachment before adding MNBS to respective wells. A MNBS solution was prepared by 
mixing MNBS with MSC growth media at a concentration of 0.2 mg/mL and sonicating to 
disaggregate particles before adding 2 mL of the solution to each well with adherent cells. Samples 
were then incubated for 24 hours to allow cells to interact with MNBS before PEMF treatment. 
5.3.4 Cell-MNBS Interaction 
Attachment and internalization of MNBS by hMSCs was assessed by both scanning 
electron microscopy (SEM) and transmission electron microscopy (TEM). For SEM, cells were 
seeded at a density of 2 x 104 cells/cm2 on silicon wafer substrates (16008, TED Pella, Inc., 
Redding, CA, USA) placed in a 6-well cell culture plate well. For TEM, cells were seeded at a 
density of 2 x 104 cells/cm2 on 35 mm glass-bottom dishes (P35G-1.5-14-C, MatTek Corp., 
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Ashland, MA, USA). Cells were incubated for 24 hours to allow attachment before adding the 
MNBS solution as described above. Cell-MNBS samples were fixed on day 4 of culture. All 
samples were rinsed with media, then fixed in 2.5% glutaraldehyde/2.5% PFA in 0.1 M sodium 
cacodylate buffer at pH 7.4 (15949, EMS, Hatfield, PA, USA) and incubated at room temp for at 
least 30 minutes. Samples prepared for SEM were imaged using the Hitachi S-5000 Scanning 
Electron Microscope System. Samples prepared for TEM were imaged using the Tecnai 12 
Transmission Electron Microscope. 
5.3.5 PEMF Treatment 
The PhysioStim® PEMF signal (Orthofix Medical Inc., Lewisville, TX) was used in this 
study. The signal consisted of a square wave with a 25% duty cycle, 3.85kHz pulse frequency, 
15Hz burst frequency, and a slew rate of 10 T/s. The in-vitro PEMF exposure system was powered 
by a 16V direct current power source and consists of a coil surrounding a multi-level stage that 
was placed inside an incubator. Cell culture plates were placed on this stage and exposed to PEMF 
waveform for 4 hours daily. Non-treated control samples were also placed on the PEMF stage with 
the power turned off. 
5.3.6 Cell Viability 
Cell viability was evaluated using the LIVE/DEAD® Viability/Cytotoxicity Kit (L3224, 
Molecular Probes, Eugene, OR, USA) and was qualitatively assessed by manufacturer’s 
instructions. Briefly, adherent cells were cultured with or without MNBS or PEMF treatment for 
up to 7 days. Cells were gently washed with PBS then stained with LIVE/DEAD reagent solution 
consisting of 2 µM Calcein-AM and 4µM EthD-1 in PBS. Samples were wrapped in aluminum 
foil and incubated at room temperature for 30 minutes. Following incubation, the glass slide with 
stained, adherent cells, was inverted and mounted on a microscope slide with 10 µL of 
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LIVE/DEAD reagent and sealed with fingernail polish. Labeled cells were imaged under a 
fluorescent microscope (DMi8, Leica, Germany). For quantitative analysis, fluorescence of control 
and experimental samples was measured using a microplate reader (Spectramax M5, Molecular 
Devices, Sunnyvale, CA, USA). The percentage of dead cells was calculated from the fluorescence 
readings as: /(012)!34567%/(012)489/(012)43:%;(012)489 	𝑥	100%, where F(645)sample is the fluorescence reading at 
645 nm in each experimental sample, F(645)min is the fluorescence reading at 645 nm in a sample 
where all the cells are dead and labeled with Calcein only, and F(645)max is the fluorescence reading 
at 645 nm in a sample where all the cells are dead and labeled with EthD-1 only. 
5.3.7 DNA and Alkaline Phosphatase Quantification 
Total ALP, including intracellular (cell lysate) and extracellular ALP (medium 
supernatant) was measured daily for 10 consecutive days with three biological replicates. Medium 
supernatant samples of 1 mL volume were collected at the time of harvest and with each medium 
change. Cells were harvested by incubating with 0.5% trypsin and subsequent scraping as needed 
to remove adhered cells from the culture plate. Cell samples were resuspended in FBS-containing 
medium and divided in half for either DNA or ALP-activity quantification. Alkaline phosphatase 
(ALP) activity was quantified using the ALP assay kit (ab83369, Abcam, Burlingame, CA, USA) 
according to the manufacturer's protocol. Briefly, cells were washed with PBS, resuspended in 
50µL of assay buffer, then homogenized for one minute at 2.4 m/s using a Bead Ruptor 24 Bead 
Mill Homogenizer (19040E, Omni International, Kennesaw, GA, USA). Media and cell samples 
were plated in a clear, 96-well microwell plate and absorbance was measured on a microplate 
reader (Spectramax M5) at OD 405 nm. ALP activity was quantified by referencing a standard 
curve and normalized by DNA content. DNA content was quantified using the Quant-iT PicoGreen 
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dsDNA Assay Kit (P11496, Thermo Fisher, Waltham, MA, USA) and measured on a microplate 
reader (Spectramax M5) with 480 nm absorption and 520 nm excitation. 
5.3.8 Alizarin Red Staining and Quantification 
Medium was aspirated and the cells were fixed with 10% formalin for 10 minutes followed 
by washing with D-PBS twice. Calcium deposit was stained using 2% Alizarin Red S Staining Kit 
(0223, ScienCell Research Lab., Carlsbad, CA, USA). Dye was added to each sample and 
incubated at room temperature for 30 minutes before washing with D-PBS. Stained samples were 
visualized via brightfield microscope (Nikon Eclipse E800). 
For quantification of Alizarin Red S (ARS) dye incorporation, the dye was extracted from 
the stained monolayer using cetylpyridinium the chloride (CPC) extraction method [201]. Briefly, 
350 mg of CPC (6004-24-66, Sigma) were dissolved in 10 mL of ddH2O to obtain a working 
solution, and 1 mL of the working solution was added to each well and incubated for 2 hours at 
37°C before aspiration. The aspirated samples were transferred to a 96-well plate and absorbance 
was measured on a microplate reader at OD 405 nm. ARS content was calculated using an ARS 
standard curve. 
5.3.9 Gene Expression Analysis 
 Gene expression levels of osteogenic markers were assessed on days 1, 4, and 7. To extract 
total RNA, cells were digested in TRIzol (15596018, Life Technologies, South San Francisco, 
USA) and homogenized using the Bead Ruptor as described above. RNA was isolated with two 
steps of chloroform extraction and purified with a RNeasy Mini Kit (74104, Qiagen, Redwood 
City, USA). cDNA was transcribed using the iScript cDNA Synthesis Kit (1708890, Bio-Rad, 
USA). RT-qPCR was performed using TaqMan Universal PCR Master Mix (4444557, Applied 
Biosystems, Foster City, CA, USA) and TaqMan primers and probe sets for osteopontin (SPP1), 
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bone morphogenetic protein-2 (BMP2), Alkaline Phosphatase (ALP), and osteocalcin (BGLAP). 
The B2M mRNA gene was co-amplified as an internal standard. Relative expression levels were 
calculated using the ∆∆Ct method [202], normalizing first to B2M then to the expression level 
measured in the MSC - PEMF group at day 1. 
5.3.10 Statistical Analysis 
 Statistical differences in ALP activity, ARS concentration, and relative gene expression 
were compared using one-way analysis of variance (ANOVA) among treatment groups, followed 
by Tukey HSD test for multiple comparisons. All analyses were performed using JMP® Pro, 
Version 13 (SAS Institute Inc, Cary, NC, USA). Data are depicted as mean ± standard deviation. 
P-values less than 0.05 were considered significant. 
5.4 Results 
5.4.1 MNBS Characteristics  
The synthesized MNBS has the crystal structure of the calcium iron hydro-phosphate 
Ca9FeH(PO4)7 with 85 nm average crystal size which exhibits good coherence with its respective 
JCPDS card no 89-0513 and small content of magnetite Fe3O4 (Figure 5.1 A). The FTIR spectra 
demonstrates that the vibrational modes of iron-doped MNBS, are similar to the characteristic 
vibrations of pure β-TCP and are apparently determined at 553, 602, 625, 940, 996, 1041, 1091 
and 1142 cm−1, with the obvious iron-doping effect by generating a new band at 871 cm-1 
(Figure 5.1 B). MNBS are predominantly agglomerated, with some isolated particles showing 
spheroidal and elongated shapes (nanoworms) and ranging in size from 100 to 150 nm 
(Figure 5.1 C). Magnetic properties of the MNBS were evaluated using VSM. The hysteresis 
curve displays ferromagnetic behavior with saturation magnetization (Ms) of 0.42515 emu/g and 
remanent magnetization (Mr) of 0.012805 emu/g (Figure 5.1 D). 
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Figure 5.1 Characterization of MNBS 
XRD pattern of the MNBS indicates the presence of Ca9FeH(PO4) primary phase (A), which is 
confirmed by FTIR spectra with the obvious iron-doping effect by generating a band at 871 cm-1 
(B). TEM image that shows the morphology of the MNBS; scale bar = 100 nm (C) and the 
magnetization curve in a function of the applied magnetic field up to 25 KG (D). 
5.4.2 MNBS - MSC Interaction 
 MNBS appeared to preferentially attach to and become internalized by the MSCs after two 
days of culture (Figure 5.2). Additionally, various morphologies of MNBS can be seen in high 
magnification SEM images, including particles ranging from 100 nm to 1 µm as well as single 
nanoparticles, nanoworms, and larger aggregates on the order of several µm. 
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Figure 5.2 Cell-MNBS interaction 
Representative images demonstrate the interaction between MSCs and MNBS. SEM images (A) 
highlight MNBS cell-surface attachment and internalization just below the cell surface (empty 
arrowhead) as single nanoparticles or nanoworms (solid arrowhead). TEM images (B) confirm 
MNBS internalization as both single nanoparticles (empty arrow) and nanoworm morphologies 
(solid arrow). While single MNBS are 100+ nm, smaller glycogenic particles (approx. 20 nm) are 
also apparent in TEM images (dashed circle). 
5.4.3 Cell Viability 
 Viability of hMSCs was not greatly impacted by PEMF or MNBS exposure for up to 7 
days (Figure 5.3). Quantitative assessment of cell viability indicated < 1% dead cells present in 
MSCs cultured with MNBS with or without PEMF treatment for 7 days. Quantification of cell 
viability herein only includes % dead cells, as we found that the Calcein-AM dye binds to the 
MNBS, creating an artifactual signal and giving greater than 100% live cells when normalized by 
cells-only.  
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Figure 5.3 Effect of PEMF and MNBS treatment on cell viability 
Representative images from LIVE/DEAD staining of hMSCs after 7 days of culture and treatment 
(green: live, red: dead); scale bar = 100 µm. (A) MSCs only without PEMF treatment; (B) MSCs 
only with PEMF treatment (C) MSCs cultured with MNBS without PEMF treatment; (D) MSCs 
cultured with MNBS with PEMF treatment. Cell viability was quantified by relative fluorescence 
readings at 645 nm. Values in red represent the percentage of dead cells. Neither PEMF nor MNBS 
treatment significantly affected cell viability. 
5.4.4 ALP Activity 
The total ALP activity of the PEMF-treated groups was significantly greater than 
corresponding samples that did not receive PEMF treatment at days 2, 3, 4, 5, and 9 (p < 0.01), 
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with an average increase of 2.47-fold (0.08 ± 0.04 U/ng DNA vs 0.21 ± 0.12 U/ng DNA) 
(Figure 5.4). The increase in total ALP appears to be largely driven by an increase in extracellular 
ALP activity, which was increased by 3.79-fold (0.04 ± 0.02 U/ng DNA vs 0.15 ± 0.09 U/ng DNA) 
(Figure 5.5). Note that the reduction in both the intracellular and extracellular ALP activity at days 
4 and 7 (Figure 5.4) is likely an artifact of medium changes which occurred on these days, as 
medium change may disrupt normal ALP activity. 
In addition to an increase in ALP activity with PEMF treatment, there is a notable shift in 
the day at which peak ALP activity is observed. While peak ALP activity in untreated MSCs is 
expected around day 14 [203], MSCs treated with PEMF demonstrated peak ALP activity at day 
5 and MSCs treated with both MNBS and PEMF demonstrated a greater shift to day 3, with total 
ALP significantly greater than all other groups at day 3 (p < 0.01) (Figures 5.4 and 5.5).  
 
Figure 5.4 Effect of PEMF and MNBS treatment on total ALP activity 
Total ALP activity remained low in samples without PEMF treatment. On day 2, 3, 4, 5, and 9, 
total ALP activity was increased with PEMF treatment alone, and was significantly greater than 
samples without PEMF treatment (* p< 0.01). On day 3, total ALP activity was significantly 
greater than all other groups (# p< 0.01). 
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Figure 5.5 Effect of PEMF and MNBS treatment on intra- and extracellular ALP activity 
Both intracellular and extracellular ALP activity remained low in samples without PEMF 
treatment. While intracellular ALP remained relatively low in all groups, PEMF treatment alone 
significantly increased extracellular ALP activity, and the combination of PEMF and MNBS 
further increased ALP Extracellular ALP activity and shifted peak ALP activity to day 3. 
Extracellular ALP activity was significantly greater in the PEMF + MNBS group at all time points 
starting at day 2 (p< 0.01). 
5.4.5 Mineralization 
ARS staining was present in all treatment groups, with the most staining visible in the 
MNBS + PEMF group on day 7 (Figure 5.6 A). On day 1, ARS concentration was greatest in the 
MNBS - PEMF group (0.016 ± 0.003 mM), which was significantly greater than all other groups 
(p < 0.01). On day 4, ARS concentration of the MNBS - PEMF group remained similar to day 1 
and was significantly greater than all groups (p < 0.01) except the MNBS + PEMF group, which 
had increased by 1.76-fold compared to day 1 (0.05 ± 0.001 mM  vs 0.028 ±  0.0006  mM). On 
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day 7, ARS concentration was greatest in the MNBS + PEMF group, which had increased by 1.30-
fold compared to day 4 (0.05  ±  0.002  mM  vs  0.06  ±  0.001  mM). 
Change in ARS concentration over time was quantified as the difference in ARS 
concentration from day 1 (Figure 5.6 B) to account for potential staining of residual MNBS in 
each sample. There was a continuous increase in ARS concentration over time in both of the 
PEMF-treated groups through day 7, with the MNBS + PEMF group demonstrating a significantly 
greater change in ARS concentration at 4 and 7 days compared to all other groups (p < 0.01). 
While the ARS concentration in the MSCs - PEMF group did not change from 1 to 4 days, it 
increased sharply at 7 days. The ARS concentration in the MNBS - PEMF group remained stable 
at 1 and 4 days and decreased at 7 days, likely due to removal of residual MNBS during media 
changes. 
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Figure 5.6 Representative images of Alizarin Red S staining for calcium deposits 
Images at 1 and 7 days of culture and treatment demonstrate differences in calcium deposition with 
treatment condition and duration (A). Change in Alizarin Red S concentration was quantified as 
the difference from the corresponding day 1 concentration for each group (B). MNBS + PEMF 
samples demonstrated continuously increasing concentration over time, with significantly greater 
change in Alizarin Red S concentration compared to all other groups at day 4 and day 7 
(* p < 0.01). 
5.4.6 Gene Expression 
Osteogenic performance was analyzed by measuring the gene expression of BMP-2 (cell 
growth and differentiation marker), ALP (marker of the initiation of osteogenesis), BGLAP and 
SPP1 (ossification and mineralization markers). The MSC - PEMF group exhibited low BMP-2 
expression at 1, 4, and 7 days (Figure 5.7). However, at 1 and 7 days, BMP-2 gene expression for 
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the MNBS + PEMF group was significantly greater than both the MSC - PEMF and MSC + PEMF 
groups (p < 0.0001), but similar to the MNBS - PEMF group.  
All groups exhibited continuously decreasing ALP expression at 1, 4, and 7 days 
(Figure 5.7). At 1 day, ALP gene expression for both of the MNBS - PEMF and MNBS + PEMF 
groups were significantly lower than MSC + PEMF group and the MNBS - PEMF group was 
significantly lower than the MSC - PEMF group (p < 0.05). On day 4 and 7, ALP expression in 
both the MNBS - PEMF and MNBS + PEMF groups were significantly lower than the 
MSC - PEMF and MSC + PEMF groups (p < 0.0001).  
All groups exhibited an overall increase in BGLAP expression at each timepoint, with only 
the MSC - PEMF group exhibiting a decrease in expression at 4 days (Figure 5.7). On day 1, 
BGLAP expression in the MNBS - PEMF group was significantly lower than the MSC - PEMF 
group (p < 0.05). On day 4, BGLAP expression in the MNBS + PEMF group was significantly 
greater than MSC - PEMF (p < 0.05). On day 7, BGLAP expression in the MNBS + PEMF group 
was significantly greater than all other groups (p < 0.05) and MNBS - PEMF was significantly 
greater than MSC + PEMF (p < 0.001).  
Both the MSC - PEMF and MSC + PEMF groups exhibited relatively low SPP1 gene 
expression at 1, 4, and 7 days (Figure 5.7). At 1, 4, and 7 days, SPP1 gene expression was 
significantly higher in both the MNBS - PEMF and MNBS + PEMF groups compared to 
MSC - PEMF and MSC + PEMF (p < 0.0001) and SPP1 expression in the MSC - PEMF group 
was significantly higher than MSC + PEMF on day 1 (p < 0.05), but not different at 4 and 7 days. 
Additionally, MNBS + PEMF SPP1 expression is significantly greater than all groups at 7 days (p 
< 0.001). 
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Figure 5.7 Osteogenic gene expression after 1, 4, and 7 days of treatment 
ALP expression was significantly reduced with MNBS + PEMF treatment at all time points, while 
BMP-2 expression was significantly increased at days 1 and 7. BGLAP expression was 
significantly greater at days 4 and 7, and SPP1 expression was significantly increased at all time 
points (* p < 0.05). 
5.5 Discussion  
We hypothesized that PEMF and MNBS would synergize to enhance bone healing. To test 
this hypothesis, we developed an iron-doped TCP nanoparticle material and characterized its 
material and magnetic properties along with its interaction with cells. Utilizing our MNBS and an 
FDA-approved PEMF signal, we treated hMSCs and observed peak ALP activity 2 days sooner 
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than PEMF alone, with 2.1-fold average increase in total ALP activity and 2.3-fold average 
increase in mineralization compared to the untreated control group. 
The main advantage of the ionic modification of β-TCP in this study is the addition of an 
intrinsic magnetization quality. We substituted the Ca2+ ions with Fe3+ ions to produce an intrinsic 
MNBS (Fe-TCP).  Both the XRD and FTIR specify the accommodation of iron ions as 
Ca9FeH(PO4) suggesting the substitution of two Fe3+ for three Ca2+ cations in the β-TCP lattice.  
Other MNBS formulations have been used in-vitro, including cobalt-based MNBS which 
have shown to have a dramatic inhibitive effect on cell proliferation even when the administered 
concentration was as low as 0.02 mg/mL [204].  However, the iron-based MNBS concentration of 
0.2 mg/mL in this study did not show a detrimental effect on the MSC viability (Figure 5.3). Due 
to the potential adverse effects and cytotoxic risk, magnetic materials such as cobalt are less 
favorable for biological research compared to iron-based materials [193]. Moreover, iron-based 
MNBS exhibit excellent properties for applications in bone regeneration including increased 
hydrophilicity, accelerated resorption, and apatite-forming ability. It has also been demonstrated 
that iron-based MNBS can stimulate osteogenesis in-vitro and demonstrates tissue 
biocompatibility and bone regenerative ability in-vivo [200, 205, 206]. 
The interaction between MNBS and MSCs likely occurred in two distinct steps: First, 
MNBS, in either a spherical or elongated “nanoworm” form (Figure 5.2), are initially attached to 
cell surface receptors, and second, MNBS are internalized by the cell (Figure 5.2). Nanoworm 
structures are believed to bind more cell surface receptors compared to the single, spherical NP, 
and facilitate their internalization [207]. 
Our observations of PEMF-only treatment are consistent with prior reports showing 
osteogenic differentiation. PEMF has been shown to affect various cellular responses, including 
 98 
cell proliferation, differentiation, and maturation [48, 153, 187]. Its effects are mostly well-known 
among musculoskeletal research, where PEMF has been shown to induce osteogenesis and bone 
tissue mineralization [187]. 
5.5.1 PEMF + MNBS stimulates early ALP activity, an initial marker for osteogenic 
activity  
While several groups have reported intracellular ALP activity in human mesenchymal stem 
cells over time [208, 209], to our knowledge we are the first group to report total ALP activity by 
assessing all cells, media, and media changes daily throughout 10 days of culture. 
ALP is a well-known marker for osteogenic activity and bone-cell differentiation and is 
essential to supply phosphate for bone mineral, as lack of ALP leads to under-mineralization of 
bone [210]. Successful osteogenesis is commonly indicated by high ALP levels, which 
mineralization of the bone matrix ensues. Therefore, we assessed ALP expression enzymatically, 
histochemically, and at the mRNA level over time to investigate the synergistic effect of PEMF 
and MNBS on in-vitro osteogenesis.  
In an earlier study, the combined treatment of BMP-2 and PEMF showed an increase in 
ALP gene expression during the differentiation phase of rat primary osteoblasts cells with 
maximum ALP activity at day 14 [211]. Our data indicates a shift in peak ALP activity to day 3 
with PEMF + MNBS treatment (Figure 5.4). This is notably earlier than PEMF treatment alone, 
which also induced earlier-than-nominal peak ALP activity at day 5. Moreover, we did not observe 
a significant change in ALP activity over time in the non-treated control group. This finding aligns 
well with findings of others, which has shown that nominal peak in-vitro ALP activity occurs at 
the end of the cell differentiation and proliferation stage from days 5 to 14 with decreasing ALP 
levels thereafter [203], suggesting that PEMF treatment alone may stimulate early ALP activity 
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that is further shifted when additional receptions for the transduction of the PEMF energy by the 
cell are presented by the attachment and internalization of MNBS. This shift to earlier peak ALP 
activity can be accounted for by an increase in extracellular ALP activity in MNBS + PEMF 
samples (Figure 5.5). In addition, gene expression results showed high ALP expression initially, 
followed by decreasing expression over time for all treatment groups (Figure 5.7). This trend in 
ALP expression was in parallel with an increase in osteocalcin (BGLAP) expression for all groups 
and an increase in osteopontin (SPP1) expression for the PEMF + MNBS group over time. Our 
results are consistent with those of others which shows a decrease in ALP activity over time as 
mineralization increases [208, 212]. 
5.5.2 PEMF + MNBS stimulates stable increase in calcium deposition, an indicator of 
osteogenic maturation 
Our data indicate a stable increase in calcium deposition through 7 days of treatment with 
PEMF + MNBS at levels significantly greater than PEMF treatment alone, as demonstrated by 
ARS staining and quantification (Figure 5.6). This contrasted with the non-treated control group, 
which had a low concentration of calcium deposits through day 4 followed by a peak at day 7. In 
addition, this trend in calcium deposition was in parallel with gene expression results indicating a 
gradual and significant increase in osteocalcin (BGLAP) and osteopontin (SPP1) expression over 
time. 
Our study is limited by potential artifactual trends throughout our time course experiments 
due to medium changes. We observed a dip in extracellular ALP activity on the days where media 
were changed, which may be due to disruption of the signaling cascade driven by secreted factors 
in the media. However, to our knowledge, this is the first in-vitro study of ALP activity to include 
intracellular and extracellular ALP and is strengthened by the fact that all ALP activity was 
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evaluated through a 10-day time course, allowing us to capture this change in activity 
corresponding with media changes.  Another limitation is the potential staining of MNBS by ARS, 
causing artifactual signal in the quantification of calcium deposition. While samples were 
thoroughly washed to remove excess MNBS, particles adhered to or internalized by MSCs 
remained present and may have been stained. Specifically, ARS signal was observed in samples 
with MNBS on day 1 of culture, before the expected initiation of osteogenesis. Fan et al., 
demonstrated that alizarin red can be removed from an aqueous environment by magnetic chitosan 
or polypyrrole nanoparticles [213], which could explain the results seen at day 1. However, after 
7 days, there was a significant increase in ARS signal due to the synergistic effect of MNBS 
combined with PEMF treatment that is large enough to overcome the noise of the MNBS-staining 
artifact, while PEMF-treatment alone did not significantly increase mineralization at any time 
point. Moreover, our ARS results align with our gene expression results for BGLAP and SPP1, 
which are not susceptible to artifactual signals from the MNBS. 
Despite these limitations, we demonstrate statistically significant effects in-vitro that may 
translate in the future to clinically relevant effects in humans. Potential clinical indications would 
include accelerated bone regeneration for large bone defects where bone healing takes several 
months and may also benefit patients with osteoporosis to counter decreasing bone density. 
Additionally, the PEMF + MNBS system may also be applied to other cell types such as cartilage, 
and intervertebral disc cells. There is an additional safety benefit to utilizing this combination 
therapy in that it allows localized treatment delivery to the injury site. Other therapies for 
stimulating bone growth, such as growth factor injections, cause excess bone growth [214] 
potentially cause aberrant effects (e.g. spinal stenosis). 
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In summary, we observed that PEMF treatment combined with MNBS synergistically 
stimulated early peak ALP expression and significantly upregulated calcium deposition over time 
in hMSCs. By demonstrating this synergistic effect of PEMF and MNBS on osteogenesis, these 
findings support that this combination therapy may provide a method for accelerated bone healing. 
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6 Conclusions and Future Work 
6.1 Summary and Main Conclusions 
The experiments performed in this dissertation represent significant contributions to the 
development of two novel energy-based therapies for painful spine conditions. This work 
demonstrates the design and application of pre-clinical systems for therapeutic ultrasound and 
magnetic-field exposure, along with the thorough assessment of responses at tissue, cellular, and 
molecular levels. The findings described in this dissertation are a pivotal pre-clinical step towards 
the advancement of energy-based therapeutics to clinical use. In Chapter 2, we demonstrate the 
technical feasibility of targeted, noninvasive delivery of acoustic energy to rat-tail intervertebral 
discs (IVD) and assessment of biological responses to Low-intensity Pulsed Ultrasound (LIPUS) 
exposure. We found that LIPUS exposure regulates extracellular matrix (ECM) and inflammatory 
gene expression in rat-tail IVDs with increased pro-inflammatory gene expression. Chapter 3 
describes the design, fabrication, characterization, and validation of an in-vitro LIPUS 
exposimetry system for delivering uniform acoustic energy to distal targets with negligible heating. 
We found that far-field LIPUS exposure upregulates total collagen content in annulus fibrosus 
cells with a magnitude similar to growth factor treatment. Chapter 4 presents the use and validation 
of Design of Experiments (DOE) for LIPUS parameter exploration, response prediction, and 
optimization. The LIPUS system described in Chapter 3 was used, and we found that Pulse 
Repetition Frequency (PRF) was the most significant factor for modulating catabolic and pro-
inflammatory gene expression while peak intensity was most significant for modulating anabolic 
gene expression, and that both factors interacted with treatment duration to influence ECM gene 
expression in inflammatory annulus fibrosus cells. Lastly, in Chapter 5 we show that magnetic 
nanoparticles (MNBS) synergize with pulsed electromagnetic fields (PEMF) to accelerate the 
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induction of osteogenesis by stimulating early peak alkaline phosphatase (ALP) activity and 
upregulating calcium deposition over time in mesenchymal stem cells (MSCs). Taken together, 
these studies support the following main conclusions: 
(1) LIPUS energy can be delivered noninvasively to damaged IVDs in-vivo to stimulate 
anabolic and anti-inflammatory gene expression; 
(2) Annulus fibrosus cells exposed to far-field LIPUS demonstrate increased total collagen 
synthesis at a magnitude similar to growth factor treatment; 
(3) Metabolic activity in annulus fibrosus cells is influenced by LIPUS pulse repetition 
frequency, peak intensity, and treatment duration settings, and; 
(4) Combining magnetic nanoparticles with PEMF accelerates peak ALP activity and 
mineralization rate in MSCs.  
6.2 Interpretation of Key Findings 
In Chapter 2 we demonstrated the technical feasibility of targeted delivery of LIPUS energy 
to rat-tail IVDs and assessment of tissue response via gene expression analysis. While several 
previously published studies have demonstrated anabolic and anti-catabolic activity in IVD cells 
with LIPUS exposure, to our knowledge, this was the first published in-vivo study of LIPUS 
bioeffects in IVDs with acute injury. We found that LIPUS increases type II collagen gene 
expression and reduces TNFα gene expression in inflammatory discs, suggesting that previously 
observed in-vitro LIPUS effects may translate in-vivo. These findings motivated the development 
of the robust in-vitro system that was used to the parametric studies described in Chapters 3 and 
4, respectively. The findings in Chapter 2 where supported by results in Chapter 3 and 4, which 
also showed LIPUS-induced matrix synthesis and anti-inflammatory activity. Specifically, in 
Chapter 2 we observed anabolic and anti-inflammatory effects only in rats with high expression of 
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IL6 after injury, a finding was supported by results in Chapter 4. In Chapter 3, we fabricated, 
characterized, and validated a pre-clinical, in-vitro model for delivering uniform LIPUS energy to 
cell cultures which included an acoustic standoff for low frequency sources to place target samples 
within the uniform acoustic far-field. We show that by exposing IVD cells to far-field LIPUS 
energy, collagen synthesis was increased with a magnitude similar to that of growth factor 
treatment. While intradiscal growth factor injections have shown some promise, this technique 
suffers from long-term safety and efficacy concerns, likely due to the potential depressurization 
and reduction in mechanical integrity of the disc. However, our results indicate the potential to 
noninvasively stimulate the repair of damaged IVD tissues. Moreover, compared to typical near-
field LIPUS systems described in literature, our far-field system is more clinically relevant for 
extracorporeal stimulation of deep tissues such as the IVD. We also introduced the novel use of 
gradient analysis to evaluate the uniformity of acoustic intensity fields and demonstrated that 
typical systems may be more susceptible to acoustic artifacts that my result in inaccurate or 
inconsistent dosing. By mitigating these acoustic artifacts, and thereby removing potentially 
confounding factors, we could successfully use this LIPUS system in parametric studies. In 
Chapter 4, we evaluated LIPUS dosing parameters using DOE and found PRF to be the most 
influential factor for stimulating anti-catabolic and anti-inflammatory activity in inflammatory 
annulus fibrosus cells. When PRF was varied, total energy was held constant, suggesting that the 
cells may be sensing and responding to pulsing characteristics such as pulse duration and 
frequency. One possibility is that the long pulse intervals of the low PRF group are less efficiently 
transduced by mechanosensitive cell receptors, resulting in a damped response. While type I 
collagen gene expression was not increased with LIPUS exposure, there was a significant 
reduction in the expression of matrix metalloproteinase 1 and 13, which are the primary enzymes 
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capable of cleaving interstitial collagen molecules. The reduction in catabolic gene expression 
observed in Chapter 4 may explain the increase in collagen content observed in Chapter 3. Chapter 
4 illustrates the capability and benefits of implementing DOE for exploring dose-response 
relationships in energy-based therapeutics and motivates expanding the use of DOE to other 
modalities such as PEMF. Chapter 5, we evaluated interactions between MNBS and PEMF and 
found synergistic effects on ALP activity and mineralization in MSCs. By demonstrating an 
acceleration of the onset of osteogenesis as well as an increase in mineralization over time, these 
findings support the use of PEMF and MNBS as a combination therapy for accelerating bone 
healing. These results also suggest that by introducing MNBS to enhancing the effects of PEMF 
alone, it may be possible to reduce the overall dose of PEMF without sacrificing efficacy, and in 
turn reduce the potential for off target effects. 
This dissertation presents novel contributions to the development of two energy-based 
therapeutics that could potentially translate to improved patient outcomes in the clinical 
management of low back pain. Overall, we found dose-response relationships between LIPUS and 
annulus fibrosus cells, which may inform patient-specific dosing, and we identified synergistic 
effects from the combination of PEMF and MNBS, which may be used to improve success rates 
in spinal fusion cases. Notably, our results demonstrate consistent anabolic and anti-inflammatory 
activity in inflammatory disc cells exposed to LIPUS both in-vitro and in-vivo and show that these 
effects may be influenced by LIPUS parameter settings. Taken together, this suggest that future 
clinical use could benefit from patient-specific dosing. However, LIPUS may not be effective in 
cases of severe IVD degeneration which may ultimately require spinal fusion. The synergistic 
effects observed in our study of PEMF and MNBS motivates its potential in rescuing unsuccessful 
fusions by accelerating the onset of osteogenesis and increasing mineralization rates.  
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6.3 Future Work 
In Chapter 4 we demonstrated the successful use of screening DOE to identify factors and 
interactions that influence ECM gene expression and to predict gene expression responses with 
reasonable accuracy. These will inform expanded parameter ranges to be used in more complex 
(i.e. non-linear) modeling of responses via Response Surface Methodology. Data from this study 
may expand effect ranges, improve model fit, and ultimately increase the reliability of response 
predictions. The in-vitro experiments presented in Chapter 5 could be expanded upon in future 
studies to investigate whether our findings translate to an in-vivo model of spinal fusion. These 
studies will require the development of an in-vivo nanoparticle carrier and delivery method which 
could include the injection or implantation of a hydrogel or 3D-printed scaffold.   
Collectively, the work presented in this dissertation is of great importance for the 
advancement of energy-based therapeutics for IVD injuries. These findings will motivate the novel 
use of noninvasive, energy-based therapeutics to improve clinical outcomes for patients 
experiencing low back pain. 
  
 7 Bibliography 
1. Vallfors B (1985) Acute, subacute and chronic low back pain: clinical symptoms,
absenteeism and working environment. Scand J Rehabil Med Suppl 11:1–98.
2. DePalma MJ, Ketchum JM, Saullo T (2011) What Is the Source of Chronic Low Back
Pain and Does Age Play a Role? Pain Med 12:224–233. doi: 10.1111/j.1526-
4637.2010.01045.x
3. Peng B-G (2013) Pathophysiology, diagnosis, and treatment of discogenic low back
pain. World J Orthop 4:42. doi: 10.5312/wjo.v4.i2.42
4. Guterl CC, See EY, Blanquer S (2013) Challenges and strategies in the repair of
ruptured annulus fibrosus. European Cells and Materials 25:1–21. doi:
10.22203/ecm.v025a01
5. DePalma MJ, Ketchum JM, Saullo TR, Laplante BL (2012) Is the History of a
Surgical Discectomy Related to the Source of Chronic Low Back Pain? Pain
Physician 15:E53–E58.
6. Likhitpanichkul M, Dreischarf M (2014) Fibrin-genipin adhesive hydrogel for
annulus fibrosus repair: performance evaluation with large animal organ culture, in
situ biomechanics, and in vivo …. European Cells and Materials 28:25–38. doi: 
10.22203/ecm.v028a03 
7. Handa T, Ishihara H, Ohshima H, et al (1997) Effects of hydrostatic pressure on
matrix synthesis and matrix metalloproteinase production in the human lumbar
intervertebral disc. SPINE 22:1085–1091. doi: 10.1097/00007632-199705150-00006
 8. Matsumoto T, Kawakami M, Kuribayashi K, et al (1999) Cyclic mechanical stretch
stress increases the growth rate and collagen synthesis of nucleus pulposus cells in
vitro. SPINE 24:315–319. doi: 10.1097/00007632-199902150-00002
9. Reza AT, Nicoll SB (2007) Hydrostatic Pressure Differentially Regulates Outer and
Inner Annulus Fibrosus Cell Matrix Production in 3D Scaffolds. Ann Biomed Eng
36:204–213. doi: 10.1007/s10439-007-9407-6
10. Lee CR, Sakai D, Nakai T, et al (2007) A phenotypic comparison of intervertebral
disc and articular cartilage cells in the rat. Eur Spine J 16:2174–2185. doi:
10.1007/s00586-007-0475-y
11. Lotz JC, Fields AJ, Liebenberg EC (2013) The Role of the Vertebral End Plate in Low
Back Pain:. Global Spine J. doi: 10.1055/s-0033-1347298
12. Skaggs DL, Weidenbaum M, latridis JC, et al (1994) Regional Variation in Tensile
Properties and Biochemical Composition of the Human Lumbar Anulus Fibrosus.
SPINE 19:
13. MARCHAND F, AHMED AM (1990) Investigation of the Laminate Structure of
Lumbar Disc Anulus Fibrosus. SPINE 15:
14. Cloyd JM, Malhotra NR, Weng L, et al (2007) Material properties in unconfined
compression of human nucleus pulposus, injectable hyaluronic acid-based hydrogels
and tissue engineering scaffolds. Eur Spine J 16:1892–1898. doi: 10.1007/s00586-
007-0443-6
15. Wong J, Sampson SL, Bell-Briones H, et al (2019) Nutrient supply and nucleus
pulposus cell function: effects of the transport properties of the cartilage endplate and
 potential implications for intradiscal biologic therapy. Osteoarthritis and Cartilage 
27:956–964. doi: 10.1016/j.joca.2019.01.013 
16. Dolor A, Sampson SL, Lazar AA, et al (2019) Matrix modification for enhancing the
transport properties of the human cartilage endplate to improve disc nutrition. PLoS
ONE 14:e0215218–18. doi: 10.1371/journal.pone.0215218
17. Roberts S, Evans H, TRIVEDI J, MENAGE J (2006) HISTOLOGY AND
PATHOLOGY OF THE HUMAN INTERVERTEBRAL DISC. The Journal of Bone
and Joint Surgery-American Volume 88:10–14. doi: 10.2106/00004623-200604002-
00003
18. Pattappa G, Li Z, Peroglio M, et al (2012) Diversity of intervertebral disc cells:
phenotype and function. Journal of Anatomy 221:480–496. doi: 10.1111/j.1469-
7580.2012.01521.x
19. Hastreiter D, Ozuna RM, Spector M (2001) Regional variations in certain cellular
characteristics in human lumbar intervertebral discs, including the presence of α‐
smooth muscle actin. J Orthop Res 19:597–604. doi: 10.1016/S0736-0266(00)00069-
3
20. Bron JL, Helder MN, Meisel H-J, et al (2008) Repair, regenerative and supportive
therapies of the annulus fibrosus: achievements and challenges. Eur Spine J 18:301–
313. doi: 10.1007/s00586-008-0856-x
21. Smith LJ, Nerurkar NL, Choi K-S, et al (2011) Degeneration and regeneration of the
intervertebral disc: lessons from development. Dis Model Mech 4:31–41. doi:
10.1242/dmm.006403
 22. Roberts S, Evans H, TRIVEDI J, MENAGE J (2006) Histology and Pathology of the
Human Intervertebral Disc. J Bone Joint Surg Am 88:10. doi: 10.2106/JBJS.F.00019
23. Yoon ST, Patel NM (2006) Molecular therapy of the intervertebral disc. Eur Spine J
15:379–388. doi: 10.1007/s00586-006-0155-3
24. Roberts S (2002) Disc morphology in health and disease. Biochem Soc Trans 30:864–
869. doi: 10.1042/bst0300864
25. Freemont AJ (2009) The cellular pathobiology of the degenerate intervertebral disc
and discogenic back pain. Rheumatology (Oxford) 48:5–10. doi:
10.1093/rheumatology/ken396
26. Dowdell J, Erwin M, Choma T, et al (2017) Intervertebral Disk Degeneration and
Repair. Neurosurgery 80:S46–S54. doi: 10.1093/neuros/nyw078
27. Boos N, Weissbach S, Rohrbach H, et al (2002) Classification of age-related changes
in lumbar intervertebral discs: 2002 Volvo Award in basic science. SPINE 27:2631–
2644. doi: 10.1097/00007632-200212010-00002
28. Schroeder GD, Guyre CA, Vaccaro AR (2016) The epidemiology and
pathophysiology of lumbar disc herniations. Seminars in Spine Surgery 28:2–7. doi:
10.1053/j.semss.2015.08.003
29. Berg-Johansen B, Fields AJ, Liebenberg EC, et al (2017) Structure-function
relationships at the human spinal disc-vertebra interface. J Orthop Res 38:1491–10.
doi: 10.1002/jor.23627
30. Ghannam M, Jumah F, Mansour S, et al (2017) Surgical anatomy, radiological
features, and molecular biology of the lumbar intervertebral discs. Clin Anat 30:251–
266. doi: 10.1002/ca.22822
 31. Auerbach JD, Johannessen W, Borthakur A, et al (2006) In vivo quantification of
human lumbar disc degeneration using T(1rho)-weighted magnetic resonance
imaging. Eur Spine J 15 Suppl 3:S338–44. doi: 10.1007/s00586-006-0083-2
32. Fields AJ, Battié MC, Herzog RJ, et al (2019) Measuring and reporting of vertebral
endplate bone marrow lesions as seen on MRI (Modic changes): recommendations
from the ISSLS Degenerative Spinal Phenotypes Group. Eur Spine J 28:2266–2274.
doi: 10.1007/s00586-019-06119-6
33. Carragee EJ, Don AS, Hurwitz EL, et al (2009) 2009 ISSLS Prize Winner: Does
Discography Cause Accelerated Progression of Degeneration Changes in the Lumbar
Disc: A Ten-Year Matched Cohort Study. SPINE 34:2338–2345. doi:
10.1097/BRS.0b013e3181ab5432
34. OSTI OL, VERNONROBERTS B, MOORE R, FRASER RD (1992) Annular Tears
and Disk Degeneration in the Lumbar Spine - a Postmortem Study of 135 Disks. J
Bone Joint Surg Br 74:678–682.
35. Thomas Edwards W, Ordway NR, Zheng Y, et al (2001) Peak Stresses Observed in
the Posterior Lateral Anulus. SPINE 26:1753.
36. Urban JP, McMullin JF (1988) Swelling pressure of the lumbar intervertebral discs:
influence of age, spinal level, composition, and degeneration. 13:179–187.
37. Urban JP, McMullin JF (1988) Swelling pressure of the lumbar intervertebral discs:
influence of age, spinal level, composition, and degeneration. SPINE 13:179–187.
doi: 10.1097/00007632-198802000-00009
38. Urban JP, Roberts S (2003) Degeneration of the intervertebral disc. Arthritis Res Ther
2003 5:3 5:1. doi: 10.1186/ar629
 39. Vergroesen PPA, Kingma I, Emanuel KS, et al (2015) Mechanics and biology in
intervertebral disc degeneration: a vicious circle. Osteoarthritis and Cartilage
23:1057–1070. doi: 10.1016/j.joca.2015.03.028
40. Chen M-H, Sun J-S, Liao S-Y, et al (2015) Low-intensity pulsed ultrasound stimulates
matrix metabolism of human annulus fibrosus cells mediated by transforming growth
factor β1 and extracellular signal-regulated kinase pathway. Connective Tissue
Research 56:219–227. doi: 10.3109/03008207.2015.1016609
41. Hukins DWL, Meakin JR (2015) Relationship Between Structure and Mechanical
Function of the Tissues of the Intervertebral Joint. Am Zool 40:42–052.
42. Guiot BH, Fessler RG (2000) Molecular biology of degenerative disc disease.
Neurosurgery 47:1034–1040. doi: 10.1097/00006123-200011000-00003
43. Naqvi SM, Buckley CT (2016) Bone Marrow Stem Cells in Response to Intervertebral
Disc-Like Matrix Acidity and Oxygen Concentration: Implications for Cell-based
Regenerative Therapy. SPINE 41:743–750. doi: 10.1097/BRS.0000000000001314
44. Horner HA, Urban JP (2001) 2001 Volvo Award Winner in Basic Science Studies:
Effect of nutrient supply on the viability of cells from the nucleus pulposus of the
intervertebral disc. 26:2543–2549. doi: 10.1097/00007632-200112010-00006
45. Gilbert HTJ, Hodson N, Baird P, et al (2016) Acidic pH promotes intervertebral disc
degeneration: Acid-sensing ion channel -3 as a potential therapeutic target. Sci Rep
6:37360. doi: 10.1038/srep37360
 46. Gabr MA, Jing L, Helbling AR, et al (2011) Interleukin-17 synergizes with IFNγ or
TNFα to promote inflammatory mediator release and intercellular adhesion molecule-
1 (ICAM-1) expression in human intervertebral disc cells. J Orthop Res 29:1–7. doi:
10.1002/jor.21206
47. Burke JG, Watson RWG, McCormack D, et al (2002) Intervertebral discs which cause
low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br
84:196–201. doi: 10.1302/0301-620x.84b2.12511
48. Miller SL, Coughlin DG, Waldorff EI, et al (2016) Pulsed electromagnetic field
(PEMF) treatment reduces expression of genes associated with disc degeneration in
human intervertebral disc cells. Spine J 16:770–776. doi:
10.1016/j.spinee.2016.01.003
49. Le Maitre CL, Freemont AJ, Hoyland JA (2005) The role of interleukin-1 in the
pathogenesis of human Intervertebral disc degeneration. Arthritis Res Ther 2003 5:3
7:1–14. doi: 10.1186/ar1732
50. Rajasekaran S, Bajaj N, Tubaki V, et al (2013) ISSLS Prize winner: The anatomy of
failure in lumbar disc herniation: an in vivo, multimodal, prospective study of 181
subjects. SPINE 38:1491–1500. doi: 10.1097/BRS.0b013e31829a6fa6
51. Hegewald AA, Medved F, Feng D, et al (2013) Enhancing tissue repair in annulus
fibrosus defects of the intervertebral disc: analysis of a bio-integrative annulus implant
in an in-vivoovine model. J Tissue Eng Regen Med 9:405–414. doi:
10.1002/term.1831
52. SMITH JW, WALMSLEY R (1951) Experimental incision of the intervertebral disc.
J Bone Joint Surg Br 33-B:612–625.
 53. Hampton D, Laros G, McCarron R, Franks D (1989) Healing potential of the anulus
fibrosus. SPINE 14:398–401.
54. OSTI OL, Vernon-Roberts B, FRASER RD (1990) 1990 Volvo Award in
Experimental Studies: Anulus Tears and Intervertebral Disc Degeneration: An
Experimental Study Using an Animal Model. SPINE 15:762–767. doi:
10.1097/00007632-199008010-00005
55. Ahlgren BD, Vasavada A, Brower RS, et al (1994) Anular incision technique on the
strength and multidirectional flexibility of the healing intervertebral disc. SPINE
19:948–954.
56. Phillips FM, Slosar PJ, Youssef JA, et al (2013) Lumbar spine fusion for chronic low
back pain due to degenerative disc disease: a systematic review. SPINE 38:E409–22.
doi: 10.1097/BRS.0b013e3182877f11
57. Omidi-Kashani F, Hasankhani EG, Ashjazadeh A (2014) Lumbar Spinal Stenosis:
Who Should Be Fused? An Updated Review. Asian Spine Journal 8:521–530. doi:
10.4184/asj.2014.8.4.521
58. Hedlund R, Johansson C, Hägg O, et al (2016) The long-term outcome of lumbar
fusion in the Swedish lumbar spine study. The Spine Journal 16:579–587. doi:
10.1016/j.spinee.2015.08.065
59. Yoshihara H, Yoneoka D (2015) National trends in the surgical treatment for lumbar
degenerative disc disease: United States, 2000 to 2009. The Spine Journal 15:265–
271. doi: 10.1016/j.spinee.2014.09.026
60. Xu X-M, Zhang G, Wang F, et al (2016) Bone Graft Options for Spine Fusion in
Adolescent Patients with Idiopathic Scoliosis. Chinese Medical Journal 129:105–107.
doi: 10.4103/0366-6999.172605
61. Reid PC, Morr S, Kaiser MG (2019) State of the union: a review of lumbar fusion
indications and techniques for degenerative spine disease. Journal of Neurosurgery:
Spine 31:1–14. doi: 10.3171/2019.4.SPINE18915
62. Cottrill E, Pennington Z, Ahmed AK, et al (2019) The effect of electrical stimulation
therapies on spinal fusion: a cross-disciplinary systematic review and meta-analysis
of the preclinical and clinical data. Journal of Neurosurgery: Spine 32:106–126. doi:
10.3171/2019.5.SPINE19465
63. Knaub MA, Won DS, McGuire R, Herkowitz HN (2005) Lumbar spinal stenosis:
indications for arthrodesis and spinal instrumentation. Instr Course Lect 54:313–319.
64. Schek RM, Orthopaedics LAPWMDO, Medicine MSSO, et al (2011) Genipin-
crosslinked fibrin hydrogels as a potential adhesive to augment intervertebral disc
annulus repair. European Cells and Materials 21:373–383. doi:
10.22203/ecm.v021a28
65. Chan S, Gantenbein-Ritter B (2012) Intervertebral disc regeneration or repair with
biomaterials and stem cell therapy - feasible or fiction? Swiss Med Wkly 1–12. doi:
10.4414/smw.2012.13598
66. Kennon JC, Awad ME, Chutkan N, et al (2018) Current insights on use of growth
factors as therapy for Intervertebral Disc Degeneration. Biomol Concepts 9:43–52.
doi: 10.1515/bmc-2018-0003
67. Miyamoto K, An HS, Sah RL, et al (2005) Exposure to pulsed low intensity ultrasound
stimulates extracellular matrix metabolism of bovine intervertebral disc cells cultured
in alginate beads. SPINE 30:2398–2405. doi: 10.1097/01.brs.0000184558.44874.c0
68. Huang Y-C, Urban JPG, Luk KDK (2014) Intervertebral disc regeneration: do
nutrients lead the way? Nature Publishing Group 10:561–566. doi:
10.1038/nrrheum.2014.91
69. Vasiliadis ES, Pneumaticos SG, Evangelopoulos DS, Papavassiliou AG (2014)
Biologic treatment of mild and moderate intervertebral disc degeneration. Mol Med
20:400–409.
70. Masuda K, Imai Y, Okuma M, et al (2006) Osteogenic Protein-1 Injection Into a
Degenerated Disc Induces the Restoration of Disc Height and Structural Changes in
the Rabbit Anular Puncture Model. SPINE 31:
71. Gilbertson L, Ahn S-H, Teng P-N, et al (2008) The effects of recombinant human
bone morphogenetic protein-2, recombinant human bone morphogenetic protein-12,
and adenoviral bone morphogenetic protein-12 on matrix synthesis in human annulus
fibrosis and nucleus pulposus cells. The Spine Journal 8:449–456. doi:
10.1016/j.spinee.2006.11.006
72. Chujo T, An HS, Akeda K, et al (2006) Effects of growth differentiation factor-5 on
the intervertebral disc--in vitro bovine study and in vivo rabbit disc degeneration
model study. SPINE 31:2909–2917. doi: 10.1097/01.brs.0000248428.22823.86
73. O'Connell GD, Malhotra NR, Vresilovic EJ, et al (2011) The effect of discectomy and
the dependence on degeneration of human intervertebral disc strain in axial
compression. ncbinlmnihgov 36:1765–1771. doi: 10.1097/BRS.0b013e318216752f
74. Illing RO, Kennedy JE, Wu F, et al (2005) The safety and feasibility of extracorporeal
high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney
tumours in a Western population. British Journal of Cancer 93:890–895.
75. Zhu L, Altman MB, Laszlo A, et al (2019) Ultrasound Hyperthermia Technology for
Radiosensitization. Ultrasound in Medicine & Biology 45:1025–1043.
76. Mizrahi N, Zhou EH, Lenormand G, et al (2012) Low intensity ultrasound perturbs
cytoskeleton dynamics. Soft Matter 8:2438–2443.
77. Escoffre JM, Bouakaz A (2016) Therapeutic Ultrasound. doi: 10.1007/978-3-319-
22536-4
78. Kristiansen TK, Ryaby JP, McCabe J, et al (1997) Accelerated healing of distal radial
fractures with the use of specific, low-intensity ultrasound - A multicenter,
prospective, randomized, double-blind, placebo-controlled study. J Bone Joint Surg
Am 79A:961–973.
79. Hayton MJ, Dillon JP, Glynn D, et al (2005) Involvement of adenosine 5′-triphosphate
in ultrasound-induced fracture repair. Ultrasound in Medicine & Biology 31:1131–
1138. doi: 10.1016/j.ultrasmedbio.2005.04.017
80. Erdogan Ö, Esen E (2009) Biological Aspects and Clinical Importance of Ultrasound
Therapy in Bone Healing. J Ultrasound Med 28:765–776. doi:
10.7863/jum.2009.28.6.765
81. Harrison A, Lin S, Pounder N, Mikuni-Takagaki Y (2016) Mode & mechanism of low
intensity pulsed ultrasound (LIPUS) in fracture repair. Ultrasonics 70:45–52. doi:
10.1016/j.ultras.2016.03.016
 82. Naruse K, Sekiya H, Harada Y, et al (2010) Prolonged endochondral bone healing in
senescence is shortened by low-intensity pulsed ultrasound in a manner dependent on
COX-2. Ultrasound in Medicine & Biology 36:1098–1108. doi:
10.1016/j.ultrasmedbio.2010.04.011
83. Katano M, Naruse K, Uchida K, et al (2011) Low Intensity Pulsed Ultrasound
Accelerates Delayed Healing Process by Reducing the Time Required for the
Completion of Endochondral Ossification in the Aged Mouse Femur Fracture Model.
Exp Anim 60:385–395.
84. Haar Ter G, Dyson M, Oakley EM (1987) The use of ultrasound by physiotherapists
in Britain, 1985. Ultrasound in Medicine & Biology 13:659–663. doi: 10.1016/0301-
5629(87)90064-0
85. Iwashina T, Mochida J, Miyazaki T, et al (2006) Low-intensity pulsed ultrasound
stimulates cell proliferation and proteoglycan production in rabbit intervertebral disc
cells cultured in alginate. Biomaterials 27:354–361. doi:
10.1016/j.biomaterials.2005.06.031
86. Enwemeka CS (1989) The Effects of Therapeutic Ultrasound on Tendon Healing: A
Biomechanical Study. American Journal of Physical Medicine & Rehabilitation
68:283.
87. Demir H, Menku P, Kirnap M, et al (2004) Comparison of the effects of laser,
ultrasound, and combined laser + ultrasound treatments in experimental tendon
healing. Lasers Surg Med 35:84–89. doi: 10.1002/lsm.20046
88. Yeung CK, Guo X, Ng YF (2006) Pulsed ultrasound treatment accelerates the repair
of Achilles tendon rupture in rats. J Orthop Res 24:193–201. doi: 10.1002/jor.20020
89. Fu SC, Shum WT, Hung LK, et al (2008) Low-Intensity Pulsed Ultrasound on Tendon
Healing: A Study of the Effect of Treatment Duration and Treatment Initiation. Am J
Sports Med 36:1742–1749. doi: 10.1177/0363546508318193
90. Lu H, Liu F, Chen H, et al (2016) The effect of low-intensity pulsed ultrasound on
bone-tendon junction healing: Initiating after inflammation stage. J Orthop Res
34:1697–1706. doi: 10.1002/jor.23180
91. Iwabuchi S, Ito M, Hata J, et al (2005) In vitro evaluation of low-intensity pulsed
ultrasound in herniated disc resorption. Biomaterials 26:7104–7114. doi:
10.1016/j.biomaterials.2005.05.004
92. Iwabuchi S, Ito M, Chikanishi T, et al (2008) Role of the tumor necrosis factor-α,
cyclooxygenase-2, prostaglandin E2, and effect of low-intensity pulsed ultrasound in
an in vitro herniated disc resorption model. J Orthop Res 26:1274–1278. doi:
10.1002/jor.20525
93. Marvel S, Okrasinski S, Bernacki SH, et al (2010) The development and validation of
a lipus system with preliminary observations of ultrasonic effects on human adult stem
cells. IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
57:1977–1984. doi: 10.1109/TUFFC.2010.1645
94. Hensel K, Mienkina MP, Schmitz G (2011) Analysis of Ultrasound Fields in Cell
Culture Wells for In Vitro Ultrasound Therapy Experiments. Ultrasound in Medicine
& Biology 37:2105–2115. doi: 10.1016/j.ultrasmedbio.2011.09.007
95. Padilla FDR, Puts R, Vico L, Raum K (2014) Stimulation of bone repair with
ultrasound: A review of the possible mechanic effects. Ultrasonics 54:1125–1145.
doi: 10.1016/j.ultras.2014.01.004
96. Puts R, Ruschke K, Ambrosi TH (2016) A Focused Low-Intensity Pulsed Ultrasound
(FLIPUS) System for Cell Stimulation: Physical and Biological Proof of Principle.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control 63:91–100.
doi: 10.1109/tuffc.2015.2498042
97. Duan X, Yu ACH, Wan JMF (2019) Cellular Bioeffect Investigations on Low-
Intensity Pulsed Ultrasound and Sonoporation: Platform Design and Flow Cytometry
Protocol. IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
66:1422–1434. doi: 10.1109/TUFFC.2019.2923443
98. Leskinen JJ, Hynynen K (2012) Study of factors affecting the magnitude and nature
of ultrasound exposure with in vitro set-ups. Ultrasound in Medicine & Biology
38:777–794. doi: 10.1016/j.ultrasmedbio.2012.01.019
99. Berber R, Aziz S, Simkins J, et al (2020) Low Intensity Pulsed Ultrasound Therapy
(LIPUS): A review of evidence and potential applications in diabetics. Journal of
Clinical Orthopaedics and Trauma
100. Schumann D, Kujat R, Zellner J, et al (2006) Treatment of human mesenchymal stem
cells with pulsed low intensity ultrasound enhances the chondrogenic phenotype in
vitro. Biorheology 43:431–443.
101. Loi F, Córdova LA, Pajarinen J, et al (2016) Inflammation, fracture and bone repair.
Bone 86:119–130. doi: 10.1016/j.bone.2016.02.020
102. Kraiwattanapong C, Boden SD, Louis-Ugbo J, et al (2005) Comparison of
Healos/Bone Marrow to INFUSE(rhBMP-2/ACS) With a Collagen-Ceramic Sponge
Bulking Agent as Graft Substitutes for Lumbar Spine Fusion. SPINE 30:1001–1007.
doi: 10.1097/01.brs.0000160997.91502.3b
103. Erbe E, Marx J, Clineff T, Bellincampi L (2001) Potential of an ultraporous β-
tricalcium phosphate synthetic cancellous bone void filler and bone marrow aspirate
composite graft. Eur Spine J 10:S141–S146. doi: 10.1007/s005860100287
104. Muschler GF, Nitto H, Matsukura Y, et al (2003) Spine fusion using cell matrix
composites enriched in bone marrow-derived cells. Clinical Orthopaedics and Related
Research® 407:102–118. doi: 10.1097/00003086-200302000-00018
105. Li H, Zou X, Xue Q, et al (2004) Anterior lumbar interbody fusion with carbon fiber
cage loaded with bioceramics and platelet-rich plasma. An experimental study on
pigs. Eur Spine J 13:354–358. doi: 10.1007/s00586-003-0647-3
106. Gupta A, Kukkar N, Sharif K, et al (2015) Bone graft substitutes for spine fusion: A
brief review. World J Orthop 6:449–456. doi: 10.5312/wjo.v6.i6.449
107. Cahill KS, Chi JH, Day A, Claus EB (2009) Prevalence, Complications, and Hospital
Charges Associated With Use of Bone-Morphogenetic Proteins in Spinal Fusion
Procedures. JAMA 302:58–66. doi: 10.1001/jama.2009.956
108. Shi H-F, Xiong J, Chen Y-X, et al (2013) Early application of pulsed electromagnetic
field in the treatment of postoperative delayed union of long-bone fractures: a
prospective randomized controlled study. BMC Musculoskelet Disord 14:35. doi:
10.1186/1471-2474-14-35
109. Garland DE, Moses B, Salyer W (1991) Long-term follow-up of fracture nonunions
treated with PEMFs. Contemp Orthop 22:295–302.
110. Mooney V (1993) Pulsed electromagnetic fields: an adjunct to interbody spinal fusion
surgery in the high risk patient. Surg Technol Int 2:405–410.
111. MS SLM, PhD DGC, PhD EIW, et al (2016) Pulsed electromagnetic field (PEMF)
treatment reduces expression of genes associated with disc degeneration in human
intervertebral disc cells. The Spine Journal 16:770–776. doi:
10.1016/j.spinee.2016.01.003
112. Simmons JWJ, Mooney V, Thacker I (2004) Pseudarthrosis after lumbar spine fusion:
nonoperative salvage with pulsed electromagnetic fields. Am J Orthop (Belle Mead
NJ) 33:27–30.
113. Singh RK, Srivastava M, Prasad NK, et al (2017) Iron doped Î²-Tricalcium phosphate:
Synthesis, characterization, hyperthermia effect, biocompatibility and mechanical
evaluation. Materials Science & Engineering C 78:715–726. doi:
10.1016/j.msec.2017.04.130
114. Zhang X, Jiang F, Groth T, Vecchio KS (2008) Preparation, characterization and
mechanical performance of dense β-TCP ceramics with/without magnesium
substitution. J Mater Sci: Mater Med 19:3063–3070. doi: 10.1007/s10856-008-3442-
1
115. Cuneyt Tas A, Bhaduri SB, Jalota S (2007) Preparation of Zn-doped β-tricalcium
phosphate (β-Ca3(PO4)2) bioceramics. Materials Science & Engineering C 27:394–
401. doi: 10.1016/j.msec.2006.05.051
116. Martin BI, Deyo RA, Mirza SK, et al (2008) Expenditures and Health Status Among
Adults With Back and Neck Problems. JAMA 299:656–664. doi:
10.1001/jama.299.6.656
 117. Ricci JA, Stewart WF, Chee E, et al (2006) Back Pain Exacerbations and Lost
Productive Time Costs in United States Workers. SPINE 31:3052–3060. doi:
10.1097/01.brs.0000249521.61813.aa
118. Stewart WF (2003) Lost Productive Time and Cost Due to Common Pain Conditions
in the US Workforce. JAMA 290:2443–2454. doi: 10.1001/jama.290.18.2443
119. Risbud MV, Shapiro IM (2013) Role of cytokines in intervertebral disc degeneration:
pain and disc content. Nat Rev Rheumatol 10:44–56. doi: 10.1038/nrrheum.2013.160
120. Lerner A, Stein H, Soudry M (2004) Compound high-energy limb fractures with
delayed union: our experience with adjuvant ultrasound stimulation (exogen).
Ultrasonics 42:915–917. doi: 10.1016/j.ultras.2003.11.014
121. Zhang XJ, Hu ZM, Hao J, Shen JL (2016) Low Intensity Pulsed Ultrasound Promotes
the Extracellular Matrix Synthesis of Degenerative Human Nucleus Pulposus Cells
Through FAK/PI3K/Akt Pathway. SPINE 41:E248–E254. doi:
10.1097/brs.0000000000001220
122. Rousseau M, Ulrich JA, Bass EC, Rodriguez AG (2007) Stab incision for inducing
intervertebral disc degeneration in the rat. SPINE 32:17–24. doi:
10.1097/01.brs.0000251013.07656.45
123. Kobayashi Y, Sakai D, Iwashina T, et al (2009) Low-Intensity Pulsed Ultrasound
Stimulates Cell Proliferation, Proteoglycan Synthesis and Expression of Growth
Factor-Related Genes in Human Nucleus Pulposus Cell Line. European Cells and
Materials 17:15–22. doi: 10.22203/eCM.v017a02
124. Hersh DS, Kim AJ, Winkles JA, et al (2016) Emerging Applications of Therapeutic
Ultrasound in Neuro-oncology: Moving Beyond Tumor Ablation. Neurosurgery
79:643–654. doi: 10.1227/NEU.0000000000001399
125. Jiang X, Savchenko O, Li Y, et al (2018) A Review of Low-Intensity Pulsed
Ultrasound for Therapeutic Applications. IEEE Transactions on Biomedical
Engineering PP:1–1. doi: 10.1109/TBME.2018.2889669
126. Chen C, Zhang T, Liu F, et al (2019) Effect of Low-Intensity Pulsed Ultrasound After
Autologous Adipose-Derived Stromal Cell Transplantation for Bone-Tendon Healing
in a Rabbit Model. Am J Sports Med 47:942–953. doi: 10.1177/0363546518820324
127. Sheybani ND, Price RJ (2019) Perspectives on Recent Progress in Focused
Ultrasound Immunotherapy. Theranostics 9:7749–7758. doi: 10.7150/thno.37131
128. Baker KG, Robertson VJ, Duck FA (2001) A review of therapeutic ultrasound:
biophysical effects. Physical Therapy 81:1351–1358. doi: 10.1093/ptj/81.7.1351
129. Khanna A, Nelmes RTC, Gougoulias N, et al (2008) The effects of LIPUS on soft-
tissue healing: a review of literature. British Medical Bulletin 89:169–182. doi:
10.1093/bmb/ldn040
130. Martinez de Albornoz P, Khanna A, Longo UG, et al (2011) The evidence of low-
intensity pulsed ultrasound for in vitro, animal and human fracture healing. British
Medical Bulletin 100:39–57. doi: 10.1093/bmb/ldr006
131. Xin Z, Lin G, Lei H, et al (2016) Clinical applications of low-intensity pulsed
ultrasound and its potential role in urology. Transl Androl Urol 5:255–266. doi:
10.21037/tau.2016.02.04
132. Yang R-S, Lin W-L, Chen Y-Z, et al (2005) Regulation by ultrasound treatment on
the integrin expression and differentiation of osteoblasts. Bone 36:276–283. doi:
10.1016/j.bone.2004.10.009
133. Bhandari M, Mundi R, Petis S, et al (2009) Low-intensity pulsed ultrasound: Fracture
healing. Indian Journal of Orthopaedics 43:132. doi: 10.4103/0019-5413.50847
134. Pounder NM, Harrison AJ (2008) Low intensity pulsed ultrasound for fracture
healing: A review of the clinical evidence and the associated biological mechanism of
action. Ultrasonics 48:330–338. doi: 10.1016/j.ultras.2008.02.005
135. Cook SD, Salkeld SL, Popich-Patron LS, et al (2001) Improved cartilage repair after
treatment with low-intensity pulsed ultrasound. Clinical Orthopaedics and Related
Research® 391:S231–S243.
136. Lu H, Qin L, Cheung W, et al (2008) Low-Intensity Pulsed Ultrasound Accelerated
Bone-Tendon Junction Healing Through Regulation of Vascular Endothelial Growth
Factor Expression and Cartilage Formation. Ultrasound in Medicine & Biology
34:1248–1260. doi: 10.1016/j.ultrasmedbio.2008.01.009
137. Lu H, Qin L, Fok P, et al (2017) Low-Intensity Pulsed Ultrasound Accelerates Bone-
Tendon Junction Healing: A Partial Patellectomy Model in Rabbits. Am J Sports Med
34:1287–1296. doi: 10.1177/0363546506286788
138. Qin L, Lu H, Fok P, et al (2006) Low-intensity pulsed ultrasound accelerates
osteogenesis at bone-tendon healing junction. Elsevier 32:1905–1911. doi:
10.1016/j.ultrasmedbio.2006.06.028
 139. Zhou X-Y, Xu X-M, Wu S-Y, et al (2017) Low-Intensity Pulsed Ultrasound-Induced
Spinal Fusion is Coupled with Enhanced Calcitonin Gene-Related Peptide Expression
in Rat Model. Ultrasound in Medicine & Biology 43:1486–1493. doi:
10.1016/j.ultrasmedbio.2017.03.012
140. Atherton P, Lausecker F, Harrison A, Ballestrem C (2017) Low-intensity pulsed
ultrasound promotes cell motility through vinculin-controlled Rac1 GTPase activity.
Journal of Cell Science 130:2277–2291. doi: 10.1242/jcs.192781
141. Xu X, Wang F, Yang Y, et al (2016) LIPUS promotes spinal fusion coupling
proliferation of type H microvessels in bone. Sci Rep 6:1–10. doi: 10.1038/srep20116
142. Montalti CS, Souza NVCKL, Rodrigues NC, et al (2013) Effects of low-intensity
pulsed ultrasound on injured skeletal muscle. Braz J Phys Ther 17:343–350. doi:
10.1590/S1413-35552012005000101
143. Hui CFF, Chan CW, Yeung HY, et al (2011) Low-Intensity Pulsed Ultrasound
Enhances Posterior Spinal Fusion Implanted with Mesenchymal Stem Cells-Calcium
Phosphate Composite Without Bone Grafting. SPINE 36:1010–1016. doi:
10.1097/BRS.0b013e318205c5f5
144. Zhou S, Schmelz A, Seufferlein T, et al (2004) Molecular mechanisms of low
intensity pulsed ultrasound in human skin fibroblasts. J Biol Chem 279:54463–54469.
doi: 10.1074/jbc.M404786200
145. Leskinen JJ, Olkku A, Mahonen A (2014) Nonuniform temperature rise in in vitro
osteoblast ultrasound exposures with associated bioeffect. IEEE Transactions on
Ultrasonics, Ferroelectrics, and Frequency Control 61:920–927. doi:
10.1109/tbme.2013.2292546
 146. Fung C-H, Cheung W-H, Pounder NM, et al (2014) Osteocytes exposed to far field
of therapeutic ultrasound promotes osteogenic cellular activities in pre-osteoblasts
through soluble factors. Ultrasonics 54:1358–1365. doi: 10.1016/j.ultras.2014.02.003
147. Leskinen JJ, Karjalainen HM, Olkku A, et al (2008) Genome-wide microarray
analysis of MG-63 osteoblastic cells exposed to ultrasound. Biorheology 45:345–354.
doi: 10.3233/BIR-2008-0480
148. Kinoshita M, Hynynen K (2007) Key factors that affect sonoporation efficiency in in
vitro settings: The importance of standing wave in sonoporation. Biochemical and
Biophysical Research Communications 359:860–865. doi:
10.1016/j.bbrc.2007.05.153
149. OCHELTREE KB, FRIZZELL LA (1989) Sound Field Calculation for Rectangular
Sources. IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
36:242–248. doi: 10.1109/58.19157
150. Adams MS, Salgaonkar VA, Scott SJ, et al (2017) Integration of deployable fluid
lenses and reflectors with endoluminal therapeutic ultrasound applicators: Preliminary
investigations of enhanced penetration depth and focal gain. Med Phys 44:5339–5356.
doi: 10.1002/mp.12458
151. Ophir J, McWhirt RE, Maklad NF, Jaeger PM (1985) A narrowband pulse-echo
technique for in vivo ultrasonic attenuation estimation. IEEE Trans Biomed Eng
32:205–212. doi: 10.1109/TBME.1985.325530
152. Parvizi J, Wu CC, Lewallen DG, et al (1999) Low-intensity ultrasound stimulates
proteoglycan synthesis in rat chondrocytes by increasing aggrecan gene expression. J
Orthop Res 17:488–494. doi: 10.1002/jor.1100170405
 153. Tang X, Coughlin D, Ballatori A, et al (2019) Pulsed Electromagnetic Fields Reduce
Interleukin-6 Expression in Intervertebral Disc Cells Via Nuclear Factor-κβ and
Mitogen-Activated Protein Kinase p38 Pathways. SPINE 44:E1290–E1297. doi:
10.1097/BRS.0000000000003136
154. Subramanian A, Budhiraja G, Sahu N (2017) Chondrocyte primary cilium is
mechanosensitive and responds to low-intensity-ultrasound by altering its length and
orientation. The International Journal of Biochemistry & Cell Biology 91:1–5. doi:
10.1016/j.biocel.2017.08.018
155. Lee H-P, Gu L, Mooney DJ, et al (2017) Mechanical confinement regulates cartilage
matrix formation by chondrocytes. Nat Mater 16:1243–1251. doi: 10.1038/nmat4993
156. Bohari SP, Grover LM, Hukins DW (2012) Pulsed-low intensity ultrasound enhances
extracellular matrix production by fibroblasts encapsulated in alginate. Journal of
Tissue Engineering 3:204173141245467–7. doi: 10.1177/2041731412454672
157. Ouyang A, Cerchiari AE, Tang X, et al (2016) Effects of cell type and configuration
on anabolic and catabolic activity in 3D co-culture of mesenchymal stem cells and
nucleus pulposus cells. J Orthop Res 1–13. doi: 10.1002/jor.23452
158. Wang Z, Hutton WC, Yoon ST (2013) ISSLS Prize winner: Effect of link protein
peptide on human intervertebral disc cells. SPINE 38:1501–1507. doi:
10.1097/BRS.0b013e31828976c1
159. Masuda K, Takegami K, An H, et al (2003) Recombinant osteogenic protein-1
upregulates extracellular matrix metabolism by rabbit annulus fibrosus and nucleus
pulposus cells cultured in alginate beads. J Orthop Res 21:922–930. doi:
10.1016/S0736-0266(03)00037-8
 160. Thonar E, An H, Masuda K (2002) Compartmentalization of the matrix formed by
nucleus pulposus and annulus fibrosus cells in alginate gel. Biochem Soc Trans
30:874–878.
161. Augst AD, Kong HJ, Mooney DJ (2006) Alginate hydrogels as biomaterials.
Macromol Biosci 6:623–633. doi: 10.1002/mabi.200600069
162. Enobakhare BO, Bader DL, Lee DA (1996) Quantification of sulfated
glycosaminoglycans in chondrocyte/alginate cultures, by use of 1,9-
dimethylmethylene blue. Anal Biochem 243:189–191. doi: 10.1006/abio.1996.0502
163. la Cour MF, Stuart MB, Laursen MB, et al (2014) Investigation of PDMS as coating
on CMUTs for imaging. In: 2014 IEEE International Ultrasonics Symposium. IEEE,
pp 2584–2587
164. Karshafian R, Bevan PD, Williams R, et al (2009) Sonoporation by Ultrasound-
Activated Microbubble Contrast Agents: Effect of Acoustic Exposure Parameters on
Cell Membrane Permeability and Cell Viability. Ultrasound in Medicine & Biology
35:847–860. doi: 10.1016/j.ultrasmedbio.2008.10.013
165. Han SI, Oh SY, Jeon WJ, et al (2002) Mild heat shock induces cyclin D1 synthesis
through multiple Ras signal pathways. FEBS Letters 515:141–145. doi:
10.1016/S0014-5793(02)02459-6
166. Sena K, Leven RM, Mazhar K, et al (2005) Early gene response to low-intensity
pulsed ultrasound in rat osteoblastic cells. Ultrasound in Medicine & Biology 31:703–
708. doi: 10.1016/j.ultrasmedbio.2005.01.013
 167. Kim J-S, Ellman MB, An HS, et al (2010) Insulin-like growth factor 1 synergizes with
bone morphogenetic protein 7-mediated anabolism in bovine intervertebral disc cells.
Arthritis & Rheumatism 62:3706–3715. doi: 10.1002/art.27733
168. Edwards WT, Ordway NR, Zheng Y, et al (2001) Peak stresses observed in the
posterior lateral anulus. SPINE 26:1753–1759. doi: 10.1097/00007632-200108150-
00005
169. Jiang X, Savchenko O, Li Y, et al (2019) A Review of Low-Intensity Pulsed
Ultrasound for Therapeutic ApplicationsA Review of Low-Intensity Pulsed
Ultrasound for Therapeutic Applications. IEEE Transactions on Biomedical
Engineering 66:2704–2718. doi: 10.1109/TBME.2018.2889669
170. Horne DA, Jones PD, Adams MS, et al (2020) LIPUS far-field exposimetry system
for uniform stimulation of tissues in-vitro: development and validation with bovine
intervertebral disc cells. Biomed Phys Eng Express 6:035033–13. doi: 10.1088/2057-
1976/ab8b26
171. Zhang N, Chow SK-H, Leung KS, Cheung W-H (2017) Ultrasound as a stimulus for
musculoskeletal disorders. Journal of Orthopaedic Translation 9:52–59. doi:
10.1016/j.jot.2017.03.004
172. Sittampalam GS, Grossman A, Brimacombe K, et al (2004) GTPγS Binding Assays.
173. Ray CA, Patel V, Shih J, et al (2009) Application of multi-factorial design of
experiments to successfully optimize immunoassays for robust measurements of
therapeutic proteins. Journal of Pharmaceutical and Biomedical Analysis 49:311–318.
doi: 10.1016/j.jpba.2008.11.039
 174. Uhoraningoga A, Kinsella G, Henehan G, Ryan B (2018) The Goldilocks Approach:
A Review of Employing Design of Experiments in Prokaryotic Recombinant Protein
Production. Bioengineering 5:89–27. doi: 10.3390/bioengineering5040089
175. Blakney AK, McKay PF, Yus BI, et al (2019) The Skin You Are In: Design-of-
Experiments Optimization of Lipid Nanoparticle Self- Amplifying RNA
Formulations in Human Skin Explants. ACS Nano 13:5920–5930. doi:
10.1021/acsnano.9b01774
176. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time
RT-PCR. Nucleic Acids Res 29:e45–45. doi: 10.1093/nar/29.9.e45
177. Derringer G, Suich R (1980) Simultaneous Optimization of Several Response
Variables. Journal of Quality Technology 12:214–219. doi:
10.1080/00224065.1980.11980968
178. Miller AD, Chama A, Louw TM, et al (2017) Frequency sensitive mechanism in low-
intensity ultrasound enhanced bioeffects. PLoS ONE 12:e0181717. doi:
10.1371/journal.pone.0181717
179. Lewis AH, Cui AF, McDonald MF, Grandl J (2017) Transduction of Repetitive
Mechanical Stimuli by Piezo1 and Piezo2 Ion Channels. Cell Rep 19:2572–2585. doi:
10.1016/j.celrep.2017.05.079
180. Ding W, Du D, Chen S (2020) LIPUS promotes synthesis and secretion of
extracellular matrix and reduces cell apoptosis in human osteoarthritis through
upregulation of SOX9 expression. Int J Clin Exp Pathol 13:810–817.
 181. Miller AD, Subramanian A, Viljoen HJ (2017) Theoretically proposed optimal
frequency for ultrasound induced cartilage restoration. Theor Biol Med Model 14:1–
14. doi: 10.1186/s12976-017-0067-4
182. Angle SR, Sena K, Sumner DR, Virdi AS (2011) Osteogenic differentiation of rat
bone marrow stromal cells by various intensities of low-intensity pulsed ultrasound.
Ultrasonics 51:281–288. doi: 10.1016/j.ultras.2010.09.004
183. Sekino J, Nagao M, Kato S, et al (2018) Low-intensity pulsed ultrasound induces
cartilage matrix synthesis and reduced MMP13 expression in chondrocytes.
Biochemical and Biophysical Research Communications 506:290–297. doi:
10.1016/j.bbrc.2018.10.063
184. Kim K, Fisher JP (2008) Nanoparticle technology in bone tissue engineering. Journal
of Drug Targeting 15:241–252. doi: 10.1080/10611860701289818
185. Ortolani A, Bianchi M, Mosca M, et al (2016) The prospective opportunities offered
by magnetic scaffolds for bone tissue engineering: a review. Joints 4:228–235. doi:
10.11138/jts/2016.4.4.228
186. Uskoković V, Wu V (2016) Calcium Phosphate as a Key Material for Socially
Responsible Tissue Engineering. Materials 9:434–27. doi: 10.3390/ma9060434
187. Waldorff EI, Zhang N, Ryaby JT (2017) Pulsed electromagnetic field applications: A
corporate perspective. Journal of Orthopaedic Translation 9:60–68. doi:
10.1016/j.jot.2017.02.006
188. Dimitriou R, Jones E, McGonagle D, Giannoudis PV (2011) Bone regeneration:
current concepts and future directions. BMC Med 9:66–10. doi: 10.1186/1741-7015-
9-66
 189. Meng J, Xiao B, Zhang Y, et al (2013) Super-paramagnetic responsive nanofibrous
scaffolds under static magnetic field enhance osteogenesis for bone repair in vivo. Sci
Rep 3:393–7. doi: 10.1038/srep02655
190. Russo A, Bianchi M, Sartori M, et al (2016) Magnetic forces and magnetized
biomaterials provide dynamic flux information during bone regeneration. J Mater Sci:
Mater Med 27:175–13. doi: 10.1007/s10856-015-5659-0
191. Gil S, Mano JF (2014) Magnetic composite biomaterials for tissue engineering.
Biomater Sci 2:812–818. doi: 10.1039/C4BM00041B
192. Pesqueira T, Costa-Almeida R, Gomes ME (2017) Uncovering the effect of low- 
frequency static magnetic field on tendon-derived cells: from mechanosensing to
tenogenesis. Sci Rep 7:1–12. doi: 10.1038/s41598-017-11253-6
193. Mondal S, Manivasagan P, Bharathiraja S, et al (2017) Magnetic hydroxyapatite: a
promising multifunctional platform for nanomedicine application. IJN Volume
12:8389–8410. doi: 10.2147/IJN.S147355
194. Pareta RA, Taylor E, Webster TJ (2008) Increased osteoblast density in the presence
of novel calcium phosphate coated magnetic nanoparticles. Nanotechnology
19:265101–8. doi: 10.1088/0957-4484/19/26/265101
195. Zeng X, Zeng X, Hu, et al (2012) Magnetic responsive hydroxyapatite composite
scaffolds construction for bone defect reparation. IJN 3365–14. doi:
10.2147/IJN.S32264
196. Panseri S, Cunha C, D’Alessandro T, et al (2012) Intrinsically superparamagnetic Fe-
hydroxyapatite nanoparticles positively influence osteoblast-like cell behaviour.
Journal of Nanobiotechnology 10:32–10. doi: 10.1186/1477-3155-10-32
 197. Tampieri A, D’Alessandro T, Sandri M, et al (2012) Intrinsic magnetism and
hyperthermia in bioactive Fe-doped hydroxyapatite. Acta Biomaterialia 8:843–851.
doi: 10.1016/j.actbio.2011.09.032
198. Zhao Z, Espanol M, Guillem-Marti J, et al (2016) Ion-doping as a strategy to modulate
hydroxyapatite nanoparticle internalization. Nanoscale 8:1595–1607. doi:
10.1039/C5NR05262A
199. Panseri S, Cunha C, D’Alessandro T, et al (2012) Magnetic Hydroxyapatite Bone
Substitutes to Enhance Tissue Regeneration: Evaluation In Vitro Using Osteoblast-
Like Cells and In Vivo in a Bone Defect. PLoS ONE 7:e38710–8. doi:
10.1371/journal.pone.0038710
200. Singh RK, Patel KD, Lee JH, et al (2014) Potential of Magnetic Nanofiber Scaffolds
with Mechanical and Biological Properties Applicable for Bone Regeneration. PLoS
ONE 9:e91584–16. doi: 10.1371/journal.pone.0091584
201. Gregory CA, Grady Gunn W, Peister A, Prockop DJ (2004) An Alizarin red-based
assay of mineralization by adherent cells in culture: comparison with cetylpyridinium
chloride extraction. Anal Biochem 329:77–84. doi: 10.1016/j.ab.2004.02.002
202. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-
time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408.
doi: 10.1006/meth.2001.1262
203. Birmingham E, Niebur GL, McHugh PE, et al (2012) Osteogenic differentiation of
mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified
bone niche. European Cells and Materials 23:13–27. doi: 10.22203/ecm.v023a02
 204. Kramer E, Conklin M, Zilm M (2016) A Comparative Study of the Sintering and Cell
Behavior of Pure and Cobalt Substituted Hydroxyapatite. Bioceram Dev Appl 04:1–
8. doi: 10.4172/2090-5025.1000077
205. Zilm ME, Le Yu, Hines WA, Wei M (2018) Magnetic properties and
cytocompatibility of transition-metal-incorporated hydroxyapatite. Materials Science
& Engineering C 87:112–119. doi: 10.1016/j.msec.2018.02.018
206. Rau JV, Cacciotti I, De Bonis A, et al (2014) Fe-doped hydroxyapatite coatings for
orthopedic and dental implant applications. Applied Surface Science 307:301–305.
doi: 10.1016/j.apsusc.2014.04.030
207. Veiseh O, Gunn JW, Zhang M (2010) Design and fabrication of magnetic
nanoparticles for targeted drug delivery and imaging. Advanced Drug Delivery
Reviews 62:284–304. doi: 10.1016/j.addr.2009.11.002
208. Wu S, Xiao Z, Song J, et al (2018) Evaluation of BMP-2 Enhances the Osteoblast
Differentiation of Human Amnion Mesenchymal Stem Cells Seeded on Nano-
Hydroxyapatite/Collagen/Poly(l-Lactide). IJMS 19:2171–16. doi:
10.3390/ijms19082171
209. Neacsu P, Staras A, Voicu S, et al (2017) Characterization and In Vitro and In Vivo
Assessment of a Novel Cellulose Acetate-Coated Mg-Based Alloy for Orthopedic
Applications. Materials 10:686–20. doi: 10.3390/ma10070686
210. Blair HC, Larrouture QC, Li Y, et al (2017) Osteoblast Differentiation and Bone
Matrix Formation In Vivo and In Vitro. Tissue Engineering Part B: Reviews 23:268–
280. doi: 10.1089/ten.TEB.2016.0454
 211. Selvamurugan N, Kwok S, Vasilov A, et al (2007) Effects of BMP-2 and pulsed
electromagnetic field (PEMF) on rat primary osteoblastic cell proliferation and gene
expression. J Orthop Res 25:1213–1220. doi: 10.1002/jor.20409
212. Calabrese G, Giuffrida R, Fabbi C, et al (2016) Collagen-Hydroxyapatite Scaffolds
Induce Human Adipose Derived Stem Cells Osteogenic Differentiation In Vitro.
PLoS ONE 11:e0151181–17. doi: 10.1371/journal.pone.0151181
213. Fan L, Zhang Y, Li X, et al (2012) Removal of alizarin red from water environment
using magnetic chitosan with Alizarin Red as imprinted molecules. Colloids Surf B
Biointerfaces 91:250–257. doi: 10.1016/j.colsurfb.2011.11.014
214. Singh K, Nandyala SV, Marquez-Lara A, et al (2013) Clinical sequelae after rhBMP-
2 use in a minimally invasive transforaminal lumbar interbody fusion. The Spine
Journal 13:1118–1125. doi: 10.1016/j.spinee.2013.07.028
137 
Appendix A: Annulus Fibrosus Cell Viability Time Course in Alginate Bead Culture 
Introduction 
Cell viability time course experiments were performed to evaluate potential cell death during 
multi-day annulus fibrosus (AF) cell culture. The objectives of this study were (1) to assess the 
viability of cells encapsulated in alginate beads at high cell concentration and (2) to determine the 
limit of cell culture duration (i.e. when cell numbers were significantly decreased). 
Methods 
Cell Culture 
Bovine AF cells were encapsulated in alginate beads at a density of 4x106 cells/mL and 
cultured in standard disc media as described previously (Section 3.2.2.1). Four alginate beads (one 
sample) were cultured for 1, 3, 5, 8, 10, 14, or 16 days in triplicate (n = 21).  Media was changed 
every other day. 
DNA Quantification 
After the designated culture duration, alginate beads were dissolved in 55 mM sodium citrate 
and frozen at -20°C. After day 16 samples were harvested, samples were thawed and digested in 
10 µL papain (P3125, Sigma-Aldrich, St. Louis, MO, USA) at 60°C overnight, then frozen at -
20°C again before DNA quantification assay. DNA content was assayed with the Quant-iT 
PicoGreen dsDNA Assay Kit (P11496, Thermo Fisher, Waltham, MA, USA) and measured on a 
microplate reader (Spectramax M5, Molecular Devices, Sunnyvale, CA, USA) with 488 nm 
excitation and 525 nm absorption. 
Statistical Analysis 
Statistical differences in DNA concentration were compared using one-way analysis of 
variance (ANOVA) among treatment groups, followed by Tukey HSD test for multiple 
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comparisons. Data are depicted as mean ± standard deviation. P-values less than 0.05 were 
considered significant. 
Results and Discussion 
DNA concentration did not significantly decrease until 8 days of culture. Compared to 
samples cultured for 1 day, DNA concentration in day 8, day 14, and day 16 samples was decreased 
by 28%, 32%, and 38%, respectively. After 8 days of culture, the decrease in DNA concentration 
appears to reach a baseline.  These results suggest that in future studies of cellular stimuli, such as 
low-intensity pulsed ultrasound (LIPUS) exposure or growth factor treatment, cells cultured in 
alginate beads should undergo a longer pre-culture duration to allow cells to acclimate to alginate 
environment. This aligns with several other groups studying LIPUS bioeffects who have reported 
applying pre-cultures from 3-14 days [1-3]. In this experiment, change in dsDNA concentration 
was used to approximate cell number and extrapolated to estimate changes in cell viability. We 
assume that DNA from dead cells will degrade and not be detected by PicoGreen Assay, however 
it is possible that we have quantified dead cells before DNA fragmentation and therefore have 
overestimated the cell numbers. It may take several days for DNA to fully degrade, which may 
explain why DNA concentration doesn’t approach equilibrium until day 8. 
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Figure A.1 DNA concentration decreases with duration of culture in alginate beads 
Double stranded DNA concentration was significantly lower after 8, 14, and 16 days of culture 
compared to 1 day of culture. * p < 0.05, ** p < 0.01 
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Appendix B: LIVE/DEAD Cell Imaging in Alginate Beads 
Introduction 
Experiments were performed to assess the effect of low-intensity pulsed ultrasound (LIPUS) 
exposure on the viability of annulus fibrosus (AF) cells cultured in alginate beads. Moreover, these 
experiments aimed to develop an effective method for imaging whole sections of stained beads. 
This would allow visualization of local variations in cell viability potentially related to diffusion 
limitations [1]. Specifically, we were interested in whether dead cells were disproportionately 
located in the center of the bead. 
Methods 
Cell Culture and Treatment 
Bovine AF cells were encapsulated in alginate beads at a density of 2x106 cells/mL and 
cultured in standard disc media, as described previously (Section 3.2.2.1), with daily media 
changes. Single beads were divided into 4 treatment groups: (1) untreated control, (2) BMP-7 
growth factor treatment (200 ng/mL in standard disc media), (3) LIPUS-Low (600 mW peak 
Intensity, 20% duty), and (4) LIPUS-High (1000 mW peak intensity, 12% duty). All groups were 
placed in the LIPUS exposimetry system for 20 minutes per day for 7 consecutive days. LIPUS 
was turned off for samples in the untreated control and BMP-7 treatment groups. 
Protocol for LIVE/DEAD Cell Staining and Imaging in Alginate Beads 
Sample Preparation 
• Place bead into 1.5 mL tube
• Wash 3x with 1 mL D-PBS without calcium or magnesium
• Place a glass microscope slide inside a petri dish
• Carefully remove bead from 1.5 mL tube and onto the glass slide (Figure B.1)
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• Using a sharp scalpel blade, cut the bead in half (approximately 1.5 mm thickness) 
o Take care to create surfaces that are as flat as possible 
• Position bead sections on the glass slide such that a flat surface is facing up 
 
 
Figure B.1 Positioning sectioned alginate beads  
The sectioned alginate beads were placed on the glass slide with the flat surface facing up. 
Petroleum jelly was placed on the glass slide to create a square chamber to confine the bead and 
liquid reagent. LIVE/DEAD reagent was applied, filling the chamber and covering the bead-
section.  L indicates the LIPUS-Low sample; H indicates the LIPUS-High sample. 
 
LIVE/DEAD Staining 
• Prepare LIVE/DEAD reagent solution in 15 mL tube 
o 2 mL D-PBS + 2 µL Calcein-AM + 8 µL ethidium homodimer-1  
• Cover the bead sections with LIVE/DEAD reagent solution (approximately 100 µL) 
• Incubate for 20 minutes at 37°C 
Imaging 
• Imaging was performed using a Nikon AZ100M “Macro Confocal” with a 5x objective and Z 
stack range of 500 µm. 
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Results and Discussion 
The purpose of this experiment was to assess the effect of LIPUS exposure on cell viability 
when varying peak intensity, with total energy held constant by adjusting the duty factor. 
LIVE/DEAD imaging visually demonstrated that the majority of cells were live (green) with dead 
cells evenly disbursed throughout the samples (red) (Figure B.2). The ability to image across the 
whole sample allows the identification of regional differences. In this experiment, there were no 
apparent regional differences in cell viability. These staining and imaging methods can be 
expanded in the future for use in immunostaining for extracellular matrix proteins or pro-
inflammatory factors and give insight into whether LIPUS induced effects vary with distance from 
the surface of the alginate bead. 
Figure B.2 Effect of LIPUS exposure on cell viability in alginate beads 
Cell viability assessed by LIVE/DEAD stain demonstrates no apparent reduction in cell viability 
with 7 days of growth factor or LIPUS treatment compared to nontreated controls. Green: live, 
Red: dead. Scale bars = 1 mm. 
Control BMP-7
LIPUS Low LIPUS High
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Appendix C: LIPUS upregulates sGAG but not Collagen Content in Annulus Fibrosus Cells 
Cultured in Hyaluronic Acid Beads 
Introduction 
LIPUS-induced cellular deformation and response are thought to be dependent on the 
mechanical properties of the surrounding medium [1]. Moreover, cells feel and respond to the 
stiffness of their substrate [2]. To investigate the effect of scaffold stiffness on LIPUS-induced 
extracellular matrix (ECM) synthesis in annulus fibrosus (AF) cells, we identified a hyaluronic 
acid (HyA) hydrogel with tunable stiffness and containing an Arg-Gly-Asp (AGD) amino acid 
sequence for cell adhesion [3]. The aims of this proof-of-concept study were: (1) to develop a 
method for forming HyA hydrogels with a bead geometry, and (2) evaluate changes in collagen 
and sulfated glycosaminoglycan (sGAG) content in AF cells cultured in HyA beads with LIPUS 
exposure. 
Methods 
Hydrogel Formation 
Bovine AF cells were encapsulated in HyA gels at a density of 4x106 cells/mL as described 
previously [3] with the following adaptations. AF-cells were suspended in the HyA macromer 
solution (acHyA and bsp-RGD/acHyA), then this HyA-cell solution was mixed with an MMP-
cleavable crosslinker [3]. Immediately following their mixture, the solution was dispensed 
dropwise through a 22-gauge needle onto a glass slide coated with a hydrophobic material (12-50, 
Tekdon, Inc., Myakka City, FL, USA) and then incubated for 45 minutes at 37°C  to allow gelation 
to occur. After gelation, standard disc media (Section 3.2.2.1) was added and exchanged every 
other day. 
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LIPUS Exposure 
HyA beads were divided into 3 groups and treated as described previously (Section 3.2.2.2) 
with the following adaptations. Each sample (9 HyA beads) was cultured for 10 total days and 
treated for 5 consecutive days starting on the 6th day of culture. 
Quantification of Collagen and sGAG Concentration 
After 10 days of culture, HyA beads were dissolved by adding 100 U/mL hyaluronidase 
(H3631-15KU, Sigma) and incubating on a rocker at 37°C for 6 hours. Supernatants were collected 
and assayed of total collagen, sGAG, and dsDNA content as described previously (Sections 3.2.2.3 
and 3.2.2.4). Collagen and sGAG concentrations were determined by normalizing total collagen 
and sGAG content by the dsDNA concentration of each sample. 
Statistical Analysis 
Statistical differences in collagen and sGAG concentrations were compared using one-way 
analysis of variance (ANOVA) among treatment groups, followed by Tukey HSD test for multiple 
comparisons. Data are depicted as mean ± standard deviation. P-values less than 0.05 were 
considered significant. 
Results and Discussion 
HyA beads were successfully formed by dispensing the HyA solution through a needle onto 
a slide with a hydrophobic coating (Figure C.1). These beads resemble the alginate beads used in 
previous studies (Chapter 3) in shape and size. 
 
Figure C.1 Hyaluronic acid beads after gelation on glass slide with hydrophobic coating 
Beads with high contact angles were formed by dispensing the HyA-cell solution onto coated 
microscope slides. 
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While neither BMP-7 nor LIPUS treatment affected collagen synthesis when cells were 
cultured in HyA beads, sGAG concentration was significantly greater than controls with both 
BMP-7 (2.3-fold) and LIPUS (3.8-fold) treatment, with LIPUS significantly outperforming BMP-
7 treatment (Figure C.2). The opposite matrix synthesis effect was observed in AF-cells cultured 
in alginate beads (Chapter 3), indicating that cellular scaffold material properties may be an 
important factor affecting cell response to LIPUS stimulus, suggesting that tissue properties may 
be important considerations in future in-vivo application. Future work will evaluate the effect of 
varying scaffold stiffness on AF-cell matrix synthesis response. 
 
Figure C.2 LIPUS-induced matrix synthesis in hyaluronic acid beads 
Collagen concentration was not affected by BMP-7 nor LIPUS treatment. Both BMP-7 and LIPUS 
treatment groups demonstrated significantly greater sGAG concentration compared to the control 
group, with LIPUS significantly outperforming BMP-7. * p < 0.05 
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Appendix D: Effects of LIPUS Pulse Repetition Frequency on Matrix Gene Expression in 
AF cells Cultured in Alginate Beads 
Introduction 
Preliminary experiments were performed to demonstrate the technical feasibility of 
evaluating the effects of in-vitro LIPUS exposure on gene expression using qPCR. Specifically, 
we aimed to explore the effects of LIPUS pulse repletion frequency (PRF) and number of 
treatments on extracellular matrix gene expression in AF cells cultured in alginate beads. A 
secondary aim was to determine whether cells were responsive to BMP-7 treatment by evaluating 
ID-1 gene expression [1], to validate its use as a positive control. 
Methods 
Cell Culture and Treatment  
Bovine AF cells were encapsulated in alginate beads at a density of 4x106 cells/mL and 
cultured in standard disc media, as described previously (Section 3.2.2.1), with daily media 
changes. Samples of up to 10 beads were divided into 12 treatment groups with 4 replicates each 
(n = 48) (Table D.1). Samples were cultured for up to 4 total days, including 1 day of pre-culture 
to allow cells to acclimate to alginate-bead culture. All groups were placed in the LIPUS 
exposimetry system for 20 minutes per day for 3 consecutive days. LIPUS was turned off for 
samples in the untreated control and BMP-7 treatment groups. 
Table D.1 Sample grouping in preliminary LIPUS PRF study 
Samples were divided into 12 treatment groups including LIPUS High, LIPUS Low, BMP-7, and 
Control repeated for 1, 2, or 3 treatments. 
 
Treatment PRF (Hz) Burst Count Peak Intensity (mW) 
LIPUS High 1000 300 600 
LIPUS Low 100 3000 600 
BMP-7 (200 ng/mL) -  -  - 
Control - - - 
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Gene Expression Analysis 
Twenty-four hours following the last treatment, alginate beads were dissolved in 55 mM 
sodium citrate, and cell pellets were isolated by centrifugation. AF cells were lysed using PicoPure 
RNA extraction buffer, according to manufacturer’s instructions, and stored at -80°C until all 
samples were collected. Total RNA was isolated and purified, cDNA was synthesized, and qPCR 
was performed as described previously (Section 4.2.4).  
Statistical Analysis 
Statistical differences in relative gene expression among treatment groups were compared 
using one-way analysis of variance (ANOVA), followed by Tukey HSD test for multiple 
comparisons. Data are depicted as mean ± standard deviation. P-values less than 0.05 were 
considered significant. 
Results and Discussion 
When cells were exposed to a LIPUS waveform at 100Hz PRF for 20 minutes a day for 3 
consecutive days, MMP1 – a gene which encodes proteases involved in the breakdown of 
extracellular matrix proteins including collagens type I and II – expression was significantly 
downregulated compared to nontreated controls (0.71-fold decrease)  and was significantly 
reduced compared to identical LIPUS exposure at 1000 Hz PRF. Additionally, we observed 
significant increases in COL1A1, COL2A1, TIMP1, and MMP1 expression with 3 LIPUS High 
treatments compared to the same amount of LIPUS low treatments. During this preliminary study, 
we found that the expression of various matrix-related genes was dependent on PRF, a LIPUS 
waveform parameter. Overall, we found that several matrix-related genes were regulated by 
LIPUS PRF including COL1A1, COL2A1, TIMP1, and MMP1.  
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Our results do not align with previous studies demonstrating that BMP-7 growth factor 
treatment stimulates matrix synthesis in intervertebral disc cells [2-4]. Moreover, BMP-7 did not 
upregulate ID1, which mediates many of the downstream effects of BMP signaling [1]. This 
suggests that BMP signaling is being inhibited. 
In this study, we confirmed the ability to use qPCR to evaluate changes in matrix gene 
expression in response to LIPUS exposure and found that PRF was a significant factor for 
modulating matrix gene expression. We also found that BMP-7 does not regulate matrix gene 
expression in AF cells cultured in alginate and does not upregulate ID1 signaling. 
Figure D.1 Relative gene expression for select genes relevant to matrix metabolism 
Relative gene expression was calculated as fold-change relative to control expression in samples 
cultured for 2 days. n = 4 per group. # p < 0.05  
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Appendix E: BMP-7 Upregulates Type I Collagen Gene Expression in Annulus Fibrosus 
Cells Cultured in Monolayer 
Introduction 
Preliminary experiments were performed to establish BMP-7 growth factor as a positive 
control for stimulating extracellular matrix (ECM) metabolism in annulus fibrosus (AF) cells. 
Although BMP-7 is known to stimulate ECM metabolism in intervertebral disc cells [1], this was 
not observed in previous studies of AF cells cultured in alginate beads (Appendix D). This could 
be related to insufficient diffusion of BMP-7-supplemented media into the alginate matrix [2]. The 
objective of this study was to evaluate whether BMP-7 upregulates matrix synthesis in AF cells 
cultured in monolayer and whether there is a dose-response relationship with ID1, a mediator of 
downstream effects of BMP signaling, and type I collagen. 
Methods 
Cell Culture and Treatment  
Bovine AF cells were seeded in monolayer at 2x105 cells/well in a 24-well cell culture plate. 
Samples were divided into groups including 1, 2, or 3 treatments with BMP-7 at 0, 50, 100, or 
200 ng/mL. All samples were cultured for 4 total days, including 1 day for acclimation before 
initial treatment, and treated for 1, 2, or 3 of those days. To determine whether BMP-7 has an 
effect with a short culture duration, two additional treatment groups included a single BMP-7 
treatment (200 ng/mL) and harvesting after one day.  
Gene Expression Analysis 
After 4 days of culture, samples were processed for qPCR, and gene expression was analyzed 
as described previously (Section 4.2.4), including the analysis of ID1 and type I collagen gene 
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expression. Relative expression was calculated as fold-change relative to the respective untreated 
control group for the groups cultured for 4 days and 1 day. 
Statistical Analysis 
Statistical differences in relative gene expression among treatment groups were compared 
using one-way analysis of variance (ANOVA), followed by Tukey HSD test for multiple 
comparisons. Data are depicted as mean ± standard deviation. P-values less than 0.05 were 
considered significant. 
Results and Discussion 
BMP-7 treatment upregulated ID1 expression in all groups compared to the untreated control 
(Figure E.1). Notably, this effect was demonstrated with the lowest dose: 1 treatment at 50 ng/mL. 
ID1 expression appeared to have a positive correlation with BMP-7 concentration, indicating a 
dose-response relationship. BMP-7 also upregulated type I collagen expression; however, with a 
weaker positive correlation. Again, 50 ng/mL BMP-7 appears to be sufficient for stimulating 
matrix metabolism, with a 2.9-fold increase in type 1 collagen expression compared to the control. 
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Figure E.1 BMP-7 stimulates ID1 and COL1 gene expression in AF cell monolayers  
All BMP-7 treatment conditions demonstrated significantly upregulated ID1 and type I collagen 
gene expression (p < 0.05) except where indicated (ns). 
Overall, these results indicate that AF cells cultured in monolayer are stimulated by BMP-7 
treatment to upregulate matrix anabolism. Results also demonstrate a dose-response relationship 
between BMP-7 and expression of ID1 and type I collagen, suggesting that there may be an optimal 
dose. Previous experiments have utilized a dose of 200 ng/mL BMP-7 (Chapter 3, Appendix C 
and D); however, these results also indicate that a lower dose (1 treatment at 50 ng/mL) may be 
sufficient for stimulating type I collagen gene expression. 
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Appendix F: Preliminary Study of LIPUS Effects on Annulus Fibrosus Cells Cultured in 
Inflammatory Media 
Introduction 
LIPUS has been shown to stimulate matrix metabolism in degenerative intervertebral disc 
(IVD) cells [1], and IL-1α  is known to induce an inflammatory response in IVD cells [2]. The 
objective of this study was to investigate the effects of LIPUS exposure on AF-cell gene expression 
in a simulated pro-inflammatory in-vitro environment. 
Methods 
Cell Culture and Treatment  
Bovine AF cells were seeded in monolayer at 5x105 cells/well in the center of two opposing 
corner wells of  6-well cell culture plates and cultured in standard disc media, as described 
previously (Section 3.2.2.1), with daily media changes. Samples were divided into 6 treatment 
groups to be treated 1, 3, or 5 times with 50 ng/mL BMP-7, 10 ng/mL IL-1a, or 20 min of LIPUS 
(with parameters described in Section 3.2.2.2) individually or in combination (Table F.1). IL-1α 
treatment occurred at least two hours before LIPUS exposure or BMP-7 to stimulate an 
inflammatory environment. All groups were placed in the LIPUS exposimetry system for 20 
minutes per day for 1, 3, or 5 consecutive days. LIPUS was turned off for samples in the untreated 
control, IL-1α, and  BMP-7 treatment groups. 
Table F.1 Parameters for BMP-7, Il-1α, and LIPUS treatment   
Samples were treated with the with BMP-7, Il-1α, or LIPUS individually or in combination. 
Description Treatment Parameters 
Control No Treatment 
BMP-7 50 ng/mL BMP-7 
IL-1α  10 ng/mL IL-1α 
IL-1α  + BMP-7 10 ng/mL IL-1α + 50 ng/mL BMP-7 
IL-1α  + LIPUS 10 ng/mL IL-1α + 20 min LIPUS 
LIPUS 20 min LIPUS 
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Gene Expression Analysis 
After 1, 3, or 5 days of culture, samples were processed for qPCR, and matrix and 
inflammatory gene expression was analyzed as described previously (Section 4.2.4). Relative 
expression was calculated as fold-change relative to the untreated control group on day 1. 
Statistical Analysis 
Statistical differences in relative gene expression among treatment groups were compared 
using one-way analysis of variance (ANOVA), followed by Tukey HSD test for multiple 
comparisons. Data are depicted as mean ± standard deviation. P-values less than 0.05 were 
considered significant. 
Results and Discussion 
Samples treated 1, 3, or 5 times with IL-1α demonstrated significantly increased MMP1, 
MMP13, and IL6 gene expression compared to the untreated control. IL-1α treatment had no effect 
on COL1 expression. One BMP-7 treatment significantly reduced expression of MMP1 and 
MMP13, but not IL6 in inflammatory cells. Three BMP-7 treatments reduced, but not significantly, 
MMP1 and MMP13 expression in inflammatory cells. Five BMP-7 treatments reduced, but not 
significantly, MMP1 and MMP13 expression while increasing, but not significantly, COL1 
expression in inflammatory cells. One LIPUS treatment reduced, but not significantly, MMP1, 
MMP13, and IL6 expression in inflammatory cells. Three LIPUS treatments did not affect MMP1, 
MMP13, or IL6 expression but demonstrated an insignificant increase in COL1 expression in 
inflammatory cells. Five LIPUS treatments reduced, but not significantly, MMP1, MMP13, and 
IL6 expression while increasing, but not significantly, COL1 expression in inflammatory cells. 
Overall, we demonstrate that IL-1α treatment consistently induces catabolic and pro-
inflammatory gene expression in AF cells, but does not significantly affect type I collagen gene 
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expression. LIPUS appears to have an anti-catabolic effect on inflammatory AF cells that is most 
prominent with one treatment. Although there were not significant differences with LIPUS 
treatment in normal or pro-inflammatory conditions, there were trends that are promising and 
motivate dose optimization. 
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Figure F.1 Relative gene expression for select genes relevant to matrix metabolism Relative 
gene expression was calculated as fold-change relative the control sample of the in 1-
treatment group. n = 3 per group. 
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Appendix G: Additional Contributions 
This appendix includes the abstract of a manuscript that did not directly relate to my dissertation 
for which I was a co-author and contributed intellectually. My specific contributions are described 
below. 
 
A Mouse Model of Delayed Rotator Cuff Repair Results in Persistent Muscle Atrophy and 
Fatty Infiltration 
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doi: 10.1177/0363546518793403 
 
Abstract 
Background: Rotator cuff (RC) tears are common tendon injuries seen in orthopaedic patients. 
Successful repair of large and massive RC tears remains a challenge due to our limited 
understanding of the pathophysiological features of this injury. Clinically relevant small animal 
models that can be used to study the pathophysiological response to repair are limited by the lack 
of chronic repair models.  
Purpose: To develop a highly clinically relevant mouse model of delayed RC repair.  
Study Design: Controlled laboratory study.  
Methods: Three-month-old C57BL/6J mice underwent unilateral supraspinatus (SS) and 
infraspinatus (IS) tendon tear with immediate, 2-week delayed, or 6-week delayed tendon repair. 
Animals with no repair or sham surgery served as controls. Gait analysis was conducted to measure 
shoulder function at 2 weeks and 6 weeks after surgery. Animals were sacrificed 6 weeks after the 
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last surgery. Shoulder joint, SS, and IS muscles were harvested and analyzed histologically. Ex 
vivo mechanical testing of intact and repaired SS and IS tendons was conducted. Reverse-
transcriptase polymerase chain reaction was performed on SS and IS muscles to quantify atrophy, 
fibrosis, and fatty infiltration–related gene expression.  
Results: Histological and tendon mechanical testing showed that torn tendons could be 
successfully repaired as late as 6 weeks after transection. However, significant atrophy and fatty 
infiltration of muscle, with impaired shoulder function, were persistent in the 6-week delayed 
repair group. Shoulder function correlated with the severity of RC muscle weight loss and fatty 
infiltration.  
Conclusion: We successfully developed a clinically relevant mouse model of delayed RC repair. 
Six-week delayed RC repair resulted in persistent muscle atrophy and fatty infiltration with inferior 
shoulder function compared with acute repair.  
Clinical Relevance: Our novel mouse model could serve as a powerful tool to understand the 
pathophysiological and cellular/ molecular mechanisms of RC muscle and tendon degeneration, 
eventually improving our strategies for treating and repairing RC tears. 
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